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Abstract
Infectious pancreatic necrosis virus (IPNV) is responsible for serious mortalities in post- 
smolt Atlantic salmon (Salmo salar) annually in both Scotland and Norway. The huge 
financial losses involved and the lack of control measures have prompted attempts to 
produce IPN vaccines and disease resistant strains of fish. A characteristic of IPNV is 
its ability to persist in a latent carrier state and to ensure stocks of fish are truly virus 
free there is a need for highly sensitive diagnostic methods.
In this study microsatellites were employed to assign fish susceptible to IPN in the field 
to families. Laboratory challenges were performed on 24 families and various humoral 
immune parameters were measured. A variety of diagnostic techniques were also 
developed, their sensitivity and specificity evaluated and compared to tissue culture.
Parental Atlantic salmon and offspring susceptible to IPN in the field were genotyped 
using a published multiplex microsatellite PCR adapted for use with fluorescent 
genotyping systems. The reliability and utility of the genotyping system was evaluated 
with positive results. The majority of susceptible fish could not be assigned to parents 
since the fish were found to be from a mixed stock.
Various experimental challenges with IPNV infected tissue homogenate were 
performed on post-smolts, however they did not produce mortality or induce clinical 
IPN. As a result of this virus titre was used as an indirect measurement of disease 
resistance. Atlantic salmon post-smolts were found to effectively clear cell cultured 
IPNV, isolate Br from Shetland. A second Shetland isolate (Os) was found to actively 
replicate in the fish while isolate Br was rapidly cleared. To increase virulence isolate
Os was passaged once further through fish prior to use in challenging 24 families of PIT
0 8tagged Atlantic salmon. At week 3 mean viral titres for each family ranged from 10 
to 1011 TCID5o/g kidney. Using these data six families were targeted to follow through 
to week 7, two with low titres, two with medium titres and two with high titres of IPNV.
0 8 15At week 7 virus titres had decreased to between 10 ' and 1 0 ' '  TCIDso/g kidney, many 
of the fish in the families with low IPNV titres at week 3 had cleared the virus. 
Lysozyme and neutralising antibody responses were measured, however little or no 
correlation was found between either parameter and IPNV titre at weeks 3 or 7. The 
control fish were found to be positive for IPNV despite earlier negative testing. 
Reasons for this were unclear, the fish may have been exposed to the virus through the 
seawater inflow or alternatively the fish may have been carriers of the virus.
Diagnostic techniques employed to detect IPNV were RT-PCR, ELISA and 
immunohistochemistry; cell culture was used as a comparison to the RT-PCR and 
ELISA. The RT-PCR was developed using two published IPNV primer sets both of 
which amplified regions on VP2, they were found to be specific to IPNV and together 
amplified 9 out of 10 serotypes of IPNV. The most sensitive primer set detected 
between 107 and 108 TCID50 IPNV/ml in spiked tissue, in comparison to the ELISA 
which detected 1012'5 TCID50 IPNV/ml in tissue homogenate. The AS-1 monoclonal 
antibody was used successfully in immunohistochemistry to identify IPNV in fixed 
tissue. The antibody was found to identify IPNV in pancreatic lesions from infected 
fish, but did not detect the virus in the gut. All of these methods were found to be less 
sensitive than cell culture, however they are very rapid and ELISA and RT-PCR may be 
used to confirm IPNV infection once CPE has been visualised in cell culture.
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1. General Introduction
1.1. Introduction
In an intensive culture system such as the farming of Atlantic salmon (Salmo salar) fish 
are heavily stocked and fed artificial diets that enable the farmer to yield far higher 
productivity than at natural levels. Fish maintained in such systems are under many 
pressures; for example, crowding, handling, confinement and fluctuating water 
conditions. These conditions can be particularly stressful and may mean the fish are 
more vulnerable to the threat of disease. Fish susceptibility to disease depends on age, 
genetic strain differences, non-specific immune capabilities and immunocompetence 
when in the presence of a pathogen (Shepherd, 1992).
There are many pathogens that threaten the health of farmed fish. In the case of 
bacterial diseases antibiotics can be used to treat outbreaks, and indeed with many 
bacterial pathogens vaccines have been developed. Another alternative after a disease 
outbreak is to cull all remaining fish, disinfect the holding facilities and re-stock with 
disease free fish, however this method is not always practical. Viral diseases can be 
particularly problematic due to a lack of adequate control measures. There are no 
effective drug treatments for viral infections and for many fish viruses vaccination has 
not yet been possible. Infectious pancreatic necrosis virus (IPNV) is the causal agent of 
infectious pancreatic necrosis (IPN), an economically important disease of salmonid 
fish (Wolf, 1988). Although vaccination against IPNV may eventually be a possibility 
there are currently no control measures available. One possibility to reduce the impact 
of IPNV is to improve resistance to the virus by selection.
l Chapter I
1.2. Infectious Pancreatic Necrosis
1.2.1. History
IPN was initially recognised as a problem in brook trout (Salvelinus fontinalis) farming 
in North America in the early part of this century and was originally termed acute 
catarrhal enteritis (M ’Gonigle, 1940). The causal agent was then unknown. The 
disease was initially thought to be caused by a physiological problem at first feeding 
and the choice of food considered to be to blame. The pathology of the disease was first 
described by Davis in 1953, but it was not until 1955 that Wood, Snieszko and Yasutake 
noted that a disease with the same features as enteritis was highly contagious and upon 
histopathological examination termed the disease infectious pancreatic necrosis. The 
causative agent was isolated in 1957 from ground fish tissue; it was not until 1960 that 
the viral etiology was established (Wolf, Snieszko, Dunbar and Pyle, 1960, Wolf, 
Dunbar and Snieszko, 1960). Since the isolation of IPNV in the USA and Canada it has 
been shown to have a wide geographical distribution (Hudson, Bucke and Forrest,
1981). The first isolation in Europe was in France in 1965 (Besse and de Kinkelin, 
1965), very shortly afterwards the virus was found in Denmark (Vestergard Jorgensen 
and Bregnballe, 1969), Sweden (Ljunberg and Vestergard Jorgensen, 1973), Italy 
(Ghittino, 1972), and Japan (Sano, 1971). IPNV was first isolated in the UK in rainbow 
trout fry (Oncorhynchus mykiss) in Scotland (Ball, Munro, Ellis, Elson, Hodgkiss and 
McFarlane, 1971). Much later IPNV was isolated in Chile (McAllister and Reyes, 
1984).
Clinical IPN had traditionally been observed in brook trout and rainbow trout less than 
six months of age (Christie, 1997). IPNV was first isolated from Atlantic salmon fry in 
Canada (MacKelvie and Artsob, 1969), since this time the incidence of IPNV in
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Atlantic salmon has increased, particularly in Scottish fry between 1979 and 1981 
(Smail and Munro, 1985). Atlantic salmon post-smolts infected with IPNV was first 
reported in Scotland (Smail and Munro, 1985). Since this time the occurrence of IPN in 
Atlantic salmon farming has increased and is now a problem for post-smolts in their 
first year in seawater both in Scotland and Norway. In Norway the incidence of clinical 
IPN in Atlantic salmon farms was 39% in 1991 and had increased to 61% in 1995 
(Christie, 1997). IPN is thought to cost Norwegian fish farmers approximately £40 
million per year, this includes mortalities (worth about £16 million) and also reduced 
growth in surviving fish (Cripps, 1999).
1.2.2. The virus
IPNV is classified as a birnavirus and is a medium sized, unenveloped bi-segmented 
double stranded (ds) RNA containing virus (Dobos, 1995). Examination by electron 
microscopy of purified virus revealed single shelled icosahedrons having a diameter of 
60 nm (Dobos, Hallett, Kells, Sorenson and Rowe, 1977). The viral capsid consists of 
three proteins, VP1, VP2 and VP3 (Dorson, 1988). VP1 is an internal protein that 
surrounds both segments of dsRNA, VPg is the genome linked form of VP1 (Bernard 
and Bremont, 1995). VP2 is the major outer capsid protein and makes up 62% of the 
virion protein (Dobos et al., 1977). VP3 consists of two molecules of very similar 
molecular weight, the smaller one (VP3a or VP4) is thought to be the cleavage product 
of the other (Dobos and Rowe, 1977). VP3 was considered to be an internal protein 
(Dobos et a i,  1977), however recent work has shown that purified virus reacts with 
anti-VP3, therefore part of this protein may be expressed on the virion surface 
(Nicholson, 1993, Park and Jeong, 1996). Genome segment A (the larger RNA
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segment) encodes for a polyprotein which generates the major capsid proteins VP2 and 
VP3, genome segment B encodes for VP1 (Dobos, 1995).
VP3
ds RNA ■VP2
VPg
VP1
M------------------------- ►
60nm
Figure 1.1: IPNV virion (Dobos, 1995)
Sano, Okamoto, Fukuda, Saneyoshi and Sano (1992) concluded that RNA segment A 
was responsible for the fatal disease in rainbow trout fry. Genetic virulence was 
determined by reasserting segments A and B between IPNV-Buhl strain and eel virus 
European (EVE). EVE was avirulent to rainbow trout prior to reassortment with 
segment A from IPNV-Buhl, with the replacement EVE became virulent to rainbow 
trout fry.
IPNV replicates in a variety of teleost fish cell lines. Malsberger and Cerini (1963) 
showed that the virus replicates in the cytoplasm and a single cycle of replication takes 
16-20 hours at 22°C resulting in characteristic cytopathic effect (CPE). Binding 
experiments have shown that it takes 2-3 hours at 4°C for the virus to saturate all
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binding sites, and that VP2 is the cell attachment protein of the virion (Marshall and 
Dobos, unpublished, cited in Dobos, 1995).
Studies have shown IPNV serotype variation between broad geographical areas (Melby, 
Caswell-Reno and Falk, 1994). The different serotypes have been grouped into two 
groups based on their cross reactivity, European serotypes such as Sp, Ab, He and Te, 
the West Buxton serotype (VR299) from the USA and Canadian serotypes Ja, C l, C2, 
and C3 make up serogroup A (Hill and Way, 1995). While serogroup B consists of 
only one serotype to date, TV-1. From the European serotypes Ab has been shown to 
display a low virulence while Sp is often highly virulent (Wolf, 1988). There has been 
a suggestion that IPNV isolates from Shetland may be a new serotype based on the fact 
that IPNV in Shetland appears to be very virulent (Ross and Munro, 1995). However 
this was proven unlikely to be the case. Pryde, Melvin and Munro (1993) found that 
upon sequencing the VP2 protein of Sp. (A2) and the Shetland isolate they differed by 
less than 3%, indicating that the Shetland isolate is in fact A2.
1.2.3. Disease signs
Clinical signs of IPN disease include darkened pigmentation, a pronounced distended 
abdomen and a corkscrewing and spiralling swimming motion in severely moribund 
fish (Hill, 1982). Exopthalmia is another common sign along with pale gills and long 
white faecal casts (Wolf, 1988). Internal signs include a build up of ascitic fluid in the 
body cavity, the stomach and anterior intestine contain a pathognomonic clear to milky 
cohesive mucus (Wolf, 1988). The infection produces pancreatic necrosis, with the 
lesions characterised by extensive degeneration of acinar cells and marked infiltration of 
mononuclear cells (Swanson and Gillespie, 1979). Zymogen granules may be released
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and fatty tissue may also show signs of necrosis (W olf 1988, Smail, Bruno, Dear, 
McFarlane and Ross, 1992). Swanson and Gillespie (1979) and Taksdal, Strangeland 
and Danniveg (1997) showed degeneration of liver parenchymal cells, characterised by 
pyknosis and karyolysis of hepatocytes. Smail, McFarlane, Bruno and McVicar (1995) 
found a marked feature of pathology in Atlantic salmon was prominent gut enteritis 
with sloughing of the mucosa to form a catarrhal exudate. This was thought to disturb 
digestive function by leading to malabsorption of the gut contents and an interruption of 
the normal passage of food through the gut. They concluded that the effects on gut 
physiology caused by IPNV might be more acute than the effects of pancreatic necrosis.
1.2.4. Transmission
Various studies have suggested that IPNV may be transmitted vertically. Evidence for 
vertical transmission has been demonstrated by Bullock, Rucker, Amend, Wolf and 
Stuckey (1976) who showed that brook trout fry suffered IPN mortalities despite 
disinfection of eggs from infected brood stock with iodine. Dorson and Torchy (1985) 
obtained transmission via infected sperm, suggesting that IPN is adsorbed to the 
spermatozoa and carried inside the egg. It was thought unlikely that an infected embryo 
would survive and develop; however the virus may persist in the chorion or in the 
perivitelline space. Ahne and Negele, (1985) concluded that hardened egg shells can 
take up IPNV from the water because of their lobed and porous nature, the pores were 
thought to provide anchorage for the virus possibly protecting it from treatment and 
water flow. It is known that IPNV is shed with faeces and reproductive fluids (Frantsi 
and Savan, 1971) and it is possible that this may contaminate surrounding areas and 
organisms leading to horizontal transmission.
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1.2.5. Carrier status
A particular feature of IPNV infection is that many fish become virus carriers for long 
periods, possibly for life, indicating the chronic and persistent nature of the infection 
(Smail and Munro, 1985). IPNV carriers are asymptomatic but persistently infected 
fish and may carry the virus in many organs (Bootland, Dobos and Stevenson, 1991). 
MacDonald and Yamamoto (1977) demonstrated that IPNV exhibited an interference 
phenomenon that resulted in the survival of infected cell cultures, the responsible factor 
was found to co-purify with infectious virus suggesting the involvement of a defective 
interfering virus particle. It is thought that defective interfering particles (DI) are the 
result of mistakes during viral replication, DI are dependent on infectious virus to 
replicate but also interfere with the replication of infectious virus. Isolation in cell 
culture is likely to be affected by defective interfering particles and carrier status may be 
related to their presence (MacDonald and Yamamoto, 1977).
Although it has been shown that carrier fish do mount a humoral immune response they 
still periodically shed infectious virus in their faeces and reproductive fluids (Hill,
1982). This periodical shedding indicates that carrier parents may pass the virus onto 
their progeny. In 1992 Munro and Smail published the results of a ten year (1982-1991) 
monitoring programme for IPNV in both freshwater and seawater Atlantic salmon farm 
sites in Scotland. The annual sampling of broodstock reproductive fluids appeared to 
have reduced the presence of the virus in freshwater, however the incidence of IPNV in 
saltwater had increased. It was thought possible that if the virus was present in fish in 
freshwater and escaping detection there may be a mechanism as yet not described for an 
RNA virus to survive at levels below existing detection methods up to the smolt stage. 
IPNV has been commonly isolated from the kidney and use of this organ has been
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known to detect carrier status, suggesting that leucocytes may harbour the virus (Knott 
and Munro, 1986, Johansen and Sommer, 1995). Johansen and Sommer (1995) 
concluded that non-cytolytic infected cells may protect the virus from the hosts’ 
immune response leading to a carrier condition.
1.2.6. Diagnosis
The standard method for the detection of aquatic birnaviruses requires inoculation of 
fish cell cultures with homogenates of fish tissue (Amos, 1985). Once cytopathic effect 
(CPE) has been detected the virus must be further identified by titration neutralisation. 
These methods are time consuming and relatively slow. A sensitive, rapid diagnostic 
method is needed to detect IPNV (Dixon and Hill, 1983, Davis, Laidler, Perry, 
Rossington, Alcock, 1994, Lopez-Lastra, Gonzalez, Jashes, Sandino, 1994), as there is a 
lack of adequate disease control measures. There are various methods that can be used 
to detect and identify IPNV, such as ELISA (Dixon and Hill, 1983), immuno dot blot 
(Babin, Hernandez, Sanchez, Dominquez, 1991), cDNA probes (Dopazo, Hetrick, 
Samal, 1994), in-situ hybridisation and immunohistochemistry (Biering and Bergh, 
1996). However, many are not as sensitive as cell culture, indeed ELISA although rapid 
only detects IPNV in clinical cases (Rodak, Pospisil, Tomanek, Vesely, Obr, Valicek, 
1988). More recently research has turned to developing an RT-PCR (reverse 
transcription-polymerase chain reaction) to detect IPNV (Lopez-Lastra et cil. 1994, 
Suzuki, Hosono, Kusuda, 1997, Wang, Wi, Lee, 1997). This method has proven to be 
very sensitive using purified virus, (Wang et al., 1997) however its sensitivity using 
organ homogenates is not known.
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1.2.7. Viral hosts
Although IPN is often thought of as a salmonid disease, many other species of fish have 
also been found to harbour IPNV, including eels {Anguilla anguilla) (Hudson, Bucke 
and Forrest, 1981), goldfish {Carassius auratus L.) and discus fish (Symphysodon 
discus) (Adair and Ferguson, 1981). The virus has also been isolated from marine 
shellfish, for example the flat oyster {Ostrea edulis), the edible mussel {Mytilus edulis), 
and the common periwinkle {Littorina littored) (Hill and Way, 1995). It is possible 
however that the virus may not be infecting such hosts but merely contaminating the 
host tissue as a result of ingestion (Hill, 1982). Turbot {Scophthalmus maximus) and 
Atlantic halibut {Hippoglossus hippoglossus) are both susceptible to IPNV, and in these 
hosts the virus is pathogenic, causing both pathology and mortality (Mortensen, 
Evensen, Rodseth, Hjeltnes, 1993, Biering, Nilsen, Rodseth, Glette, 1994).
1.2.8. Post-smolt risk factors
IPN is often considered a disease of fry and fingerling salmonids, but increasingly 
smolts and post-smolts have been affected (Smail et al. 1992, Jarp, Gjerre, Olsen and 
Bruheim, 1994, Jarp, Taksdal and Torund, 1996). Smail et a l (1992) suggested that 
IPNV might be transmitted to new smolts by a marine vector. However Jarp et al. 
(1994) carried out an epidemiological survey of IPN in post smolts in Norway and 
noted that if smolts from more than two freshwater hatcheries were mixed at the 
seawater site the risk of IPN increased by 2.9 compared to farms purchasing from one or 
two hatcheries. Additionally the risk of IPN was related to the location of the site and 
the age, newer farm sites were shown to have a higher incidence of IPN than older farm 
sites. This does not support the theory of a marine vector. Jarp et al. (1996) suggested
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that it is likely the infection is carried with the smolt to the sea site. Smail et al. (1995) 
examined failed smolt syndrome in relation to IPNV mortalities in the Shetland Isles 
and fish with high IPNV titres were found to have a poorer condition factor. However 
the causal mechanisms triggering outbreaks of IPN after transfer to seawater are not 
known. It is likely that disease is precipitated by a combination of environmental and 
behavioural factors, especially strong competition for food, acting in competition with 
viral infection (Smail et al., 1995). Stressors such as handling and transport may lead to 
an increased susceptibility to disease and increased mortality during the first months of 
the seawater stage (Jarp et al., 1994). This is in agreement with Roberts and McKnight 
(1976) who showed that stress could induce a recurrence of IPN in latent carrier 
rainbow trout.
1.2.9. Control
Control methods for IPN have proven to have only a slight effect on resistance of fish to 
IPN. Chemotherapy with substances such as polyvinylpyrrolidone-iodine (Economon, 
1973) and virazole (Savan and Dobos, 1980) have been tried and found to be costly and 
relatively ineffective. Avoidance is the most cost effective control measure for IPN, 
although it is rarely possible.
There have been attempts to produce an IPN vaccine, however this has been 
problematic and production costs are high. A peptide vaccine has been produced 
against EPNV (Christie, 1997) but is not commercially available. An inactivated IPNV 
vaccine is available for use in Norway (Pettersen, 1997) however problems can arise 
such as inactivated virus leading to a carrier state (Bootland et al., 1991, Christie, 1997). 
A sub-unit vaccine is also available in Norway using recombinant VP2 added to the
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triple vaccine for furunculosis, vibriosis and cold water vibriosis (Frost and Ness, 1997). 
Although all these vaccines produce a good antibody response in fish experimental 
challenge to examine their efficacy has not proven possible, since experimental 
challenges with IPNV do not produce pathology or mortality (Sadasiv, 1995). Coho 
salmon (Oncorhynchus kisutch) are considered to be refractory to IPN (Chevassus and 
Dorson, 1990) and recently there have been attempts to produce IPN resistant strains of 
fish.
1.3. Genetic Markers
1.3.1. Importance of genetic markers
To manage a biological resource effectively researchers must identify the level of 
genetic variation within and between populations (O’Connell and Wright, 1997). 
Genetic variation is the basic resource of any successful commercial or rehabilitation 
culture programme (Allendorf and Ryman, 1987). More sophisticated selection 
approaches require knowledge of the pedigree of the selected population (Herbinger, 
Doyle, Pitman, Paquet, Mesa, Morris, Wright and Cook, 1995), however individual 
tagging of fish at the fry stage is not easily achieved in aquaculture (Harris, Bieger, 
Doyle and Wright, 1991). In breeding programmes families must be reared for long 
periods in separate cages, tanks or ponds until they can be physically tagged at the 
family or individual level (Doyle and Herbinger, 1994). For this reason a DNA 
profiling approach would permit the design of increased selection regimes with a 
minimal loss of genetic variability on farms without specialised facilities (O’Connell 
and Wright, 1997).
11 Chapter I
1.3.2. History of genetic markers
Initially studies on molecular phenotypes used blood group polymorphisms to 
discriminate between populations of fish (Sick, 1961), however interpretation was 
difficult and research turned to histochemical staining for specific proteins. In the 
1960’s studies involved proteins such as haemoglobin and transferrin (Ferguson, 1994). 
Later histochemical staining was used in conjunction with starch gel electrophoresis and 
permitted the detection of allozyme variation (Harris and Hopkinson, 1976). This 
provided the first readily applicable simple genetic markers for large-scale studies on 
natural populations (Ferguson, Taggart, Prodohl, McMeel, Thompson, Stone, 
McGinnity and Hynes, 1995). One of the main limitations of protein variants as genetic 
markers is the low level of polymorphisms in some species and populations (Ferguson 
et al. 1995). The need for a set of unique alleles that have been fixed in a stock specific 
manner prompted the search for other types of genetic markers (Davidson, Birt and 
Green, 1989).
Mitochondrial DNA (mtDNA) became popular for genetic studies because of its small 
size and its rapid accumulation of mutations (Davidson et al. 1989). MtDNA has a 
maternal mode of inheritance and exhibits a lack of recombination, which offered 
advantages for population studies (Ferguson et al. 1995). A significant disadvantage is 
that mtDNA is usually treated as a single character and does not always permit the 
examination of independent loci as allozyme studies do (Ward and Grewe, 1995). 
Work then focused on using restriction fragment length polymorphism (RFLP) analysis 
(Lansman, Shade, Shapira and Avise, 1981). RFLP analysis assesses variation 
occurring within a species in the length of DNA fragments generated by a specific 
restriction enzyme (Park and Moran, 1995). Most RFLP’s are not particularly
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informative since there are only two alternatives, the individual either has the restriction 
site or they don’t (Wills, 1992). Whilst RFLP’s can be very useful for population 
analysis (Pogson, Mesa and Boutilier, 1995) they have largely been replaced by a new 
marker system variable number tandem repeats (VNTR).
Research is now focused on VNTR loci examining both mini and microsatellites. In 
1985 Jeffreys Wilson and Thein reported the development of multilocus DNA 
fingerprinting by Southern blot detection of hypervariable minisatellites loci. Initially 
research concentrated on multilocus DNA fingerprinting, length variation is surveyed at 
many VNTR simultaneously (O’Reilly and Wright, 1995). Multilocus DNA 
fingerprinting gave complex results and often both members of allelic pairs at 
individual loci could not be identified (O’Reilly and Wright, 1995). This prompted the 
move to single locus VNTR markers where allelic variation is surveyed at individual 
VNTR loci. Taggart and Ferguson (1990) were the first to use minisatellites in single 
locus DNA fingerprinting. Minisatellites give a high level of resolution and have been 
useful in selection programmes where identification of parentage is required (O’Connell 
and Wright, 1997). However minisatellites do have disadvantages. Mutation 
mechanisms at minisatellites are very complex, involving intra-allelic duplication or 
deletion and also inter-allelic recombination and gene conversion (O’Reilly and Wright,
1995). This leads to alleles that may not differ in size by a discrete unit length and this 
can make accurate scoring of alleles very difficult (O’Connell and Wright, 1997). More 
recently research has turned to microsatellites where DNA analysis can be performed 
from tissue such as fins and therefore does not necessitate the sacrifice of organisms as 
allozyme studies do (Wenburg, Olsen, Bentzen, 1996).
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1.3.3. Microsatellites
Dispersed throughout the genome of most eukaryotic organisms are tandemly repeated 
blocks of DNA of identical or similar sequence (O’Reilly and Wright, 1995). 
Repetitive DNA is usually classified into two categories: 1) satellite DNA which is 
composed of large numbers of tandemly repeated sequences and can therefore be 
isolated from the bulk DNA by centrifugation in a caesium chloride gradient, and 2) 
interspersed repeated DNA (Estoup, Presa, Vaiman and Guyomard, 1993). Mini and 
microsatellites belong to the second category. Minisatellites discovered by Bell, Selby 
and Rutter in 1982 are tandem repeat units of 10-64 bp, with lengths ranging from 0.1-7 
kb (Jeffreys et al., 1985). Microsatellite DNA, discovered accidentally, consists of 
repeating units of 1-5 bp (Jarne and Lagoda, 1996), and are also termed short tandem 
repeat (STR) DNA (Edwards, Cintello, Hammond and Caskey, 1991). Microsatellites 
can be tens to hundreds of base pairs of DNA in length (Park and Moran, 1994), and can 
be composed of different types of repeats, e.g. a GT repeat adjacent to or interposed 
with GA repeats (Wright and Bentzen, 1994). Microsatellites can be di, tri or tetra 
nucleotide repeating blocks flanked by regions of non-repetitive DNA (Tautz, 1989). 
They may be classified into 3 families: pure, compound and interrupted repeats (Jarne 
and Lagoda, 1996). For example:
Pure CACACACACACACACACACA
Compound CACACACACAGAGAGAGAGA 
Interrupted CACATTCACACATTCATTCATT
Microsatellites are highly abundant in eukaryotic genomes; arrays of (GT)n repeats 
were estimated to occur on average every 7kb in Atlantic cod (Gadus morhua)
14 Chapter I
(Brooker, Cook, Bentzen, Wright and Doyle, 1994) and 24-35 kb in Atlantic salmon 
(McConnell, O’Reilly, Hamilton, Wright and Bentzen, 1995b). This figure was re­
evaluated with unpublished data and reported in O ’Reilly and Wright (1995) as 11-56 
kb (Wright pers. comm.).
Tautz (1989) first demonstrated polymorphism at microsatellite loci, since then it has 
been found that a high proportion of microsatellite loci surveyed in fish are polymorphic 
(O’Reilly and Wright 1995). For example of 7 loci surveyed in Atlantic cod by Brooker 
et al. (1994), 6 of these were polymorphic. In Atlantic salmon 4 loci were surveyed by 
McConnell, Hamilton, Morris, Cook, Paquet, Bentzen and Wright (1995a) and all were 
found to be polymorphic. Expected heterozygosities are well above 50% in general, 
although compound and interrupted loci tend to be less polymorphic (Jarne and Lagoda, 
1996). The informativeness of microsatellite markers increases with increasing 
numbers of repeats (Weber, 1990). Brooker et al. (1994) compared microsatellites in 
cod to those of mammals, it appears that microsatellites in teleost fishes differ 
significantly in length and composition from those of mammals. Microsatellite arrays 
seem to be highly susceptible to length mutation (Wright and Bentzen 1994). The 
mutational process thought to account for length changes is slipped strand mis-pairing 
or slippage during DNA replication (Wright 1993). This increases or decreases the 
current number of repeats by one unit (Jarne and Lagoda, 1996), resulting in high levels 
of heterozygosity within microsatellites.
1.3.4. Applications of microsatellites
The use of microsatellites can be applied to many molecular genetic studies. The high 
information content of microsatellite loci relative to more standard genetic markers
15 Chapter I
suggests great utility to a variety of fisheries and management issues (Scribner, Gust 
and Fields, 1996). Microsatellites are ideal genetic markers because they are abundant, 
show varying degrees of allelic variation and can be rapidly assayed by PCR from 
minute amounts of tissue (McConnell at al. 1995b).
The vast majority of fish species and strains reared globally are relatively unimproved 
for commercially important traits such as growth rates and disease resistance 
(O’Connell and Wright, 1997). Most traits of commercial importance are polygenic 
(controlled by more than one locus) and are referred to as quantitative trait loci (QTL) 
(O’Connell and Wright, 1997), to map QTLs a linkage map is required. The properties 
of microsatellites make these sequences very useful as markers for genetic mapping and 
identity control (Slettan, Olsaker and Lie, 1993). The implications for aquaculture are 
such that microsatellite loci may assist in selective breeding and show proof of breeding 
levels or strain superiority (Lie, Slettan, Grimholt, Lundin, Syed and Olsaker, 1994).
DNA fingerprinting has proven to be a powerful tool for identifying individuals and the 
pedigree of communally reared fish (Harris et al. 1991). The highly variable nature of 
microsatellites makes these markers particularly suited to investigation of kinship 
relationships and paternity analysis (O’Connell and Wright, 1997). Herbinger et al. 
(1995) established pedigrees in mixed aquaculture populations of rainbow trout based 
on genetic profiling data from microsatellite markers. Parentage was established using 
four or five microsatellite markers, and 91 % of the fish could be traced back to one or 
two parental couples. Doyle and Herbinger (1994) developed within family selection 
procedures using microsatellite markers, it was designed to increase selection intensities 
while minimising levels of inbreeding. McConnell et al. (1995b) demonstrated the
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utility of microsatellites in population genetics, and were able to discriminate clearly 
between Canadian and European Atlantic salmon stocks based on unique alleles at two 
loci. Tessier, Bernatchez, Presa and Angers, (1995) analysed genetic diversity in 
landlocked Atlantic salmon in Lake Saint-Jean, Quebec, using allozymes, mtDNA and 
microsatellites. MtDNA proved to be the most discriminating marker between wild 
populations, but showed little diversity. Microsatellites were most useful in detecting 
variation between populations and changes in allelic composition between wild and 
hatchery stocks.
McConnell et al. (1995b) demonstrated that the primers developed for three 
microsatellites in Atlantic salmon also amplified presumably homologous microsatellite 
loci in a wide range of salmonine species. Estoup et al. (1993) noted that primers 
developed for microsatellite loci in brown trout could also amplify loci in rainbow trout. 
The reason for this is that particular microsatellite loci and their flanking regions are 
conserved in related species (Olsen, Wenburg and Bentzen, 1996).
An advantage of the use of microsatellites is the use of semi-automated systems to 
genotype large numbers of individuals, for example using Perkin-Elmer ABI gene 
sequencers. This also allows for multiplexing allele fragments from more than one 
locus from an individual in one lane of an electrophoresis gel (Olsen et al. 1996). To 
increase efficiency further it is possible to co-amplify several microsatellite loci by PCR 
in a single tube (O’Reilly, Hamilton, McConnell, Wright, 1996). Not only does this 
mean the use of in lane size standards and therefore possibly increased accurate 
detection of alleles but it also allows for increased throughput of samples and savings in
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consumables (Ziegle, Su, Corcoran, Nie, Mayrand, Hoff, McBride Kronick, Diehl, 
1992).
1.4. Genetics of disease resistance
Selection for improved disease resistance in applied breeding programmes may reduce 
mortality rates in commercial fish farming, the basis for this selection is genetic 
variation in disease resistance (Lund, Gjedrem, Bentsen, Eide, Larsen, Roed, 1995b). In 
most studies QTLs with large additive effects have been found (Falconer and Mackay, 
1996), additive genetic variance results from the average effect of substituting one allele 
of a single locus for an alternate form (Parsons, 1998). Additive genetic effects are 
transmitted directly from parent to offspring. Selection will also affect non-additive 
gene effects, non-additive gene effects may be caused by interactions between alleles 
within a locus (dominance) or between alleles in different loci (epistatic interactions) 
(Bentsen, 1994). Dominance and epistatic effects are not predictably passed from 
parent to offspring because they are the result of specific allele combinations, these are 
broken up by recombination and may not be reformed in the progeny (Parsons, 1998). 
Selection is generally for traits that are affected by additive gene effects, such as disease 
resistance because these are more accurate predictors.
The relative importance of heredity in determining phenotypic values is called the 
heritability of a character; the most important function of heritability is its predictive 
role. It estimates the amount of genetic control of a characteristic, heritability is based 
on additive effects hence it also indicates the likelihood that traits can be passed onto 
the next generation and may predict the performance of successive generations
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(Parsons, 1998). Heritability (h2) is defined as the ratio of additive genetic variance 
(VA) to phenotypic variance (Vp):
h2 = VA/Vp
(Falconer and Mackay, 1996)
The genetic control of resistance to disease is highly complex and involves the 
interactions of many systems of the body; one of the most important is the immune 
system (Roed, Fjalestad and Stromsheim, 1993). Selection for disease resistance may 
be carried out using direct selection by recording survival or indirectly using correlated 
traits, such as immune parameters (Fjalestad, Gjedrem and Gjerde, 1993). This requires 
challenging fish with a disease agent in closed facilities, often these are performed on 
small fish over a short period of time (Fjalestad et a l 1993). To be useful as an indirect 
selection parameter a marker should show genetic variation and be genetically 
correlated to disease resistance (Lund et a l 1995b). Indirect selection for survival 
based on a correlated trait with no economic value results in a much lower response in 
survival compared with direct selection; the genetic correlation between survival and 
the correlated trait must be large if indirect selection is to compete with direct selection 
(Fjalestad et a l 1993). If genetic correlation between the traits is high the response will 
increase considerably. Examining underlying resistance markers such as lysozyme and 
complement allows the identification of factors responsible for differential survival 
(Marsden, Freeman, Cox and Secombes, 1996). While there have been a few studies on 
improving disease resistance in Atlantic salmon to furunculosis (Gjedrem, Salte, Gjoen, 
1991, Lund, Chiayvareesajja, Larsen, and Roed, 1995a, Lund et a l 1995b, Marsden et 
a l  1996) little research has been carried out on improving disease resistance to IPN 
using immune markers.
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1.5. Humoral Immune Mechanisms involved in Disease Resistance
1.5.1. Lysozyme
There are various immune parameters that may possibly be used as markers for disease 
resistance, one of which is lysozyme. Lysozyme has been detected in the serum, mucus 
and other tissues of many fish (Fletcher and White, 1973, Murray and Fletcher, 1976, 
Siwicki and Studnicka, 1987, Mock and Peters, 1990). It occurs mainly in neutrophils 
and monocytes of fish with small amounts detectable in macrophages (Ingram, 1980). 
Lysozyme is a mucolytic enzyme attacking structures containing p i -4 linked N- 
acetylmuramamine and N-acetylglucosamine (Alexander and Ingram, 1992). Lysozyme 
is thought to have anti-bacterial and anti-viral properties and may act on viruses by 
promoting phagocytosis as an opsonin or by directly activating leucocytes and 
macrophages (Jolles and Jolles, 1984).
1.5.2. Interferon
Interferons are cellular proteins that inhibit virus replication (Alexander and Ingram, 
1992). Interferon synthesis can be induced by a variety of microorganisms and 
substances such as nucleic acids, bacterial endotoxins and synthetic polyanions (Ingram, 
1980). Interferon, hence its name, interferes with viral replication and growth whilst 
not directly affecting the particles themselves, its action is directed against the 
intracellular phases of the virus growth cycle by damaging RNA translation and 
obstructing protein synthesis, and therefore viral replication (Ingram, 1980). De 
Kinkelin and Dorson (1973) identified interferon in rainbow trout by its specific 
protective effect upon cells and its inhibition of virus replication.
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Fish have been shown to have two types of interferon, IFN-ap and possibly IFN-y 
(Gravell and Malsberger, 1965, Sigel, 1967, Graham and Secombes, 1990). It is 
thought that the two interferon’s bind to different receptors activating genes and the 
production of proteins responsible for the activities of interferons (Alexander and 
Ingram, 1992). Graham and Secombes (1990) demonstrated the production of 
macrophage activating factor (MAF) by rainbow trout leucocytes after mitogen 
stimulation. Since IFN-y is a MAF and the MAF from rainbow trout leucocytes 
conferred resistance to IPN virus it is probably IFN-y. IFN-y activates cells involved in 
the immune response such as natural killer cells (nonspecific cytotoxic cells in fish) and 
macrophages (Yano, 1996). Sigel (1967) suggested that interferon compensated for the 
slow specific immune responses of fish, and played an important role in recovery of fish 
from viral infections. However, Dorson, De Kinkelin and Torchy (1992) demonstrated 
interferon synthesis in rainbow trout fry and noted that it coincided with viraemia. In 
the totally resistant fish no significant interferon activity could be detected.
1.5.3. Complement
Fish have a serum protein system comprising of a large number of complement 
components (Sakai, 1992). Bony fish possess a complement system similar to that of 
mammals, it consists of two pathways, the classical pathway and the alternative 
pathway. The classical pathway is activated by antigen-antibody complexes, the first 
component is Cl followed by a cascade of interactions of C4, C2, C3, C5, C6, C7, C8, 
and C9 (Yano, 1996). C5 activates the last components, C8 and C9 producing a large 
complex causing lysis of target cells (Sakai, 1992). C3 enhances the phagocytic ability 
of macrophages and neutrophils and acts as an opsonin (Manning, 1994), while C5 is a 
chemotactic factor for neutrophils and can act as an anaphylatoxin factor for mast cells
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(Yano, 1996). The alternative pathway is triggered by a variety of substances such as 
bacterial endotoxins and polysaccharides, without mediation by antigen-antibody 
complexes (Sakai, 1992). C3 is directly activated by these substances and leads to cell 
lysis (Yano, 1996).
The complement pathway may have an anti-viral function. Sakai, Suzuki and Awakura 
(1994) demonstrated that complement is capable of inactivating pathogenic fish viruses. 
Rainbow trout and masu salmon (Oncorhynchus mcisou) fry sera showed no haemolytic 
activity and proved to be much more susceptible to both IPN and IHN (infectious 
haemopoietic necrosis) viruses than chum salmon (O. keta). Virus solutions were 
incubated with fresh normal serum for 20 hours and showed a reduction in the virus 
titre. Upon heat inactivation of serum the anti-viral activity was reduced (Sakai, 1992), 
suggesting complement may have a role in anti-viral defence.
1.5.4. Antibodies
Initial characterisation of fish antibody structure led to the general supposition that fish 
immunoglobulin (Ig) was comparable to mammalian IgM (Kaattari and Piganelli,
1996). However it is now known that fish have isotypic (structural) differences among 
Igs (Killie, Espelid and Jorgensen, 1991) which are likely to have different functions in 
the immune response.
The most direct effect of the interaction of an antibody with its antigen is the act of 
blocking a critical function of the antigen e.g. a receptor or enzymatic active site 
(Kaattari and Piganelli, 1996). These antibodies are known as neutralising antibodies. 
In this way the invaded host can respond to infection with for example IPNV by
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production of specific antibodies against the virus surface (Sadasiv, 1995). Havarstein, 
Endresen, Hjeltnes, Christie and Glette (1990) demonstrated the production of antibody 
in response to IPNV infection in Atlantic salmon, the antibodies were considered likely 
to be neutralising antibodies to VP2. Research with monoclonal antibodies suggests 
that the majority of neutralising antibodies against IPNV are to VP2 (Caswell-Reno, 
Reno and Nicholson, 1986).
Antibody is also capable of promoting phagocytosis of the antigen by a phagocyte and 
this is known as opsonisation. Although this is mostly used with bacteria, fungi and 
parasites, target molecules do not need to be antibody, this may also occur by the 
activation of complement.
1.6. Stress and Immune Response
Stress may influence the ability of fish to resist pathogenic insults by affecting both the 
specific and non-specific immune system (Schreck, 1996). Stress caused by 
transportation and differences between rearing and stocking environment together with 
elevated water temperatures at the time of release in spring, increases the disease 
susceptibility of fish (Muona and Soivio, 1992). A substantial body of literature now 
exists that indicates that corticosteriods secreted in response to stress are partly 
responsible for the suppression of immunocompetence observed in stressed fish (Barton 
and Iwama, 1991). One of the main mechanisms involved in stress induced reduction in 
disease resistance is a suppressive effect on numbers and function of circulating 
lymphocytes (Ellsaesser and Clem, 1986). Negative effects of stress on disease 
resistance appear to be due to the depression of antibody synthesising capability via 
effects on lymphocytes (Schreck, 1996). This has been demonstrated to occur in among
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others striped bass stimulated with corticosteroid injection and infected with IPNV 
(Wechsler, McAllister, Hedrick and Anderson, 1986).
1.7. Genetic Variation in Selection Parameters
1.7.1. Survival/Mortality
Mortality is a very complex trait and commonly has very low heritability (Gjedrem, 
1983). Various authors have examined mortality/survival heritabilities. Gjedrem and 
Aulstad (1974) found significant differences in resistance between river strains of 
salmon parr to Vibrio anguillarum and suggested that the differences were partly 
heritable. Amend and Nelson (1977) examined the differences in susceptibility of 
sockeye salmon (Oncorhynchus nerka) to IHN virus, they found large differences in 
mortality between families, ranging from 52% to 98%, suggesting some natural 
selection for resistance to IHN had occurred. Both studies showed significant 
differences between full and half-sib families. Gjedrem et al. (1991) examined 
variation in susceptibility of Atlantic salmon to furunculosis and demonstrated that 
heritability of mortality was high, h2 = 0.48 ± 0.17 for sires and 0.32 ± 0.10 for dams. 
Standal and Gjerde (1987) measured survival in Atlantic salmon during the sea rearing 
period when infected with Vibrio spp., heritability was found to be high but there was 
great variation between year classes and sires.
Silim, Elazary and Lagace (1982) found variations in the susceptibility of IPN between 
three strains of brook trout where mortalities ranged from 30.9 to 72.3%. Okamoto, 
Tayama, Kawanobe, Fujiki, Yasuda, Sano (1993) reported a rainbow trout strain 
(RT201) to be resistant to IPN after years of natural selection. Outbreaks of IPN 
occurred regularly on the fish farm so survivors were naturally selected IPN resistant
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fish. After finding IPNV in the sexual fluids of broodstock the fish were challenged 
several times a year for 8 years and resistance to IPN was found to be stable with the 
character persisting even without exposure to natural disease pressure. However the 
RT201 strain still exhibited some mortalities to IPN indicating that RT201 had not 
acquired complete resistance to IPN. Ramstad, Taksdal and Korsvoll (1997) noted that 
mortality in Atlantic salmon fry varied between families (1.3% to 82%) suggesting a 
possible genetic resistance in certain families of Atlantic salmon.
1.7.2. Immune Parameters
Various associations between immune responses and disease resistance in fish have 
been reported, however this has mainly been in response to bacterial infections (Refstie, 
1982, Chevassus and Dorson, 1990, Roed, Fjalestad, Larsen and Midthjel, 1992). Roed 
et al. (1992) examined genetic variation in haemolytic activity of complement (both 
spontaneous and antibody dependent) in families of Atlantic salmon. Considerable 
variation in haemolytic activity was detected, suggesting additive genetic variation of 
the trait that may be considered as a marker for disease resistance.
Lund et al. (1995b) examined genetic variation in haemolytic activity, antibody and 
lysozyme activity in Atlantic salmon challenged with Aeromonas salmonicida. A 
significant genetic variation in lysozyme activity and an association between low 
lysozyme activity and high survival rates was demonstrated. Lund et al. (1995b) 
suggested that lysozyme may be a candidate for use in indirect selection to improve 
resistance against furunculosis, however neither antibody or SH activity were thought to 
be promising marker traits to improve disease resistance, contradictory to Roed et al. 
(1992) and Roed et al. (1993). Lund et al. (1995a) examined antibody response as in
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indirect marker for improved disease resistance to furunculosis in Atlantic salmon. 
Antibody alone was not thought to be a very promising marker, however when 
examined with survival in a regression model the effect of antibodies against the A- 
layer protein was highly significant.
Balfry, Shariff, Evelyn and Iwama (1994) studied survival and immune response in 
coho salmon and tilapia (Oreochromis niloticus) infected with Vibrio spp.. In both 
species of fish the strains exhibiting the highest survival also possessed a more active 
respiratory burst, plasma lysozyme activity and increased differential leucocyte counts. 
Gjedrem and Gjoen (1995) studied differences in susceptibility of Atlantic salmon to A. 
salmonicida, Renibacterium salmoninarum and V. salmonicida. Heritabilities were 
found to be low, the highest for BKD (0.23), and the lowest for cold water vibriosis 
(0.13), selection to develop disease resistant strains of Atlantic salmon was suggested.
Marsden et al. (1996) demonstrated differential susceptibilities to furunculosis in 
Atlantic salmon at farm sites, mortalities ranged from 0.5% to 42.5%, indicating a large 
phenotypic variation. Non-specific phagocyte functions such as respiratory burst 
activity and migration were not found to be significantly different between resistant and 
susceptible families. Both complement and non-az macroglobulin antiprotease activity 
were found to be higher in families of salmon resistant to A. salmonicida.
1.8. Summary
In light of the problems in controlling IPN it is highly desirable to obtain disease 
resistant strains of fish. This is a long term goal and preliminary evidence suggests that 
different families of Atlantic salmon do exhibit varying degrees of resistance to viral
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diseases such as BPN. The reasons for this varying resistance are unknown but may be
genetic and are likely to lead to differing abilities to elicit an immune response to the
virus between families.
1.9. Objectives
1. To adapt a previously developed mutliplex PCR to fluorescent genotyping.
2. To genotype Atlantic salmon susceptible to IPNV in the field.
3. To develop a laboratory based challenge on Atlantic salmon post-smolts for IPNV.
4. Using this to challenge different families of Atlantic salmon and examine differing 
levels of disease resistance and compare the results with those of natural field 
challenges.
5. To examine certain aspects of the humoral immune response in Atlantic salmon 
challenged with IPNV.
6. To assess the sensitivity of various diagnostic techniques for IPNV.
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2. General Methods
2.1. Cell culture
IPNV was propagated in Chinook salmon embryo cells (CHSE-214). Cells were 
maintained in Eagles minimum essential medium (EMEM, without L-Glutamine, 
Gibco) supplemented with 10 % FBS (foetal bovine serum, Gibco), 2 mM L-Glutamine 
(Gibco) and lx  non-essential amino acids (Sigma). Cells were cultured at 22°C. Where 
tissue samples were used media was additionally supplemented with 50 IU/ml 
penicillin, 50 Jig/ml streptomycin and 100 p,g/ml kanamycin (Gibco). CHSE-214 cells 
were sub-cultured regularly by washing twice with PBS Dulbeccos (without calcium, 
magnesium and sodium bicarbonate, Gibco) and cells harvested using trypsin-EDTA 
(lx , in Hanks Balanced Salt Solution (HBSS) without calcium and magnesium, Gibco), 
and split to a ratio of 1:3.
2.2. Virus culture
IPNV was cultured using either pre-formed or simultaneous inoculation of CHSE-214 
cells. For a pre-formed inoculation the media was removed from a fully confluent flask 
(Iwaki) of CHSE-214 cells and retained. Enough IPNV suspension was inoculated into 
the flask to cover the monolayer and the virus adsorbed for 30 minutes at 15°C. After 
this time the conditioned media was replaced and the cells/virus further incubated at 
15°C until full CPE was visible. For a simultaneous inoculation a flask of fully 
confluent CHSE-214 cells was split to a ratio of 1:3 and virus inoculated at l/10th of the 
volume of the suspended cells. Cells and virus were incubated at 15°C until full CPE 
was evident. In both cases a mock flask was used where HBSS (Gibco) was inoculated 
onto the cells. The viral supernatant was harvested and clarified by centrifugation in a
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Denley BR401 refridgerated centrifuge at 1000 g for 10 minutes. Virus was stored in 
aliquots at -20°C.
2.3. Virus isolation
Virus was extracted from head kidney samples kept on ice for no longer than 24 hours 
or previously frozen. The kidney was placed into a cold sterile mortar with a small 
quantity of sterile sand and ground together with a pestle. HBSS (Gibco) containing 2 
% FBS (Gibco) was then added to the mortar having been previously calculated by 
weighing the tissue and then diluting it 1:50. The kidney homogenate and HBSS were 
thoroughly mixed and placed in a centrifuge tube. The solution was then centrifuged at 
1000 g for 15 minutes in a Denley BR401 refrigerated centrifuge. The supernatant was 
removed from the middle of the tube to avoid fatty deposits at the top and passed 
through a sterile 0.45 pm filter (Sartorius).
One fully confluent 25 cm2 flask of CHSE-214 cells was then harvested and re­
suspended to a volume of 36 ml in EMEM, 1.5 ml of cell suspension was placed into 
each well of a 24 well plate (Iwaki). Samples were simultaneously inoculated onto 
CHSE-214 cells at l/10th the volume of cell suspension in each well. Each sample plus 
HBSS controls were cultured in quadruplicate. The plate was incubated in a 2 % CO2 
incubator at 15°C for 21 days then at day 7 all samples regardless of CPE were 
passaged and incubated for 14 days. Samples were stored long term at -20°C.
2.4. Virus titration
Where virus titre only was required the method used is as below, section 2.5. except no 
antisera were used.
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2.5. Neutralisation titration
Antisera produced at the SERAD laboratory against reference strains of IPNV A2 (Sp.) 
and A3 (Ab.) were diluted using HBSS plus 2 % FBS to give final working dilutions of 
1:200 and 1:5000 respectively. Each batch of antisera upon arrival at the virology 
laboratory at Stirling was titrated using an alpha titration to determine the optimal 
dilution for usage in neutralisations; the above dilutions were optimal for the batch used 
in this study. Using a sterile flat bottomed 96 well plate (Iwaki); all wells except the 
first column were filled with 90 pi of HBSS plus 2 % FBS. Column one, rows one and 
two, were filled with 100 pi of HBSS, the other rows in column one were filled with 
100 pi of test virus. The samples were then titrated 1:10 across the plate and 10 pi 
discarded from the last column, 90 pi of A3 and A2 antisera were added to duplicate 
rows containing test virus, the other rows all contained a further 90 pi of HBSS plus 2 
% FBS. Virus was adsorbed for a minimum of 30 minutes at 15°C. During this time a 
25 cm“ tissue culture flask (Iwaki) of confluent CHSE-214 cells were harvested. Cells 
were made up to 12 ml with EMEM, lOOpl of cells was added to every well and the 
plate incubated in a 2 % CCP incubator at 15°C for 7 days. Estimation of virus titre was 
calculated using the Spearman-Karber method for estimation of 50% end points 
(Karber, 1931).
Mean logTCID50 (m) = x + ]/ i  d -  d X (r/n)
Where x  = log of the highest reciprocal dilution
d = log of the dilution interval
r = number of test subjects not infected at any dilution 
n = number of test subjects inoculated at any dilution
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2.5. Virus purification
Virus was propagated and clarified by centrifugation at 1000 g for 10 minutes. The 
resulting supernatant was removed and placed into ultra-centrifuge tubes (Beckman) 
previously disinfected with 70 % ethanol (Fisher), weighed to ensure the tubes were 
accurately balanced. Tubes were filled to within a couple of millimetres from the top. 
Viral supernatant was ultra-centrifuged in a Beckman L80 ultra centrifuge at 12,000 g 
for 35 minutes as an ultra clarification step. The supernatant was removed and placed 
into clean newly disinfected tubes, weighed and centrifuged at 100,000 g for 1 hour 35 
minutes to pellet the virus. The supernatant was then removed and discarded, the viral 
pellet was re-suspended in 100 jil TNE buffer (Appendix 1) at room temperature for 15 
minutes, the tubes sealed with parafilm and left at 4°C overnight. Purified virus was 
then pooled and stored at -20°C.
2.6. Histology
2.6.1. Tissue sampling, preservation and processing
Atlantic salmon organ samples (liver, kidney, gut and pancreas, heart, gill and spleen) 
were placed in 10 % neutral buffered formalin (Appendix 1). The tissues were cut to 
the correct size and placed into coded cassettes, the cassettes were immediately placed 
into water until processing. Processing was carried out in an automatic tissue processor 
(Shandon Citadel). The tissues were passed through increasing percentages of alcohol 
until at absolute alcohol, then through chloroform and molten wax (Appendix 2).
2.6.2. Tissue embedding
After overnight processing the cassettes were placed into the molten wax bath of the 
histoembedder (Leica). The organs were then embedded in paraffin wax in suitable
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moulds and immediately placed onto a cool plate. Once solidified the blocks were 
removed from the mould and stored at room temperature until sectioning.
2.6.3. Tissue sectioning
Initially the blocks were trimmed to access the tissues, all sectioning was carried out on 
a Leica 2035 BIOCUT microtome. Soft tissues such as kidney, liver, heart, spleen and 
pyloric ceaca were placed into distilled water after trimming, hard tissues such as gills 
were placed in decalcifier for an hour unless immunohistochemistry was planned and 
then the tissue was also placed into distilled water. Blocks were sectioned at 5 pm, 
ribbons of sections were floated on distilled water in a water bath at 40°C and the best 
section slipped onto a glass slide, the slide labelled and left to dry on a drying rack at 
40°C. When all the sections had been taken the slides were dried in a drying oven at 
60°C overnight.
Slides were stained with haematoxylin and eosin (H&E) and mounted with pertex. See 
Appendix 2 for exact staining procedure.
2.7. Bacteriology
2.7.1. Isolation
Bacteria were isolated by taking a swab of the kidney, which was then streaked onto 
tryptic-soya agar (TSA, Oxoid), plus 1.5 % sodium chloride (BDH) plates (Appendix 
1). Plates were incubated at 20°C until bacterial growth or for 7 days.
2.7.2. Identification
Cultures were identified using standard bacteriological techniques.
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2.7.2.1. Gram’s stain
Using aseptic techniques a loopful of sterile saline was placed onto a clean glass slide. 
A minute quantity of culture was placed on the slide, the culture and the saline were 
emulsified and spread evenly over the slide. Once the slide was dry the slide was 
passed through a bunsen flame three times to fix the culture and left to cool. The slide 
was then covered in 1 % crystal violet (BDH, Appendix 1) solution and left for one 
minute, washed with distilled water and then covered with iodine (BDH) and left for 
one minute. The slide was then covered with acetone (Fisher) for 10 seconds and 
thoroughly washed with distilled water and air dried. The slide was then covered with 
safranine solution (Sigma, Appendix 1) for two minutes, washed in distilled water and 
air dried. The slide was then examined microscopically under oil, the size and shape of 
the culture were noted along with its Gram status.
2.1.2.2. Motility test
Vaseline was placed on all four comers of a coverslip, a loopful of saline was placed 
into the middle of the coverslip, a minute amount of culture was then emulsified with 
the saline. A microscope slide was gently lowered onto the coverslip and the slide 
turned over and examined microscopically using x40 objective.
2.1.2.3. Oxidase test
Oxidase sticks (Oxoid) were touched onto the culture, a colour change from red to 
purple within thirty seconds indicated the test was positive and the reagent oxidised.
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2.7.2.4. 0/129 sensitivity
This test is specifically used to identify Vibrio species of bacteria as 0/129 (2, 4- 
diamino-6, 7-di-iso-propyl pteridine phosphate) is a bacteriostatic agent effective 
against Vibrio sp.. Several colonies of culture were inoculated into 1 ml of sterile saline 
and the culture suspended by gently shaking. Using a sterile pipette 5 drops of the 
suspension were dropped onto a TSA plus 1.5% sodium chloride agar plate and spread 
evenly around the plate using a sterile glass spreader. The plate was left to dry for 1 
minute and then one 10 |ig disc impregnated with 0/129 (Oxoid) placed one side of the 
plate and one 150 jug disc (Oxoid) placed on the other side. The plate was inverted and 
incubated at 20°C.
2.1.2.5. API 20E microbial identification
The API 20E (BioMerieux) test is a microtube system that enables 23 standard 
biochemical tests to be carried out on a gram-negative bacterial culture. Several 
colonies of pure culture were placed into 5 ml of sterile saline and the mixture gently 
shaken to suspend the bacteria. The API 20E test strips were placed inside disposable 
plastic trays supplied by the manufacturer, which were then filled with distilled water to 
form a humid chamber. The trays were titled and using a sterile pipette the microtubes 
were filled with suspension, with three enzymes CIT. VP and GEL the wells along with 
the microtubes were filled with bacterial suspension. After this inoculation the well 
section of ADH, LDC, ODC, PLS and URE tubes were filled with liquid paraffin. The 
strip was incubated at 20°C for 3 days. After this time I drop of TDA reagent was 
added to the TDA tube, 1 drop of VP1, then 1 drop of VP2 reagent was added to VP 
tube and 1 drop of IND reagent was added to the IND tube. The subsequent colour 
change was scored and compared with the results of known fish pathogens.
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2.8. Anaesthesia of fish
Atlantic salmon were anaesthetised using ethyl p-aminobenzoate (Sigma) at a stock 
concentration of 40 g/1 in methanol (Fisher), the stock was diluted 1:1000, 1 ml of ethyl 
p-aminobenzoate was mixed with 1 litre of seawater. Where fish were to be terminally 
anaesthetised the spinal cord was also severed.
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3. The use of microsatellites to assign Atlantic salmon susceptible to IPNV in the 
field to a family
3.1. Introduction
IPNV has been recognised as a problem for post-smolt Atlantic salmon since the 
1980’s. Outbreaks usually occur between 6-8 weeks post transfer to seawater in 
Scotland, the Shetland Isles and Norway (Krosgrud, Hastein and Ronnigen, 1986, Smail 
et al., 1992, 1995). Smail et al. (1992) reported clinical outbreaks of IPN on two 
Scottish Atlantic salmon farms in 1987 with mortality higher than 10% per week in 
certain cages. Smail et al. (1995) demonstrated that in 1990 Shetland suffered major 
outbreaks of IPN and noted that fish exhibited particularly marked IPN pathology 
unlike anything that had been seen before with very high titres of IPNV. The pattern 
has changed very little since this time, for this reason Shetland was the ideal location for 
placing a stock of Atlantic salmon to undergo a natural challenge with IPN. An 
indication of the variation in disease resistance between families of Atlantic salmon to 
IPN could be determined by mixing offspring from known parents and placing them at a 
location where they were likely to be challenged with the virus and monitor mortalities.
Microsatellite markers have been extensively used in the reconstruction of proximal 
relationships between individuals for many and varied applications (O’Reilly, 
Herbinger and Wright, 1998). Atlantic salmon microsatellite markers developed by 
O ’Reilly et al. (1996) for use in parentage determination were used in this study to 
assign fish susceptible to IPN to their parents. O ’Reilly et al. (1996) developed a 
system using four microsatellites; one di-nucleotide locus, Ssa85 and three tetra- 
nucleotide loci, Ssal97, Ssal71, Ssa202, all four loci could be co-amplified
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(multiplexed) in a single reaction. This system was developed using radioactively 
labelled primers and PCR products visualised using standard sequencing gels.
The utility of this system was evaluated using different wild populations of Atlantic 
salmon in three different rivers in Nova Scotia, Canada O ’Reilly et a l (1996) examined 
allele frequency, heterozygosity and conformance with Hardy-Weinberg (H-W) 
equilibrium. Heterozygosity values at the four loci ranged from 80-91%, it was also 
found using the three populations that the number of alleles at each locus was high and 
varied from 12-25. To test for H-W equilibrium and Mendelian inheritance three sets of 
parents with 20 offspring from each were typed and were found to exhibit classic 
Mendelian inheritance with no significant departures from H-W equilibrium. O ’Reilly 
et a l  (1998) assigned 800 Atlantic salmon offspring to a set of 12 parents using the 
same microsatellites and found that 99.5% of the offspring analysed could be assigned 
unambiguously to one set of parents. For the above reasons this particular set of 
microsatellites were considered to be very suitable for use in parentage assignment in 
this study.
3.2. Aims
1. Using a pedigreed stock of Atlantic salmon from Landcatch Ltd. to establish the 
occurrence of an outbreak of IPN using virus culture and histopathology.
2. To genotype the susceptible fish using microsatellites and assign these fish to pairs 
of previously genotyped parents.
3. To examine the resulting data for any correlation between family and susceptibility.
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3.3. Methods
3.3.1. Fish rearing and natural challenge
Atlantic salmon from single pair matings of genetically known parental stock were 
maintained in 160 separate family groups’ at the hatchery until smoltification. A 
suitable fish farm was chosen in Out Skerries, Shetland to transfer 39,000 of these 
Atlantic salmon smolts, known as the sentinel fish, (equal numbers of fish from each 
family) to seawater in April 1998. The chosen farm had a history of repeated outbreaks 
of IPNV causing mortality annually 8-12 weeks post transfer to seawater. Fish were 
transferred by well boat and upon arrival at the farm were distributed into 4 cages, at 
transfer the fish were approximately lOOg in weight. Mortalities were removed from 
the cages by divers every week until a large increase in deaths was noted 
(approximately 10 weeks post transfer), mortality collection was then increased to twice 
a week. Data was collected from 5 dives during a period of 3 weeks in July 1998. Dead 
salmon were sorted according to state of decomposition, whole fish were weighed, their 
length measured and a fin clip taken. Fin clips were either placed straight into extraction 
buffer for immediate DNA extraction at the farm or into absolute ethanol for extraction 
at a later date.
3.3.2. Tissue sampling
Organ samples were taken from six fish at the fish farm and immediately placed into 
10% neutral buffered formalin for histopathology. A swab of the kidney was taken 
from each fish and streaked onto TSA plus sodium chloride agar. Samples of head 
kidney were also taken from the same fish for virus culture and kept at 4°C for 24 hours 
until processing. A fresh sterile scalpel blade was used for each fish. For tissue 
processing, histopathology, bacteriology, virus culture and identification see Chapter 2.
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3.3.3. DNA extraction
DNA was extracted from fin tissue using a modified method of van de Ven, Lanham, 
Brennan (1996). Fin tissue was placed in 400p.l of extraction buffer (Appendix 1) in 
sterile 1.5ml microcentrifuge tubes (Alpha) and left at room temperature overnight. The 
tissue was then homogenised using a sterile disposable pestle (Sigma) and vortexed for 
5 seconds. The tube was centrifuged in an MSE Micro Centaur at 14000g for 1 minute, 
and 300jnl of the supernatant was removed and placed into a fresh sterile tube. An equal 
volume of cold (4°C) isopropanol (BDH) was added to each tube, incubated at room 
temperature for 2 minutes and centrifuged for 10 minutes at 14000g. The supernatant 
was then discarded, the pellet washed once with 300pl of 70% ethanol (BDH) and 
centrifuged for 5 minutes at top speed. The supernatant was discarded and the pellet 
air-dried, DNA was re-suspended in lOOpl of TE buffer (Appendix 1) and stored at 4°C 
until use and at -20°C for long term storage.
3.3.4. Multiplex PCR
The multiplex PCR consisted of four salmon microsatellites, Ssa202, Ssal71, Ssal97 
and Ssa85, these microsatellite loci were isolated and specific primers designed by 
O’Reilly et al. (1996). Primers were synthesised at Perkin-Elmer Applied Biosystems 
and one member of each primer pair was fluorescently labelled. The ABI 377 was able 
to recognise 4 colours using filter set C, TET (green), HEX (yellow), 6 -FAM (blue) and 
TAMRA (red). The size of alleles in the multiplex indicated the use of GS350 TAMRA 
size standard (Perkin-Elmer).
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The primers were labelled with:
Ssa202- green (TET) 
Ssal71- blue (6 -FAM) 
Ssal97- yellow (HEX) 
Ssa85 - green (TET)
Table 3.1: Nucleotide sequences of primers and microsatellites (taken from O’Reilly et 
a l  1996).
Locus Repeat Motif Sequence (5’-3’) Allele size 
range
Ssa85 (GT),4 a) GG TGG GTC CTC CAA GCT AC 123-160
b) ACC CGC TCC TCA CTT AAT C*
Ssal97 (GT)5C(TG)4TC(TG)3
A(GTGA)i5
a) GGG TTG AGT AGG GAG GCT TG 164-264
b)TGG CAG GGA TTT GAC ATA AC*
Ssal71 (TGTA)14(TG)7 a) TTA TTA TCC AAA GGG GTC AAA A 200-250
b) GAG GTC GCT GGG GTT TAC TAT*
Ssa202 (CA)3(CTCA),7 a) CTT GGA ATA TCT AGA ATA TGG C 240-276
b) TTC ATG TGT TAA TGT TGC GTG*
*fluorescently labelled primer
Due to the marked difference in sizes of alleles at Ssa202 and Ssa85 it was possible to 
label both sets of primers with TET. Despite the use of a previously optimised PCR the 
different primer labelling methods, different equipment and DNA quality required 
optimisation of the PCR. Initially annealing temperature was varied from 50-58°C until 
an optimum was found. Magnesium chloride (MgCh) was titrated from 1.5 mM to 5 
mM in 0.5 mM increments using primer concentrations of 0.5jiM for each locus. Once 
an annealing temperature was chosen and MgCL concentration decided primer
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concentrations were gradually lowered until optimum amplification at all loci was 
obtained. Amplification reactions were carried out in a volume of 10|J.l containing 1 jul 
PCR buffer, 0.5 units of Taq (Promega), 1.5 mM MgCE and 200 pM each dNTP 
(Promega). Primer concentrations were 0.1 pM for 85 a and b, 0.2 pM for 202 a and b, 
0.2 pM for 197 a and b and 0.25 pM for 171 a and b.
Thermal cycling conditions were:
10 cycles of: 20 s at 94°C (denaturing)
20 s at 53°C (primer annealing)
20 s at 72°C (extension)
35 cycles of: 20 s at 90°C 
20 s at 53°C 
20 s at 72°C.
7 minutes at 72°C (final extension)
30 minutes at 60°C (ensures A addition to every copy)
NO 4°C hold
Amplification was performed on a PE Applied Biosystems GeneAmp® PCR System 
9700 thermal cycler, in 96 well plates (Elkay).
3.3.5. Electrophoresis
PCR products were separated using a Perkin-Elmer ABI 377 Automated Sequencer. 
The denaturing acrylamide gels were made by mixing 5.2ml acrylamide:bis 19:1 
solution (Biorad) with 27.5ml nanopure water, 0.5g mixed bed resin (Sigma) and 18g 
urea (Biorad), once at room temperature the mix was then 0.2pm filtered (Whatman) 
and 5ml lOx TBE (Appendix 1) added through the filter. The solution was then
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degassed for 4 minutes; 250(ll of freshly prepared APS (ammonium persulfate, 
Amresco) and 35|il TEMED (Biorad) were added and the mix gently swirled. The gel 
mix was taken up in a 50ml syringe and injected between 36cm gel plates using the 
injection device supplied with the sequencer and allowed to polymerise for 2.5 hours 
prior to use.
The PCR products were diluted 1:10 with nanopure water, 1.5jil of diluted PCR product 
was mixed with 0.6|il GS350 TAMRA size standard, 0.5(il loading dye (Appendix 1) 
and 2.4pl formamide (Sigma). Samples were denatured at 95°C for 5 minutes on the 
PE GeneAmp® PCR System 9700 thermal cycler and held on ice until use. The gel 
was pre-run for 10 minutes at 1200 volts. After this each lane of the gel was loaded 
with 1 .Ojil of the PCR product mix, alternate lanes were loaded to avoid contamination 
between lanes, the gel was then pre-run for 3 minutes to run the first samples into the 
gel and then the remaining lanes loaded. Each gel was run for 2 hours at 1200 volts.
3.3.6. Genotyping
The lanes on the gel were tracked manually and the data from each lane extracted and 
sent to GeneScan™ version 2.1 to be analysed. GeneScan™ then created a project 
containing all the data from the gel. Analysis was carried out by firstly applying a 
previously created matrix to the samples to allow the machine to distinguish between 
the colours. Previously programmed analysis parameters were applied to the data, 
GeneScan™ performed size calling by using the local southern method, no peak 
smoothing and called peaks above a height of 50 units. Results were then imported into 
Genotyper™ which then used two macros written specifically for this multiplex system 
to further analyse the data. The first macro removed stutter peaks from Ssa85 alleles
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and indicated the presence of more than two peaks at any one locus that could then be 
manually adjusted. The second macro organised data into tabular form ready to be 
imported into Excel as a spreadsheet.
3.3.7. Parental genotyping
The post-smolts used in this study were hatched in December 1996 from 328 
broodstock Atlantic salmon, the parental fish were fin clipped and specific crosses 
carried out and recorded. Prior to this study the parental fin clips were sent to the 
Marine Gene Probe Laboratory, Dalhousie, Canada to assess that the parental stock was 
indeed variable and to such a degree that offspring could be assigned. These samples 
were genotyped using radioactive labelling techniques, to ensure compatibility of the 
fluorescent genotyping with radioactive genotyping 1 0 0  parents already genotyped in 
Canada were also run on the PE ABI 377 sequencer.
3.3.8. Parentage assignment
Once in Excel allele sizes for parents were altered to letters and genotypes analysed 
using Pedigree Analysis - Family Genotype Comparisons, Version 2.03 a program 
written and kindly provided by Dr. John Taggart (University of Stirling). The resulting 
output file gives a predictive figure on the percentage of all offspring that could be 
assigned to a family and within each family the percentage of offspring that could be 
assigned unambiguously to that family. Offspring genotypes were also altered to letters 
and parentage assigned using the same programme. Both sets of data, the parents and 
potential offspring were also analysed using Genepop Version 3.1a to establish allele 
frequencies and if the data were Hardy-Weinberg equilibrium. Estimation of exact P-
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values were calculated using Markov chain parameters, with dememorization set at 
2 0 0 0 , testing was carried out in batches of 2 0 0  with 2 0 0 0  iterations per batch.
3.3.9. Parental genotyping of the 1997 parents
In preparation for sampling IPN susceptible fish the next summer the parents of those 
fish were also genotyped and resulting genotypes analysed using the Pedigree Analysis 
programme.
3.3.10. Sibling genotyping and parentage assignment
After genotyping the Skerries group of 1996 offspring 64 of their siblings maintained at 
the hatchery to later become broodstock were also genotyped. The individuals were fin 
clipped, the samples genotyped and parentage assigned as above.
3.3.11. Reliability testing
To ensure the DNA extraction, PCR, genotyping and parental assignment were all 
accurate and reliable 4 sets of parents and 6  offspring from each set of parents from the 
1998 broodstock were fin clipped. The samples were genotyped and parentage assigned 
as above.
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3.4. Results
3.4.1. Disease signs
3.4.1.1. Mortality
Mortalities were collected at weeks 13, 14 and 15 post transfer to seawater, only 401 
salmon were fin clipped during this time because the majority of the fish were too 
decomposed to sample. The mean condition factor of the fish sampled was 0.8 
(standard deviation, 0 .2 1 ).
25
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Weeks Post Transfer
Figure 3.1: Cumulative percentage mortalities in the stock at Out Skerries during an 
outbreak of IPN.
3.4.I.2. Bacteriology
All fish sampled at the fish farm were found to be infected with Vibrio spp., the cultures 
were very mixed, with no one species appearing to be the most prominent.
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Table 3.2: Characteristics of bacterial cultures isolated at the fish farm.
Test Result
Gram negative
Shape curved rods
Size medium
Motility none
Oxidase positive
0/129-10|ig positive
0/129-100pg positive
The API 20E test was found to be inconclusive and the reactions were not indicative of 
any one Vibrio species.
3.4.1.3. Virology
All the fish sampled were found to be infected with a virus, after a neutralisation 
titration was carried out the virus was confirmed to be IPNV A2 (Sp.) strain.
3.4.1.4. Histopathology
The gut and pancreas in all fish exhibited varying degrees of IPN pathology (Figure 
3.2). Pancreatic pathology included necrosis of fatty tissue surrounding the pancreas, a 
mononuclear infiltrate into the fatty tissue, release of zymogen granules and pancreatic 
acinar cell necrosis. The gut contained a catarrhal exudate indicating gut enteritis 
typical of IPN.
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Figure 3.2: IPN pathology in the pancreas o f Atlantic salmon stained with H & E. 
Magnification: x20. Nuclear debris from exocrine cells (solid arrow). Degenerate 
exocrine cells (open arrow).
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3.4.2. Genotyping
3.4.2.1. Gel interpretation
Initial results from the PCR are shown in the gel image below. From this the lanes were 
tracked using the tracker lane shown. As already mentioned the red bands are the size 
standard GS350, sizes from bottom to top are 139, 150, 160, 200, 250, 300, 340, 350 
bases. Green bands around 100-160 bases are alleles o f Ssa85, yellow bands alleles o f 
Ssal97, blue bands alleles o f Ssal71 and green bands around 230-300 bases are alleles 
o f Ssa202.
5 6 7 E l  9 10 11 12 13 14 t5  16 17 18 19 20 21 22 23 24 25 28 21
Figure 3.3: Example o f gel image to show microsatellites and size standard (red) in each 
lane and tracking method.
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3.4.2.2. GeneScan™ analysis
Once the data from the gel had been extracted and imported into GeneScan™ 2.1 the 
data was analysed using the analysis parameters mentioned in section 3.3.6. Each 
lane/sample is represented as an electropherogram as seen below, individual peaks 
could then be highlighted and sized (yellow is seen as black).
H l l  7G : 07»5L3F79 /  EL3F79 
□  □  7R : 07 »5t3F73 /  GS3S01200XL
Dye/Sample 
Peak
Minutes
144.58
Figure 3.4: Electropherogram to show the microsatellite profile o f one individual and 
size marker in GeneScan™.
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3.4.3.1996 parental genotyping
Comparison of radioactively labelled genotyping with fluorescent genotyping indicated 
that although the alleles at two loci were seen as a slightly different size (Ssa202 was 
two bases larger and Ssal97 was one base larger) this was consistent throughout all the 
individuals. Alleles at Ssal71 were the same size using both methods. However locus 
Ssa85, as a di-nucleotide is subject to stutter, this can cause problems with typing the 
correct allele and for this reason alleles were not consistently different. Therefore all 
the parental samples were genotyped for this locus only and analysed as above.
Table 3.3: A comparison of genotypes using traditional radioactive genotyping and 
fluorescent genotyping methods.
Genotypes
Traditional Fluorescent
Individual Ssa202 Ssal71 Ssal97 Ssa85 Ssa202 Ssal71 Ssal97 Ssa85
1 246 246 2 2 0  228 195 255 133 139 248 248 2 2 0  228 196 256 131 138
2 238 246 2 2 0  228 255 255 133 139 240 248 2 2 0  228 256 256 131 138
3 238 246 216 2 2 0 195 255 125 133 240 248 216 2 2 0 196 256 123 131
4 238 246 2 0 0  216 195 255 135 139 240 248 2 0 0  216 196 256 133 138
3.4.4. Parentage assignment
3.4.4.1. Assignment of the Skerries stock
The Pedigree Analysis programme predicted that 83% of offspring from the 1996 
parents could be assigned unambiguously to a family assuming equal numbers of 
offspring from each family were present. This result indicated that the majority of 
individuals sampled at Skerries would be able to be correctly assigned to their parents.
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In total in Shetland 401 dead or dying fish were fin clipped, from these fish 27 could not 
be fully genotyped probably due to degraded DNA, a full genotype was required for the 
assignment programme and consequently these fish were excluded from the analysis. 
Analysis was carried out on the remaining 374 fully genotyped individuals, however, 
only 119 offspring out of the 374 could be typed to a family. The programme could find 
no parental matches for the remaining individuals using the given parental crosses. 
Analysis was carried out in total on three different occasions, with the data being re­
entered into the computer each time to discount data entry errors. Prior to this samples 
had been run more than once on the ABI sequencer to ensure accuracy, with the same 
results obtained. Therefore 32% of the individuals sampled were assigned to one or 
more families, with 25% of the total number of fish genotyped assigned to one family 
only. A breakdown of family assignment and allele coding can be seen in Appendix 3.
Table 3.4: An example of genotype and family assignment results from the first 10 
Skerries offspring mortalities.
Offspring
ID
Genotype 
Ssa202, Ssal71, Ssal97, Ssa85
Families Sharing 
Genotype
1 CF, BF, JQ, GI No match
2 AC, AG, BE, AA No match
3 AD, CD, EH, CD No match
4 AC, CG, QQ, CC 91, 100
5 AF, DE, GM, AJ No match
6 AD, CD, EH, GI 153
8 AD, CE, EH, AA No match
9 AA, CC, n, KK No match
10 Cl, GI, IQ, GG 93
11 DD, GG, BH, AA No match
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3.4.4.2. Assignment of siblings
After the lack of offspring matches from the Skerries fish DNA was extracted from 100 
siblings still at the hatchery, 64 siblings were genotyped (a full gel run), full genotypes 
were obtained from 44 fish out of the total 64. Although there was an increase in the 
matches to 64% there were still 36% whose parentage was unaccounted for.
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Table 3.5: Results of the family assignment from the Skerries offspring siblings chosen
at random for genotyping.
Fish ID Genotype 
Ssa202, Ssal71, Ssal97, Ssa85
Families sharing 
genotype
1 AC, AF, CH, DG No match
2 AA, DF, HP, GL No match
3 GG, DF, JJ, CF No match
4 Al, AD, IJ, GG 145
5 BC, CC, BI, CG 41, 128
6 CC, CG, JJ, CG No match
8 AF, DD, HL, CK 107
12 CD, AG, FI, CC No match
14 AC, AF, BQ, AA No match
16 CD, DF, BL, CC 26
18 Al, DG, HQ, GG 154
19 DD, CG, BH, AG 50, 104
20 CD, DH, JN, CF No match
23 CC, CG, BE, CG 89
24 AC, GH, EO, DG 109
25 AF, DE, BO, CF No match
26 BC, CF, JP, GI 31
27 AA, DF, GP, GL No match
28 AC, CD, QQ, GG 62, 139, 143
29 AC, DG, EJ, KK 151
30 DI, GI, GI, CG 93
31 CE, CD, MQ, FG No match
33 CG, AF, BL, Cl 40
35 Al, AD, JQ, CG 1 1 1
37 BC, AC, CM, IL 1, 15
38 DD, CG, HH, AG No match
40 AD, CG, JM, GK 69
44 AA, AA, U, AG 145
47 BC, CG, EQ, CG 157
49 AC, CG, JQ, CF 76
50 AA, AC, LQ, GK 63
51 AD, AF, HH, CD No match
61 BI, CC, BH, CG 128
62 AC, AE, KQ, GG 143
76 BC, DG, IQ, CC 1 0 0
83 El, GJ, HM, FG No match
88 Cl, CF, HQ, CG 128, 146
95 AC, CC, HH, GG 56, 144
99 AD, BE, BF, AF No match
100 AB, CJ, GQ, FN No match
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3.4.4.3. Reliability Testing
Table 3.6 (overleaf) shows the offspring of the first three families genotyped from the 
1998 broodstock and offspring were assigned to the correct parents. The offspring 
reported to belong to the fourth set of parents did not match, although the offspring did 
all appear to be from the same family.
AT 
C i '
r L
i .  a
; -i-.. ■ i I
; V -
■V : ■ A .  .
■ -■ 1-
-  • '— <y
fc'il :
' A A ;
■ A A :■
: A A : ;AA : 
* . A f  : Am ;
54 Chapter 3
Table 3.6: Results of parentage assignment in the 6 families of fish used to test the
reliability of the genotyping system.
Family Genotype Family
202 171 197 85 Assignment
Family 1
Parents Female CD CD HJ CG
Male AD CF BQ GN
Offspring 1 DD CC HQ GN 1
2 AD CF BJ CN 1
3 CD CD BH CN 1
4 AC CD HQ CN 1
5 CD CD JQ CG 1
6 individual not fully genotyped
Family 2
Parents Female CD AD DG Cl
Male AD AD HN GG
Offspring 1 CD DD GH GI 2
2 CD DD GH CG 2
3 CD AD DN CG 2
4 DD DD GN GI 2
5 AC AA DH Cl 2
6 DD AD GH GI 2
Family 3
Parents Female AC CC BE AN
Male AC CG HJ IK
Offspring 1 AA CG BH Al 3
2 AC CC BH KN 3
3 CC CG BH KN 3
4 CC CC BH AK 3
5 AA CG EJ AK 3
6 AA CG BH KN 3
Family 4
Parents Female AC AH KQ GG
Male AC DD HH GL
Offspring 1 AB CG EH IJ NO MATCH
2 AC CG EH IK NO MATCH
3 AC CC El KK NO MATCH
4 AC CG El IJ NO MATCH
5 AB DG EH KK NO MATCH
6 AB CG IQ KK NO MATCH
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3.4.4.4. Polymorphism and Heterozygosity
Table 7 indicates that there was little variation in numbers of alleles between the three 
groups of fish. The 1997 parents do have fewer alleles at Ssal97, however there was an 
increase in allele number at Ssal71 compared to the other groups. Locus Ssal97 was 
found to be the most polymorphic in all groups with 15-19 alleles, locus Ssa85 was also 
very polymorphic with 14-15 alleles.
Table 3.7: Number of alleles in the 1996 and 1997 parents and Skerries offspring.
Stocks Locus
Ssa202 Ssal71 Ssal97 Ssa85
1996 Parents 9 1 0 19 15
Skerries
Offspring
9 1 0 16 14
1997 Parents 1 0 1 2 15 14
Total no. of 
different alleles
1 0 13 19 16
Heterozygosity at loci Ssa202, Ssal97 and Ssa85 were very similar in the 1996 parents 
and the Skerries stocks (Table 3.8). However heterozygosity (Ho) at locus Ssal71 is 
markedly different, with the incidence 1 2  % lower in the parental stock compared to the 
Skerries stock. The 1996 parents appear to be more variable in terms of Ho than the 
1997 parents at two loci, Ssa202 and Ssa85. However, at Ssal71 and Ssal97 Ho was 
lower by 3 or 4 % in the 1996 parents than the 1997. Observed heterozygosities in the 
1996 parental stock differed from the expected values at Ssa202, Ssal71 and Ssal97 by 
7, 10 and 6  % respectively, the values at Ssa85 only differed by 2 %. Table 3.8 shows 
an excess of heterozygotes at Ssa202, all other loci were found to be deficient in
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heterozygotes to varying extents. Ssal71 was the most deficient by 11 %. In contrast 
observed heterozygosities were only slightly different than expected in the Skerries 
stock, with Ssa202 exactly the same. Expected heterozygosity in the 1997 parents was 
very similar to the observed for loci Ssal97 and Ssa85, Ssa202 was found to have more 
heterozygotes than would be expected, however Ssal71 was found to be deficient. In 
comparing the different groups it can be seen that both year classes of parents are very 
deficient in heterozygotes at Ssal71. Comparison between Ho and He within year 
classes 1996 and 1997 gave no significant differences using two tailed t-tests, 
comparison of Ho between year classes also gave no significant differences.
Table 3.8: Heterozygosity (%) in the 1996 and 1997 parents and Skerries stocks.
Stocks Locus
Ssa202 Ssal71 Ssal97 Ssa85
1996 Ho 84.0 70.9 81.1 78.9
Parents He 76.9 81.8 86.9 81.2
Skerries Ho 79.4 83.2 84.8 83.2
Offspring He 79.4 81.3 88.5 82.8
1997 Ho 73.8 73.8 85.1 71.3
Parents He 68.4 80.4 84.7 70.5
= Observed F eterozygosity He = Expected Heterozygosity
N.B. Expected heterozygosity was computed using Levenes correction.
3.4.4.5. Allele Frequency
Allele frequencies were very similar in each year class at all loci, however larger alleles 
at loci Ssa202 and Ssal71 were much rarer than smaller alleles (Figure 3.5). Allele A at 
Ssa202 was very common in both year classes, while allele G at Ssal71 was far more 
common in the 1997 parents than the 1996. The allele distribution at Ssal97 (Figure
57 Chapter 3
3.6) was quite even, unlike those at Ssa202, Ssal71 and Ssa85; larger alleles at this 
locus were more common than at others. Allele H at Ssal97 was much more common 
in the 1997 parents and slightly distorts the even distribution of alleles. Allele 
distribution at Ssa85 (Figure 3.6) is very uneven, mostly due to allele G which is far 
more common than any other allele.
Genic differences between populations (year class) were calculated using Genepop, 
significant differences were found between allele frequencies at each year class at all 
loci (p = 0 .0 0 0 0 0 ).
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Figure 3.5: A comparison of allele frequencies for each parental year class at loci 
Ssa202 and Ssal71.
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Figure 3.6: A comparison of allele frequencies for each year class at loci Ssal97 and 
Ssa85.
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3.4.4.6. Hardy-Weinberg equilibrium
Results from Genepop 3.1a indicated that neither the 1996 parental fish nor the Skerries 
fish were in Hardy-Weinberg equilibrium. The probability that the groups were not in 
H-W equilibrium was highly significant at 0.0000 to infinity using %2 (Df: 8 ). However 
in the 1997 parents although Ssa202, Ssal71 and Ssa85 were not in Hardy-Weinberg 
equilibrium, Ssal97 was found to be. Values for the 1997 parents may be seen below.
Table 3.9: Hardy-Weinberg probability test results for the 1997 parents.
P-Value S.E.
Ssa202 0 . 0 2 0 1 0.0059
Ssal71 0 . 0 0 0 0 0 . 0 0 0 0
Ssal97 0.2375 0.0236
Ssa85 0.0238 0.0079
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3.5. Discussion
The initial task before any genotyping was carried out was to establish that the fish at 
Out Skerries were suffering from an outbreak of IPN. Bacteria were isolated from the 
fish and identified as Vibrio spp., however they were considered to be opportunistic, 
non-specific pathogens as determined by the very mixed cultures isolated. IPNV was 
isolated from moribund fish and histopathology carried out on the Skerries fish was 
indicative of clinical IPN.
A proportion of the post-smolts sampled at Skerries were very thin suggesting that some 
of the fish were failing to transfer to seawater and suffering from Failed Smolt 
Syndrome (FSS). In a classic outbreak of IPN it is often the larger, healthy looking fish 
which succumb to the disease and although the exact cause of FSS is unknown it has 
been speculated that IPN may play a contributory role. Smail et al. (1995) measured 
viral titres and histopathology of two groups of Atlantic salmon in Shetland, healthy 
smolts (mean condition factor, 0.91) and thin failing smolts (mean condition factor, 
0.71). Thin smolts demonstrated much higher viral titres than healthy fish, 109 TCID50 
g ' 1 and 104 '5 TCED50 g' 1 respectively and also exhibited marked pathology unlike that of 
the healthy fish. The mean condition factor for the fish sampled at Skerries was 0.8, 
suggesting that the fish were a mixture of both healthy and thin post-smolts. Although 
IPNV may have contributed to causing FSS in certain cases, possibly indicating a 
chronic condition, larger healthier fish were also susceptible to the virus suggestive of a 
classic acute IPN outbreak.
Mortalities during an outbreak of IPN vary from 2% to 20% (Smail et al. 1990, Smail et 
al. 1995). From the 4 cages at Skerries that contained the sentinel group mortalities
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peaked at 20%, therefore approximately 7800 fish were lost during the outbreak. Only 
a small number of dead fish were sampled for this study for varying reasons. Although 
the placement of the sentinel group at Skerries was considered to be the best option at 
the time the difficulties involved in mortality collection were not fully realised. Skerries 
Salmon employed divers to collect mortalities once a fortnight, additional dives were 
required to ensure collection of the majority of susceptible fish. Qualified staff at the 
farm did carry out an additional dive once during the fortnight increasing collection of 
mortalities to once a week, but due to time constraints were unable to dive more 
frequently. This was however still too infrequent to ensure good quality DNA from 
many fish. Unfortunately due to the location of Out Skerries, an island two hours from 
the Shetland mainland, there was only one day a week where divers could get on and off 
the island the same day by ferry. Mortalities decompose very quickly in a farm 
situation, meaning that many fish were lost before collection distorting the mortality 
figures. Also those fish that were sampled were only a small proportion of the data set 
since only whole fish were sampled at each dive, rendering the majority of the 
mortalities collected unsuitable for DNA sampling.
Analysis carried out on the 1996 parents predicted that 100% of the offspring could be 
assigned to one or more families and that 83% could be assigned unequivocally to only 
one family. Once it had been established that the farm was experiencing an outbreak of 
clinical IPN and that a high proportion of offspring could be assigned unambiguously to 
one family it seemed reasonable to genotype the DNA samples taken at Skerries. 
Analysis revealed only one third of the offspring could be assigned to their parents and 
reasons for this needed to be examined in detail to ensure confidence in the genotyping 
system. There were four likely possibilities for the lack of assignment; firstly that the
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samples had been genotyped incorrectly, secondly that the fish had been mixed at the 
hatchery with the rest of the production fish whose parents had not been genotyped. A 
third possibility was that the fish had been mixed during transfer to seawater and upon 
arrival at Skerries, a fourth possibility was that the given parental crosses might have 
been incorrectly recorded.
To ensure that each step of the methodology was accurate, the genotyping system was 
compared to the conventional genotyping system used to type the parents at The Marine 
Gene Probe Laboratory prior to sampling susceptible fish. A high degree of similarity 
was established between the two methods and the observed difference in allele sizes 
was found to be consistent at each locus and between gel runs. Later to support this the 
Skerries offspring were also genotyped more than once and the same results were 
obtained each time. A further possibility for the low numbers of individuals assigned to 
a family was data entry error whilst the data was being transformed for the parentage 
assignment programme, in an effort to exclude this the processing was repeated in total 
on 3 occasions with the same results obtained each time.
To examine the suggestion of mixing at the hatchery 64 siblings (one gel run) from the 
sentinel fish still maintained at the hatchery were genotyped. The number of fish 
sampled was very small but gave a clear indication that the fish were indeed being 
mixed at the hatchery as only 64% of the siblings could be assigned to a set of parents. 
Although this was double the percentage of matches for the Skerries offspring a third of 
the fish could still not be assigned to their parents. The data suggested that the fish 
were being progressively mixed firstly at the hatchery and later at seawater transfer and 
possibly also on arrival at Skerries. It was impossible to check for incorrect parental
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crosses, however the increase in matches with fish still at the hatchery suggested that 
mixing of the fish was more likely to be responsible for the lack of parental assignment 
rather than incorrect crosses.
In a final effort to prove that the genotyping system and the ABI 377 were accurate a set 
of four parents from the 1998 sentinel fish and 6  offspring from each pair were 
genotyped. The DNA was extracted at Landcatch and the PCR carried out at the 
laboratory at Landcatch and at Stirling. The results indicated that the genotyping 
system was capable of correctly calling alleles consistently despite the location of the 
PCR and also that the parentage assignment programme was functioning correctly. 
Three out of four groups of offspring were correctly assigned to their parents, however 
the fourth group of offspring did not match the given parents. It was later discovered 
that the fish had been incorrectly labelled at the hatchery and the wrong set of parents 
sampled. Yet again the sample size was very small but this only highlighted the fact 
that a larger sample was not needed to prove that the genotyping was accurate and that 
there were still problems at the hatchery even in the third year of the breeding 
programme.
In light of these problems it was decided not to sample IPN susceptible offspring from 
the 1997 parents. However the genetic data obtained from those fish was still of use in 
this study to examine variation in terms of allele diversity, heterozygosity and 
conformance with Hardy-Weinberg equilibrium.
It has been reported that wild stocks of Atlantic salmon are likely to have greater 
genetic variability than farmed salmon stocks (Cross and King, 1983, Verspoor, 1988).
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However upon examination of allelic diversity at the four microsatellites used in this 
study it would seem that this might not always be the case. O’Reilly et al. (1996) 
reported variation in polymorphism at the four loci in a wild population of salmon in the 
LaHave River to vary from 9 to 22 alleles. Norris, Bradley and Cunningham (1999) 
examined allelic diversity in wild salmon from various rivers in Ireland and the 
Numedalslagen River in Norway using the same microsatellites. In the Norwegian river 
allele number varied from 9 to 18 alleles, in the Burrishoole, in Ireland, allele number 
varied from 8  to 15 alleles. In comparison the allelic diversity in the present study was 
found to vary from 9 to 19 alleles suggesting that this farmed stock was no less variable 
in terms of number of alleles than wild populations. In support of this Norris et al. 
(1999) also examined allelic diversity in farmed stock of Atlantic salmon in Ireland, the 
number of alleles was found to be between 10 to 17. S sa l7 1 was found to be extremely 
variable in the Canadian population studied by O’Reilly et al., (1996) however it was 
not the most variable locus in the stocks examined in this study. Ssal97 and Ssa85 
were found to be the most variable loci in the present study, similar to that of both Irish 
and Norwegian populations examined by Norris et al., (1999).
O ’Reilly et al. (1996) examined heterozygosity in wild populations of Atlantic salmon 
in Canada for the four loci and found it varied from 80 to 91%. Heterozygosity in both 
Norwegian and Irish wild stocks were found to be between 79 and 92% (Norris et al., 
1999). Although farmed stocks did demonstrate lower heterozygosities, 74 to 8 6 % and 
35 to 92 % for Irish and Norwegian stocks respectively, the sample size was very small 
for the Norwegian stock and may have accounted for this. Heterozygosity varied from 
71 to 84% in all groups of Atlantic salmon in the present study, although lower than
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wild populations it compares favourably with heterozygosities of other farmed salmon 
stocks using the same microsatellites.
Although the above measures give an indication of variation within and between 
populations or groups of fish the frequency of the alleles at each locus is also very 
important. A group of parents may exhibit very high heterozygosity and have high 
allelic diversity at certain loci. However, if the distribution of alleles at a locus is not 
even many parents will share common alleles and the utility of the locus for parentage 
assignment is likely to be limited due to fewer possible genotypes (Letcher and King, 
1999). This was demonstrated to a degree in this study, despite no significant 
differences between mean heterozygosity between year classes there were highly 
significant differences between allele frequencies. Using simulations Letcher and King
(1999) established that with four loci with a normal distribution and at least seven 
alleles at each locus it should be possible to identify 1 0 0 % of offspring to a set of 
parents.
Norris et a l (1999) upon examining variability between two farmed Norwegian stocks 
and one Irish stock noted that one unnamed Norwegian stock (most likely Akevagen) 
was much less variable in terms of heterozygosity, allele number and allele size 
variance than the others. The particular stock was in its sixth year of combined family 
and individual selection, the farm maintained - 2 0 0  families of salmon from each 
generation and approximately 2 0 % of the families were used to provide parents for each 
successive generation. Norris et al. (1999) suggested that family selection reduced the 
effective population size by maintaining a limited number of families, resulting in a
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decrease in genetic variability in terms of allelic diversity which was not detectable 
from levels of heterozygosity.
Although the loci used in this study exhibited high heterozygosities and numbers of 
alleles, the distribution of alleles was not particularly even at certain loci, especially 
Ssa202 where many individuals shared very common alleles. It is probable that in the 
stock used in this study the four microsatellites may not have been adequately variable. 
It is suggested that the number of microsatellites used to identify offspring be increased 
in the future to allow maximal parentage assignment. Norris, Bradley and Cunningham
(2 0 0 0 ) noted that increasing the number of microsatellites in their system from four to 
eight resulted in very little extra discrimination because in their population the extra 
markers were not very variable. For this reason it is also suggested that any new 
markers added to the genotyping system be screened for variability within the particular 
population in use prior to addition.
The Landcatch stock was originally 5 strains of Atlantic salmon that were maintained as 
separate entities within the hatchery, these strains have since 1996 been used in a cross 
breeding experiment to eventually homogenise the stock as one. It is not likely that all 
the year classes have yet been homogenised as regards genetic variation, however the 
numbers of alleles and heterozygosities observed in the two year classes in this study 
suggests the cross breeding is succeeding in maintaining genetic variation. It will 
eventually result in all alleles being present in all generations.
The majority of the data analysed was found not to be in Hardy-Weinberg equilibrium, 
however many of the assumptions that are made when testing for Hardy-Weinberg
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equilibrium are not applicable to farmed stocks. Such significant departures from HW 
equilibrium indicates that one or more of the preconditions for observing HW 
equilibrium do not hold (Lessios, 1992). On comparison of the observed
heterozygosities with expected there seems to be no consistent reason why the data did 
not fit into HW equilibrium. From the data generated it is possible to see that certain 
loci exhibited an excess of homozygotes while others exhibited an excess of 
heterozygotes. An excess of homozygotes at all loci would suggest that null alleles 
were a reason for the disequilibrium, however since certain loci exhibited an excess of 
heterozygotes null alleles were not likely to be the cause of the data not fitting into HW 
equilibrium. The groups of fish used in this study were from a population that was not 
infinitely large as a wild population would be and a large proportion of the parental 
population was tested. Testing such a high proportion of the population gives the study 
a high power to detect disequilibrium with HW and it would be almost expected that the 
data would not fit into HW equilibrium since it falls so far short of meeting the 
assumptions made when testing for HW equilibrium.
During the development of the multiplex PCR various problems were encountered with 
allele scoring at two loci, Ssal97 and Ssa85, scoring errors were very uncommon at 
Ssa202 and Ssal71. The use of semi-automated technology simplifies the calling of 
alleles using GeneScan™ software with preset analysis parameters to call the peaks and 
Genotyper™ software that later extracts the genotypes. However it was still necessary 
to manually sort through all individuals which Genotyper™ called as homozygotes at 
Ssal97 and Ssa85. Differential amplification of smaller alleles over larger alleles at 
these two loci was the reason for almost all size calling errors, in this situation 
Genotyper™ would call an individual as a homozygote for the smaller allele. The
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reason for this was that Genotyper™ was programmed to filter allele peaks that were 
less than 32% of the size of the highest allele at a locus, in this way stutter peaks were 
eliminated. Differential amplification at Ssa85 only occurred when the genotype 
included the smallest allele (123 bases), however as a precaution all homozygotes at this 
locus were checked manually in GeneScan™. A possible reason for the differential 
amplification may be DNA template quality, due to the potential for large numbers of 
DNA samples it was necessary to use a rapid but crude DNA extraction method. DNA 
extracted in this way is likely to be of a lesser quality than that extracted by traditional 
phenol/chloroform methods and may have lead to the preferential amplification of the 
smaller allele.
Locus Ssal97 was found to exhibit partial null alleles, the larger allele would amplify 
but often very weakly in comparison to the smaller, Genotyper™ would then call the 
individual a homozygote. The problem was overcome by manually checking all 
homozygotes at Ssal97 as for Ssa85 in GeneScan™, however this significantly limited 
the efficiency of the semi-automated system. O’Reilly et a l (1998) also encountered 
this problem with this locus using radioactive genotyping and suggested it may have 
been due to DNA sequence variation or deletions in regions encompassing the primer 
sites. Pemberton, Slate, Bancroft, Barrett (1995) and Callen, Thompson, Shen, Philips, 
Richards, Mulley, Sutherland (1993) previously suggested this possibility for human 
genotyping systems.
Fishback, Danzmann, Sakamoto and Ferguson (1999) developed an octaplex and 
hexaplex PCR system for genotyping rainbow trout, they experienced similar problems 
to those discussed above. One problem was differential amplification of smaller alleles
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over larger alleles, they found that increasing the potassium chloride (KC1) from 50mM 
to lOOmM in the PCR alleviated the problem. This may be considered as a possibility 
for future work. Fishback et al., (1999) also found problems with ‘plus A ’ modification 
of certain alleles, this is the non-templated adenylation of the 3’ end of the amplified 
sequence by Taq polymerase (Brownstein, Carpten and Smith, 1996). Fishback et al., 
(1999) found that minimising primer concentrations (0.016 to 0.325 pM) and increasing 
Taq polymerase concentration (up to 3 units in a 15pl PCR volume) resulted in 
consistent ‘plus A ’ modification of alleles for all loci. Plus A modification was not a 
problem in the current study, after researching the problem PE Applied Biosystems 
recommended the addition of 30 minutes at 60°C after the final extension of the PCR 
with no hold at 4°C. ‘A’ addition is affected by limiting reagents especially in a
multiplex PCR, as a result adenines will not be added to all copies of an allele; alleles 
can therefore appear as a split peak. A rapid drop in temperature from 72°C to 4°C can 
also cause problems as a proportion of the adenines may drop off with the sudden 
change in temperature. The addition of 30 minutes at 60°C caused the adenylation of 
almost all copies, ensuring single peaks. Primer and Taq concentrations used in the 
present study were very low, however it may be beneficial to examine the effect of 
increased Taq and KCL concentrations on the multiplex as tried by Norris et al. (1999) 
to eliminate problems such as differential amplification.
Although this work was unsuccessful in determining differences in resistance to IPN 
between families of Atlantic salmon it was still possible to analyse the data for 
variability. The variation in the farmed salmon stock used in this study was found to be 
very similar to that of other farmed Atlantic salmon. The utility of the microsatellites in 
this particular stock was examined and found to be good, although it may be useful if
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additional microsatellites are added to the multiplex for increased discrimination. In 
conclusion it must be acknowledged that this work was carried out using salmon 
hatched during the first year the breeding programme had been in place at Landcatch. 
The results have demonstrated the need for a trial period to iron out such unforeseen 
problems before embarking on a detailed research programme. This study does at least 
serve to demonstrate some of the problems involved in integrating scientific research 
with large-scale production. However the problems enabled the accuracy of the 
fluorescently adapted genotyping system to be thoroughly scrutinized ensuring its’ 
utility for parentage assignment in a commercial situation in the future.
72 Chapter 3
4. Investigations into Variation in Disease Resistance between families of Atlantic 
salmon and Aspects of the Humoral Immune Response to IPNV
4.1. Introduction
Considering the economic problems caused by IPNV in both Shetland, Norway and 
more recently in Chile it is desirable to develop vaccines against IPNV or ideally 
disease resistant fish. To achieve this a reproducible experimental challenge model is 
necessary to determine the efficacy of a potential vaccine and also to establish resistant 
or susceptible families of fish. Several challenge models with IPNV in Atlantic salmon 
post-smolts have been published (Strangeland, Hoie, Taksdal, 1996, Taksdal, Ramstad. 
Strangeland, Dannevig, 1998). However despite the demonstration of mortality, virus 
isolation and lesions indicating clinical IPN by Strangeland et a l, (1996) their method 
was found not to be reproducible. Taksdal et al., (1998) found that their fish were latent 
carriers of IPNV and induction of clinical IPN may have been due to a stress mediated 
recurrence such as that demonstrated by Roberts and McKnight (1976) in rainbow trout. 
Currently there is no experimental challenge model available for IPNV in post-smolts 
and vaccination efficacy trials and disease resistance challenges have been based on the 
ability of fish to clear the virus after challenge (Ellis, 2000).
Challenges with IPNV in young salmonids have often been successful (Frantsi and 
Savan, 1971, Elahzary, Lagace, Cousineau and Roy, 1976, Silim, Elazhary and Lagace, 
1982, McAllister and Owens, 1986, Bootland, Dobos and Stevenson, 1990, Dorson et 
a l,  1992, Shankar and Yamamoto, 1994). Recently there have been reports of 
successful IPN challenges using families of very small Atlantic salmon fry (0.17 g) in 
Norway (Taksdal, Strangeland, Dannevig, 1997, Ramstad et a l, 1997). Ramstad et al. 
(1997) found varying degrees of susceptibility between different families of Atlantic
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salmon fry. These fish were challenged before the onset of immunocompetence and 
while this does demonstrate the potential for improving disease resistance to IPN it is 
unknown how this relates to differences in susceptibility at the post-smolt stage.
Various studies on genetic variation in immune response in fish suggest that certain 
immune parameters may have potential as markers for disease resistance (Balfry et al., 
1994, Fevolden, Roed and Gjerde, 1994, Lund et al., 1995a, 1995b, Wiegertjes, Stet and 
van Muiswinkel, 1995). The use of marker assisted selection for increased disease 
resistance is a strategy that among other things circumvents the risk of having to 
challenge the population with the disease agent (Roed et a l, 1992). Knowledge of the 
immune response of Atlantic salmon to IPNV may reveal an immune parameter that is 
associated with increased disease resistance and may have potential as an immune 
marker.
4.2. Aims
1. To establish an experimental challenge model for IPNV in post-smolt Atlantic 
salmon.
2. To challenge different families of Atlantic salmon post-smolts using the model.
3. To examine differences in mortality and virus titre between the different families.
4. To measure various humoral immune parameters in response to IPNV infection 
between the families to examine possible mechanisms of resistance.
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4.3. Methods 
4.3.1. Challenge 1
4.3.1.1. Fish Acclimatisation
Atlantic salmon were obtained from Howietoun Fish Farm at Stirling. The fish farm 
was regularly tested by the Scottish Office for IPNV and the virus had never been 
isolated, indicating IPNV free status. The 500 SVi’s were transported to the CEFAS 
laboratory, Weymouth, Dorset, in freshwater, the average weight of the fish upon 
arrival was 39 g. The fish had been vaccinated using the triple vaccine against 
Aeromonas salmonicida, Vibrio anguilcirum and Vibrio salmonicida with oil adjuvant 2 
months prior to transport to Weymouth. The fish were placed into a 2 metre tank of 
freshwater, the water temperature on arrival was 6 ° and this was gradually increased 
over 48 hours to 10°C. The fish were left to acclimatise for 4 days in freshwater. After 
4 days the water flow was switched to seawater and within 4 hours the fish were in full 
salinity seawater.
4.3.1.2. Infective Material
The IPNV isolate was originally isolated from Brindister, Shetland in the summer of 
1998 at a site where mortalities caused by IPNV were very high and was kindly 
provided by Dr. David Smail, SERAD Marine Laboratory, Aberdeen. The virus was 
cultured by pre-formed inoculation of virus onto CHSE-214 cells; the virus was 
passaged twice through cells, harvested and titrated as in Chapter 2.
4.3.1.3. Challenge
Prior to challenge kidneys were sampled from 10 fish to ensure the fish were IPNV free. 
Fish were challenged 48 hours after transfer to seawater and held at 10°C throughout
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the trial. The fish were split into 4 groups of 120; 75 fish from each group were 
injected, the other 45 were to act as co-habitants and were not injected but fin clipped 
for identification purposes. The negative control group was injected intra-peritoneally 
(EP) with 0.1 ml of HBSS (Gibco) plus 2% FBS (Gibco). The other 3 groups were IP 
injected with 0.1 ml of 106, 105, 104 TCIDso/ml IPNV. For the challenge the fish were 
moved to four 1 metre tanks, with 14 hours daylight. Fish were fed smolt transfer diet 
at 1.5 % of their body weight on automatic feeders.
4.3.I.4. Disease Sampling
Fish were monitored twice daily for 28 days, mortalities and moribund fish were 
removed and the kidney sampled for virus isolation. Moribund fish and fish used for 
sampling were terminally anaesthetised (Chapter 2). At day 14 a kidney sample was 
taken from 2 fish from the highest dose tank (106 TCIDso/ml) and the control tank. 
These samples were processed as in Chapter 2 and placed onto CHSE-214 cells, for a 
rapid diagnosis samples were also tested by Enzyme Linked Immunosorbant Assay 
(ELISA).
At day 21, 10 fish were sampled from the highest dose tank and the control tank. All 
organs were sampled for histopathology, kidneys were sampled for virus isolation, 
processed and placed onto cells as in Chapter 2. Blood samples were taken from the 
caudal vein; blood was collected using Terumo 2 ml syringes and Terumo 0.5 x 16 mm 
needles. The blood was left to clot overnight at 4°C and centrifuged at 3500 g for 5 
minutes in an MSE Mistral 3000i centrifuge. Serum was removed and pooled for each 
group of fish and frozen at -70°C until it could be assayed for neutralising antibody to 
IPNV.
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4.3.I.5. ELISA
A flat bottomed 96 well plate (Iwaki) was coated with anti-IPNV y globulin purified 
from rabbit polyclonal antiserum supplied by Keith Way at a concentration of 5 pg/ml 
in bicarbonate buffer (pH 9.6, Appendix 1) and incubated overnight in a waterbath at 
22-26°C. After this time the plate was washed using a rinse and one 2 minute wash 
with PBS-thiomersal (Appendix 1), in a Dynatech MR7000. Each well was blocked 
with 200 pi 5% fish skin gelatin (FSG, Sigma) in bicarbonate buffer (pH 9.6), and 
incubated in a water bath at 37°C for 1 hour. The plate was washed as previously with 
PBS-thiomersal.
The sample to be tested was used neat and diluted to 1:16 using doubling dilutions made 
in PBS-Tween20 (PBST) with 2.5 % FSG (Appendix 1), both positive and negative 
controls were diluted 1:20 in PBST plus 2.5 % FSG. Duplicate 100 pi aliquots of each 
sample and controls were incubated for 30 minutes at 37°C in a water bath. The plate 
was washed using a rinse followed by 3 x 2 minute washes with PBST. Biotinylated 
anti-EPNV y globulin provided by Keith Way was diluted 1:1000 with PBST plus 1.5 % 
bovine serum albumin (BSA) (Appendix 1). Into each well 100 pi of biotinylated y 
globulin was added and incubated for 30 minutes at 37°C and the previous washing step 
repeated. ExtrAvidin HRPO conjugate (Sigma) was diluted 1:1000 in PBST+BSA and 
100 pi added to each well and incubated for 30 minutes at 37°C. The previous washing 
step was again repeated and the wells finally rinsed with distilled water. The wells were 
thoroughly drained by tapping the plate on absorbent paper. The substrate indicator 
solution was prepared by dissolving one tablet of the substrate, 3,3’, 5,5’, tetramehyl- 
benzidine dihydrochloride (TMB, Sigma) in 10 ml of phosphate-citrate buffer with
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sodium perborate (Sigma). Into each well 100 (ill of the indicator was added to plus 2 
extra wells to act as blanks. After 5 minutes the reaction was stopped with 25 pi 10 % 
H2SO4 (Sigma). The plate was then read at 450 nm on the Dynatech MR7000.
4.3.2. Challenge 2 
4.3.2.1. Fish
Future challenges were carried out at the SERAD Marine Laboratory at Aultbea, Wester 
Ross. Atlantic salmon were kindly provided by the Marine Laboratory, the fish had 
been bought in as eggs and on-grown to S i ’s on site. Atlantic salmon were put to sea 2  
days prior to injection with IPNV; the average weight of the fish was 35 g. Fish were 
maintained in 1 metre tanks at ambient seawater temperature (Appendix 4) with 12 
hours daylength.
4.3.2.2. Infective material
In an effort to increase the virulence of IPNV two isolates of the virus were chosen to 
passage through fish. The first isolate was from the previous challenge (Br); the second 
was isolated from Out Skerries, Shetland in the summer of 1998 (Os). Fish were 
injected with IPNV infected kidney homogenate.
4.3.2.3. Passage 1
A group of 50 Atlantic salmon were anaesthetised (Chapter 2), 20 fish were IP injected 
with 0.1 ml of 103 5 TCIE>5o/ml IPNV isolate Br, another 20 fish were IP injected with 
0.1 ml of 1015 TCID50/111I IPNV isolate Os. The average seawater temperature during 
the challenge was 7.7°C. After 10 days 5 fish from each group were terminally 
anaesthetised and head kidney sampled from each fish. At 28 days the remaining fish
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were terminally anaesthetised and head kidney sampled; kidneys from group Br. were 
pooled into 4 groups, kidneys from group Os. were pooled into 8  groups. Kidneys were 
processed and immediately titrated on CHSE-214 cells (Chapter 2).
4.3.2.4. Passage 2
Based on the results of the earlier passage a group of 25 Atlantic salmon were IP 
injected with 0.1 ml of kidney homogenate from the previous passage, 106 TCIDso/ml 
IPNV isolate Os. The average seawater temperature during the passage was 9.6°C. At 
10 days post infection all fish were terminally anaesthetised (Chapter 2), head kidney 
was sampled from each fish and pooled into 5 groups of 5. Kidneys were immediately 
processed (Chapter 2) and diluted with HBSS plus 2% FBS (Gibco) to give the 
appropriate volume of kidney homogenate for the family challenge. Kidney 
homogenate was stored at 4°C overnight.
4.3.3. Family Challenge
4.3.3.I. Fish
Various families of Atlantic salmon were maintained from hatching until 6  months of 
age in separate tanks at Landcatch. At 8  months of age 2250 fish from 30 families were 
individually tagged with Passive Integrated Transponders (PIT-tags) (Trovan) injected 
into the abdominal cavity and maintained together in one tank until seawater transfer. 
The fish were vaccinated using Furogen 2 against Aeromonas salmonicida with oil 
adjuvant prior to seawater transfer. The fish were transferred to Aultbea Marine 
Laboratory by road in freshwater and immediately placed straight into seawater upon 
arrival at Aultbea.
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Only 24 families could be used in the challenge for practical reasons, fish were 
randomly picked from the tanks and subsequently anaesthetised (Chapter 2) and 
scanned for family data. In each family there was a total of 75 fish; 25 were to be a 
control group and the other 50 were to be split into 2 groups of 25 to act as replicate 
infected groups. The fish were allocated to 1 metre tanks according to family with 6  
families per tank, the time taken to complete this process was 10 days. Families were 
allocated to tanks on a first scan basis and replicate tanks did not contain the same mix 
of families (Figure 4.1). The fish were left for 14 days after this but prior to challenge 
to acclimatise. The fish were an average weight of 100 g and were at a stocking density 
of approximately 15 kilos/m . Fish were fed transfer diet at 1.5 % body weight on 
automatic feeders with ambient daylight (approximately 16 hours) and ambient 
seawater temperature (Appendix 4).
Prior to challenge 50 fish were terminally anaesthetised as above; blood samples were 
taken from the caudal vein of every fish using 5 ml serum vacuettes with serum 
separator (Greiner). Head kidney was sampled for virus isolation, pooled into groups of 
5 and stored at -80°C until processing. A swab was taken from each pool for bacterial 
isolation, and the kidneys processed as in Chapter 2. As a measure of health of the fish 
haematocrit was measured in every fish, the results were grouped into 1 0  groups 
corresponding to the pools for bacteriology and virology. Blood was taken up into a 
non-heparinised capillary tube (Kamlab) and sealed with Cristaseal (Alpha Supplies), 
the tubes were placed into a micro-haematocrit centrifuge and centrifuged at 9,300 g for 
10 minutes. Packed cell volume (PCV) was measured using a haematocrit scale. 
Whole blood was centrifuged using a Hereas Biofuge A at 4000 g for 20 minutes; serum 
supernatant was removed and stored at -80°C.
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4.3.3.2. Challenge
Fish were challenged 4 weeks after arrival at Aultbea. All fish were anaesthetised as in 
Chapter 2; fish were either IP injected with 0.1 ml HBSS plus 2% FBS (Gibco) or 0.1 
ml 103 5 T d D 50/ml IPNV kidney homogenate. All fish were stressed 3 times a week by 
lowering the water level for 10 minutes. The average seawater temperature during the 
challenge was 11.8°C (Appendix 4).
4.3.3.3. Disease Sampling
Fish were monitored twice daily for 7 weeks by staff at the laboratory, mortalities were 
removed and frozen at -20°C until the kidney could be sampled for virus isolation and 
PIT tag removed. Fish were sampled at week 3; 2 fish from each family in the control 
group and 3 fish from each infected family and at week 7; 5 fish from each control 
family and 10 fish from each infected family (where possible). However only 6  
families were selected from the week 7 sampling to be processed, 2 families with low 
IPNV titres, 2 with medium titres and 2 with high titres at the week 3 sampling. Where 
Vibrio lesions were visible a swab was taken and streaked onto TSA plus salt agar and 
bacteria identified using methods detailed in chapter 2. Water flow in 4 tanks was 
interrupted 2 days prior to the week 3 sampling and many fish were lost, 2 tanks of 
these fish were frozen and kidneys later removed from 1 0  fish per family to help 
corroborate the week 3 IPNV titres.
Fish were terminally anaesthetised as in Chapter 2. Head kidney, blood and all organs 
for histopathology were sampled from each fish (Chapter 2); kidneys were frozen at - 
70°C until processing (Chapter 2). The blood was left to clot overnight at 4°C and
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centrifuged at 4000 g for 5 minutes in a Hereas Biofuge A centrifuge; serum 
supernatant was removed, aliquoted and stored at -70°C. Virus isolated from every tank 
at each sampling point was confirmed as IPNV A2 (Sp.) strain by neutralisation titration 
(Chapter 2).
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Figure 4.1: Plan of Aultbea Family challenge. Numbers in circles refer to family;
numbers outside refer to tank.
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4.3.3.4. Additional post-smolt sampling
Post-smolt Atlantic salmon from a different stock to those challenged but still 
maintained at Aultbea in a different tank room were sampled 4 weeks after the end of 
the family challenge. Head kidney was sampled from 10 fish, a different scalpel was 
used for each fish and kidneys freshly processed (Chapter 2).
4.3.4. Immunology assays
4.3.4.1. Neutralising antibody assay
A 1:5 dilution of test serum in EMEM was prepared. EMEM (without L-Glutamine, 
Gibco) was supplemented with 2% FBS (Gibco), 2 mM L-Glutamine (Gibco), lx non- 
essential amino acids (Sigma), 50 IU/ml penicillin, 50 jllg/ml streptomycin and 100 
pg/ml kanamycin (Gibco). The diluted test serum was heated for 30 minutes at 45°C in 
a waterbath to inactivate the complement component. Using a flat bottomed 96 well 
plate (Iwaki) 110 pi of supplemented EMEM was placed into each well. Test serum 
was diluted 2-fold across the plate beginning with 1:10. Previously titrated IPNV was 
diluted to give 100 TCID50/IOO pi and 100 pi added to test wells and mixed. Each plate 
contained negative controls (no virus) and virus only controls. The plate was incubated 
at 15°C for 1 hour.
Prior to this a 96 well plate was seeded with CHSE-214 cells and grown to 80% 
confluence. Each well contained 100 pi of supplemented EMEM plus 10% FBS, using 
a multi-channel pipette 1 0 0  pi of the virus/serum mix and controls was transferred to 
duplicate wells with the cell monolayer. The plate was incubated in a 2 % C 0 2 
incubator at 15°C until complete CPE was observed in the virus only controls.
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4.3.4.2. Lysozyme assay
This assay was adapted from the method of Osserman and Lawler (1966). A 1 % 
agarose solution was prepared by dissolving 1 g of agarose in 80 ml of sodium 
phosphate buffer (SPB, Appendix 1). In a further 20 ml of SPB 50 mg of Micrococcus 
lysodeikticus (Sigma) was added and thoroughly mixed by vortexing. Once the 
temperature of the agar had dropped to 70°C the two solutions were mixed and poured 
into a bioassay tray (Nunc) to set. Lysozyme standards were prepared using hen egg 
white lysozyme (HEWL, Sigma). Into 10 ml of SPB 10 mg of HEWL was dissolved to 
give an activity of 506,000 lysozyme units, 1:10 dilutions were made to give further 
activities of 50,600, 5060, 506, 50.6 and 5.06. Wells of 6  mm in diameter were 
punched into the agar and 10 pi of neat serum, lysozyme standards and a control of SPB 
added to separate wells. Each sample was run in duplicate. The plate was incubated for 
24 hours at 22°C. Zones of clearance were measured using calipers (Camlab); 
lysozyme concentration of serum was estimated from a standard curve of known 
lysozyme concentrations.
4.3.4.3. Interferon production
Interferon production was attempted to act as a positive control for the interferon assay. 
A 24 well plate (Iwaki) was seeded with rainbow trout gonad (RTG-2) cells and 
incubated in a C 0 2 incubator at 15°C until at 80 % confluence. RTG-2 cells were 
propagated in EMEM (without L-glutamine, Gibco) supplemented with lx non- 
essential amino acids (Gibco), 2 mM L-Glutamine (Gibco), 10 % FBS (Gibco), 50 
IU/ml penicillin, 50 pg/ml streptomycin and 100 pg/ml kanamycin (Gibco) was used to. 
Polyinosinic:polycytidilic acid (poly I:C, Sigma) was used to stimulate interferon 
production. In 10 ml of supplemented EMEM without FBS 1 mg of poly I:C was
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dissolved to give a concentration of 100 p.g/ml. This was further diluted to give 50 
p.g/ml and 75 p.g/ml. Media was removed from the RTG-2 monolayer and 1 ml of each 
of the three concentrations and a mock of supplemented EMEM without FBS were 
placed onto the cells in quadruplicate. The plate was incubated in a C 0 2 incubator at 
15°C for 3 hours after which time 100 pi of FBS was added to give a final concentration 
of 10 % and the plate further incubated for 72 hours. Interferon was harvested and 
centrifuged at 400 g for 10 minutes and frozen in aliquots at -20°C. Interferon 
production was repeated using concentrations of 50 fig/ml, 100 p.g/ml, 150 (ig/ml and 
200 pg/ml of poly I:C.
4.3.4.4. Interferon assay
Measurement of interferon (IFN) activity was attempted using the spectrophotometric 
assay of Secombes (1994). Various cell lines were tried for this assay; CHSE-214 cells, 
rainbow trout gonad (RTG-2) cells and Atlantic salmon (AS) cells. A 96 well plate was 
seeded with cells and grown to 80 % confluence in fully supplemented EMEM (Gibco) 
containing 10 % FBS. Using a 96 well plate 10-fold dilutions of test serum were made 
in fully supplemented EMEM with 10 % FBS starting with 1:10 to a volume of 100 pi. 
The medium was removed from the cells and the cells treated with diluted test IFN 
samples. Media was also removed from mock rows and replaced with fresh EMEM 
plus 10 % FBS. The plate was incubated at 15°C in a 2 % C 0 2 incubator. After 24 
hours the samples were removed and the cells washed with EMEM containing 2 % 
FBS. Previously titrated IPNV was diluted to 100 TCID50/IOO pi in 2 % FBS EMEM 
and 200 pi of virus added to all wells including a positive control row of virus only. As 
a negative control one row was covered with EMEM only. The plate was incubated at 
15°C until advanced CPE was evident in the positive control.
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4.5. Results
4.5.1. Challenge 1
4.5.1.1. Mortality
Throughout the trial at CEFAS there were very few mortalities. The control fish 
experienced the highest mortality, with a loss of 4 fish, however these fish were fin- 
clipped and death was likely to be due to tail fin erosion. The group injected with 104 
TCID5o/ml experienced only one mortality 2  days after challenge that was attributed to 
stress experienced during infection. The group injected with 105 TCK W m l suffered no 
mortalities and the group injected with 106 TCIDso/ml suffered only 2 mortalities at day 
20 .
Table 4.1: Mortalities during Challenge 1 at CEFAS.
Days post 
infection
Controls 104TCIDso/inl 105TCID5o/ml 106TCID5o/ml
2 - 1 - -
6 1 - - -
16 1 - - -
20 2 - - 2
4.5.I.2. Disease sampling
4.5.1.2.1. Mortalities
IPNV was not isolated in cell culture from any of the control group mortalities, but was 
isolated from the mortality in the lowest dose group and those in the highest dose group. 
Titration of IPNV from the moribund fish and the mortality in the highest dose group 
gave titres of 106 and 105 T d D 50/ml, respectively. Histopathology from the moribund 
fish was indicative of clinical IPNV.
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4.5.1.2.2. Sam pled fish
The 10 fish sampled at the beginning of the trial were IPNV negative in cell culture. 
Those sampled at day 14 post IPNV injection were tested for IPNV using both ELISA 
and cell culture; all fish sampled were IPNV negative using both methods.
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Figure 4.2: Detection of IPNV in the day 14 samples using ELISA.
The fish sampled at day 21 from the control tank were IPNV negative in cell culture. 
From those sampled from the 106 TCIDso/ml tank only 5/10 were found to be IPNV 
positive in cell culture. Sera sampled from these fish were found to contain no 
neutralising antibodies to IPNV.
4.5.2. Challenge 2
4.5.2.I. Passage 1
Mortalities were not produced during this challenge. Table 4.2 shows that at day 10 
post infection 4/5 fish injected with isolate Br. (used previously for the challenge at 
CEFAS) had cleared the virus, only one fish remained infected with a titre of 103 1
:
fish 1 fish 2 control negative positive
106 TCIDso/ml controls
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TCID5o/g kidney. However 4/5 fish injected with isolate Os. were positive for IPNV 
with virus titres higher than that injected.
Table 4.2: TCID50 IPNV /g kidney at day 10 in a sample of 5 fish for each virus isolate.
Fish Group Os. Group Br.
1 104'1 0
2 1041 103‘
3 0 0
4 107-6 0
5 10“ 0
Based on these early results and the previous challenge isolate Os. was chosen to use in 
the family challenge and to passage further. The remaining 15 fish in both groups were 
sampled at day 28, the external appearance of the 2 groups was very different. The 
group injected with Os. were very dark and thin making them easily distinguishable 
from the other group. IPNV titres for the group injected with Os. may be seen in Table
4.3. All pools sampled at day 28 from the group injected with isolate Br. were found to 
be IPNV positive but CPE was visible much later than those from isolate Os. and were 
not titrated.
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Figure 4.3: M ean (± S.E.) packed cell volume in Atlantic salmon sera (pools of 5 fish) 
prior to challenge with IPNV.
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Figure 4.4: Lysozyme activity in Atlantic salmon sera (pools of 5 fish) prior to 
challenge with IPNV.
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Interferon production was apparently unsuccessful as determined by the lack of 
protection given to RTG-2 cells upon challenge with IPNV after incubation with Poly 
I:C stimulated RTG-2 cell supernatant. Various attempts to assay interferon in Atlantic 
salmon serum using both CHSE-214 cells and RTG-2 cells were unsuccessful; both cell 
lines remained susceptible to IPNV post incubation with serum. Incubation of salmon 
serum using AS cells was also unsuccessful, although interferon may have been present 
the cells were found to be refractory to IPNV.
4.5.3.2. Mortality
IPNV was isolated from all mortalities, including all the control fish. Mortality during 
the challenge was mixed, although some deaths in the infected groups may have been 
attributable to IPN, the majority of fish are likely to have died of Vibriosis, identifiable 
by the large lesions on the fish. Where lesions were noted and a swab was taken the 
resultant bacterial growth was identified as Vibrio spp. but was considered to be non­
specific. It is likely that all control fish died of Vibriosis, since lesions were noted on 
the majority of mortalities. Mortality varied greatly between families (Table 4.4), 
certain families exhibited no mortality (193 and 189) despite IPNV infection, whilst 
others, for example families 198, 167 and 192, suffered quite a high mortality. 
Generally mortality in control groups was much lower with the exception of 179 and 
168 where mortality was higher in the controls. However, mortality figures in the 
infected family groups was greatly distorted by the loss of 4 tanks of fish at week 3, 
therefore no statistical analysis was carried out.
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Table 4.4: Total mortality in each family during IPNV infection.
Family Infected Controls
(n=50) (n=25)
198 18 0
186 13 0
177 13 0
192 16 0
185 5 0
196 9 2
193 0 0
184 1 0
195 4 0
174 7 2
189 0 0
188 12 1
180 6 5
181 4 2
170 14 1
187 5 0
167 16 2
179 1 4
171 1 0
168 3 6
173 4 1
172 1 1
169 11 2
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4.5.3.3. Week 3 sampling
4.5.3.3.I. IPNV infected families
IPNV titres in the infected fish varied greatly between families. Figure 4.5 (overleaf) 
shows that families such as 185, 192, 177 and 189 have very low titres of virus as 
compared with, 169,188 and 173. The majority of the families have IPNV titres ranging 
between 105 and 107 T d D 50/g kidney. Family 185 has a particularly low virus titre, 
however 2/3 fish sampled from this family were IPNV negative, 1/3 fish sampled from 
family 192 was also IPNV negative. No IPN pathology was observed in any of the fish.
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A one way ANOVA showed a highly significant difference between the virus titres in 
each family at week 3 (F = 4.98, p = 0.000). Tukey’s pairwise comparisons showed 
significant differences between certain families as seen in the table below. Families 169 
and 173, those with the highest titres, and 185 with the lowest titre showed the most 
significant differences with other families. Families with no significant differences at 
all are not represented in Table 4.5.
Table 4.5: Results of differences in virus titre between families of salmon sampled at 
week 3 using Tukey’s pairwise comparisons.
177 180 185 189 192 195 198 188 181 169 168 171 173 174
180 -
185 - -
189 - - -
192 - - - -
195 - - - - -
198 - - - - - -
188 + - + + + - -
181 - - + - - - - -
169 + + + + + + + - -
168 - - + - + - - - - -
171 - - + - + - - - - - -
173 + - + + + - + - - - - -
174 - - + - - - - - - - - - -
179 - - + - - - - - - - - - “
N.B. + represents a significant difference.
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4.S.3.3.2. Supplem entary  week 3 samples
IPNV titres in the supplem entary fish were very similar to the 3 fish sampled at week 3 
in 7 out of the 9 families (Figure 4.6). The two different sampling methods (freezing 
whole fish com pared to immediate sampling) gave very similar results for almost all 
families, with two main exceptions, family 188 and 169. These families have a lower 
virus titre in the supplem entary fish than the week 3 samples. Family 169 showed a 
difference o f 2 orders o f magnitude, but the difference in family 188 was most marked 
with a difference o f 103 TCIDso/g kidney.
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Figure 4.6: Comparison o f mean (±S.E.) logio TCID50 IPNV /g kidney between the 
week 3 samples and the supplementary week 3 samples.
A two way ANOVA comparing virus titres between family showed highly significant 
differences (F = 7.02, p = 0.000), comparing titre between the two samples but within
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family also showed overall highly significant differences (F =3.53, p = 0.001) but this 
was due to one family. However, Tukey’s pairwise comparisons among family showed 
no significant differences between titres in the two groups for every family with one 
exception, family 188. The two sets of data for family 188 were found to be 
significantly different (p = 0.014).
A one-way ANOVA comparing the virus titres between families in the supplementary 
group showed highly significant differences (F = 4.31, p = 0.000). Tukey’s pairwise 
comparisons showed differences between family 180 with 169, 170 and 186, and 187 
with 169 and 170 (Table 4.6).
Table 4.6: Results of differences in virus titre between families in the supplementary 
groups sampled at week 3 using Tukey’s pairwise comparisons.
170 169 186 180
169 -
186 - -
180 + + +
187 + + - -
N.B. + represents a significant difference.
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4.5.3.3.3. Control families
Certain families sampled at week 3 were found to be IPNV positive for A2 serotype by 
cell culture and neutralisation (Table 4.7). In 9 families both fish sampled were 
positive, in another 2 families only one fish was positive. Almost 50% of the families 
sampled were IPNV positive, however histology did not reveal any IPN pathology in 
any of the control fish.
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Table 4.7: Number of fish in the control families infected with IPNV at week 3 post 
injection.
Family IPNV positive
198 0
186 1
177 0
192 0
185 0
196 2
193 1
184 0
195 0
174 2
189 2
188 2
180 0
181 0
170 0
187 0
167 0
179 0
171 2
168 2
173 2
172 2
169 2
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Simple regression was carried out to compare virus titre in infected families with 
families positive for IPNV at week 3 in the controls (Figure 4.7). Regression showed a 
significant relationship between titre and control status (F = 8.92, p = 0.007), although 
r2 was only 29.8%.
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Figure 4.7: The relationship between number of fish infected in the controls and mean 
logio TCID50 IPNV /g kidney at week 3. N.B. 1 = 2 positive fish, 2 = 1 positive fish, 3 = 
no positive fish.
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4.5.3.3.4. Lysozyme
Lysozyme levels at week 3 were very variable (Figure 4.8), not only between families 
but also between control and IPN infected groups within families. Families 180 and 
169 exhibited low lysozyme in both the controls and infected fish, 2000 units/ml and 
4000 units/ml respectively. Whilst families 185, 184 and 187 had much higher 
lysozyme in the infected fish than the controls, for example in families 184 and 187 the 
infected fish have lysozyme almost 18,000 units/ml higher than the controls. Families 
173 and 169 exhibited very similar lysozyme levels in both the controls and the IPN 
infected group.
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Figure 4.8: A comparison of mean (+S.E.) serum lysozyme activity at week 3 between 
the control and IPN infected fish.
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A two way ANOVA using Tukey’s pairwise comparisons compared lysozyme activity 
between families and also within family but between control and IPNV infected groups 
at week 3. This showed no significant differences between either families (p = 0.245, F 
= 1.48) or control and IPNV infected groups within the same family (p = 0.189, F = 
1.66).
Regression was carried out to compare IPNV titre and lysozyme levels at week 3 
(Figure 4.9), the regression showed there was little relationship, r2 = 13.2% which was 
not significant (p =0.139, F = 2.43).
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Figure 4.9: The relationship between logio IPNV TCIDso/g kidney and lysozyme units 
in individual fish at week 3.
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4.5.3.3.5. N eutralising Antibody
Neutralising antibody titre was generally very low at week 3 (Figure 4.10), with the 
notable exception o f the IPNV infected group of family 185. Families 169 and 173 
(with high virus titres at week 3) exhibited no neutralising antibodies to IPNV; family 
180 (with low IPNV titre at week 3) also showed no neutralising antibodies in the IPNV 
infected group but a small amount in the control group (10). Family 185 had very little 
neutralising antibody in the control group whilst the IPNV infected group of this family 
were found to have the highest antibody level (-325), however this group were very 
variable as demonstrated by the large error bar. Families 184 and 187 also exhibited 
low IPNV antibody titres.
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Figure 4.10: A comparison of mean (±S.E.) neutralising antibody titre between controls 
and IPNV infected fish at week 3.
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A two way ANOVA using Tukey’s pairwise comparisons compared differences in 
neutralising antibody between the control and IPNV infected groups and family. A 
significant difference was found between family (p = 0.004, F = 2.93) and controls and 
infected fish (p = 0.036, F 5.21). The high antibody titre in the IPNV infected fish of 
family 185 was found to be significantly different from both groups of family 173 and 
169, the infected fish of family 180 and the control fish of family 185.
IPNV titre and antibody titre at week 3 were correlated using regression. Figure 4.11 
shows a slight relationship between the two, r2 = 35.4 % which was found to be 
significant (p = 0.009, F = 8.75).
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Figure 4.11: The relationship between logio TCID50 IPNV /g kidney and neutralising 
antibody titre in individual fish at week 3.
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4.5.3.4. Week 7 sampling
4.5.3.4.I. IPNV infected families
From the 6 families chosen many of the fish sampled at week 7 had cleared the virus 
(Table 4.8). Family 187 was the notable exception with every fish sampled still positive 
for IPNV. In the families with a low IPNV titre at week 3 half the fish sampled were 
negative, whilst in the medium group there was a complete contrast with one family 
100% positive and in the other 44% were negative. In the group with high IPNV titres 
at week 3 a small percentage of the sample in each family were negative, the majority 
remained positive.
Table 4.8: Percentage of fish in each family injected with IPNV that have cleared the 
virus at the week 7 sampling.
Week 3 
IPNV titre
Family % of fish IPNV 
negative (n)
Low 180 66 (9)
185 50(10)
Medium 184 44 (9)
187 0 (10)
High 173 10 (10)
169 16 (6)
Figure 4.12 shows that mean IPNV titres at week 7 post challenge were generally very 
low. The family with the lowest titre was 180 (100 8 TCID5o/g kidney), families 185 
and 184 were very similar with titres of 101'9 and 1014 TCIDso/g kidney respectively. 
Family 187 and 173 had marginally higher IPNV titres of 103 1 and 1037 TCID50 /g 
kidney, whilst family 169 had a lower titre of 10“ ' TCIDso/g kidney.
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Comparisons o f mean week 3 IPNV titres with mean week 7 titres show that in all 
families except 185 the titre was lower at week 7. Certain families such as 173 and 169 
show a large decrease in titre at week 7 by 5 and 7 orders of magnitude respectively. 
Families 180, 184 and 185 show a reasonable decrease in titre of between 2 and 4 orders 
of magnitude. However family 185 demonstrates an increase in titre by 1 order of 
magnitude.
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Figure 4.12: Comparison of mean (±S.E.) logio TCID50 IPNV /g kidney between the 
families sampled at week 3 and week 7.
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A one-way ANOVA showed a significant difference between the virus titres in each 
family at week 7 (F = 4.50, p = 0.002). Tukey’s pairwise comparisons showed 
significant differences between families 173, 180 and 184 and 180 and 187 (Table 4.9).
Table 4.9: Results of differences in virus titres between families sampled at week 7 
using Tukey's pairwise comparisons.
169 173 180 184 185
173 -
180 - +
184 - + -
185 - - - -
187 - - + - -
N.B. + represents a significant difference
A two-way ANOVA comparing virus titres within families but between weeks 3 and 7 
showed a highly significant difference in titre (F = 16.55, p = 0.000). Tukey s pairwise 
comparisons showed significant differences between weeks in families 169 (p -  0.000), 
173 (p = 0.0004) and 184, (p = 0.0257).
4.5.3.4.2. Control families
At week 7 every family in the control group was IPNV positive (Table 4.10), confirmed 
by neutralisation as A2 serotype. In the majority of the families all 5 fish sampled we 
positive, in 2 families 4 fish were positive and in 5 families 3 fish were positive.
1 0 7 Chapter 4
Table 4.10: Number of fish in each family positive for IPNV at week 7 in the controls.
Family IPNV positive 
(n = 5)
198 4
186 5
177 5
192 3
185 5
196 5
193 5
184 5
195 3
174 5
189 3
188 5
180 3
181 5
170 5
187 3
167 4
179 5
171 5
168 5
173 5
172 5
169 5
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4.S.3.4.3. Lysozyme
Lysozyme levels at week 7 were generally higher than at week 3. Family 180 was 
unusual in that lysozyme levels were consistently lower than the other 5 families. 
Lysozyme levels were variable as with the week 3 data. Families 180, 185 and 173 
exhibited lower lysozyme levels in the controls than the IPNV infected fish, while 
families 184, 187 and 169 exhibited the opposite.
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Figure 4.13: A comparison of mean (±S.E.) serum lysozyme activity at week 7 in the 
control and IPN infected fish.
A two way ANOVA using Tukey’s pairwise comparisons compared
lysozyme activity between families and between control and IPN infected groups
showed a highly significant difference (p = 0.000, F = 6.82) between families. This
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due to the control group and the IPNV infected group of family 180 exhibiting 
significant differences (p =0.0002 and p = 0.0001 respectively) from the IPNV infected 
group of family 173. The comparison between control groups and IPNV infected fish 
within families showed no significant differences (p = 0.289, F = 1.25).
A one way ANOVA using Tukey’s pairwise comparisons compared pre-challenge 
lysozyme levels with week 3 and week 7 lysozyme levels in the control fish showed 
significant differences between time (p = 0.000) but not family (p = 0.053). Pre­
challenge and week 7 levels of lysozyme were found to be significantly different (p = 
0.0000) along with week 3 and week 7 levels (p = 0.000).
A one way ANOVA using Tukey’s pairwise comparisons compared pre-challenge 
lysozyme levels with week 3 and week 7 lysozyme levels in the IPNV infected fish 
showed significant differences between time (p = 0.043) and family (p = 0.001). Pre­
challenge lysozyme was found to be significantly different from both week 3 (p = 
0.014) and week 7 (p = 0.000) lysozyme levels. However, lysozyme levels at weeks 3 
and 7 were found not to be significantly different (p = 0.066).
Simple regression was carried out to compare lysozyme levels at week 7 with IPNV 
titre at week 7, little relationship was found (Figure 4.14), r" = 11.6 % despite this it was 
still significant (p = 0.013, F = 6.67).
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Figure 4.14: The relationship between logio IPNV TCIDso/g kidney and lysozyme units 
/ml in individual fish at week 7.
4.5.3.4.4. Neutralising Antibody
All families showed a higher titre of neutralising antibody at week 7 than week 3. 
Generally at week 7 the IPNV infected fish showed a higher titre of neutralising 
antibody than the control fish (Figure 4.15), with the exception of family 169 which was 
the reverse. The control fish in families 180, 185, 184 and 173 all exhibited very low 
antibody titres (<500), whilst titres in families 187 and 169 were higher (1200 and 2000 
respectively). Families 180 and 169 in the IPNV infected fish have low levels of 
antibody (600 and 400 respectively), whilst the other 4 families have higher levels 
ranging from 1100 to 3600. As can be seen from the large error bars neutralising 
antibody is subject to large individual variation.
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Figure 4.15: A comparison of mean (±S.E.) neutralising antibody titre at week 7 
between control and IPNV infected fish.
A two way ANOVA using Tukey’s pairwise comparisons compared differences 
between neutralising antibody in different families and between control and IPNV 
infected fish. A significant difference was found between IPNV infected fish in 
different families (p = 0.007, F = 3.24) but not the controls. The IPNV infected group 
of family 184 were found to be significantly different from the IPNV infected group of 
family 169 (p = 0.0357) and family 180 (p = 0.0241).
A one way ANOVA using Tukey’s pairwise comparisons compared neutralising 
antibody levels between the IPNV infected groups at weeks 3 and 7 and the control
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groups at weeks 3 and 7. A significant difference was found between the IPNV infected 
fish (p = 0.001) but not the control fish (p = 0.448).
Regression was carried out to compare IPNV titre and neutralising antibody titre at 
week 7 (Figure 4.16), no correlation was found, r2 = 0.4 %, this was not significant (p = 
0.650, F = 0.21).
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Figure 4.16: The relationship between logio IPNV TCID50 /g kidney and neutralising 
antibody titre in individual fish at week 7.
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4.5.3.5. Additional post-smolt sampling
Virus was isolated from the 8/10 of the additional post-smolts (non-Landcatch fish) 
sampled and was confirmed as IPNV A2 serotype.
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4.6. Discussion
Clinical IPN is very rarely reproduced under experimental conditions in Atlantic salmon 
(Sadasiv, 1995, Ellis, 2000, Reddington, 2000); more often than not fish become 
carriers of the virus and lack any attendant disease signs. Indeed clinical IPN was not 
induced in any challenge carried out in this study for varying reasons.
In considering the challenge at CEFAS there were a few possibilities for the lack of 
success with the challenge. The Br. isolate used was chosen from a site in Shetland that 
had experienced a particularly bad outbreak of IPN the previous summer, the isolate 
was therefore considered to be highly virulent. However, to ensure there was adequate 
virus available to inject all the fish the isolate was passaged twice through CHSE-214 
cells. This may have greatly reduced the virulence of the isolate so that many of the fish 
were capable of clearing the virus within 2 weeks post challenge and only 50 % 
remained positive at 3 weeks post challenge. Dorson (1977) demonstrated attenuation 
of IPNV after only a few passages in cell culture and noted that for experimental 
transmission of the disease to be successful the virus must have been passaged less than 
three times in cell culture. Hill and Dixon (1977) reported most of the IPNV strains 
isolated from rainbow trout in the UK maintained their virulence when passaged less 
than five times in cell culture.
In constrast Rimstad, Poppe, Evensen and Hyllseth (1991) demonstrated that infecting 
post-smolt Atlantic salmon with cell cultured IPNV (A2 serotype) caused no clinical 
signs and no mortality and evidence of the virus could not be demonstrated 
immunohistochemically. This suggests that the virulence of the virus is altered in some 
way during cell culture. It is possible that the isolate may have appeared more virulent
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than in actuality, the Br. isolate was chosen because of the very high mortalities 
experienced at the fish farm. However, the practice at the site of collecting IPN 
mortalities by vacuum pump may have influenced the mortality by disturbing virus and 
creating an IPNV ‘soup’.
The fish used for the CEFAS challenge were from Howietoun Fish Farm. Ideally fish 
from Landcatch would have been the best fish to use to develop the challenge since they 
were known to be susceptible to IPN in the field, however fish were unavailable and an 
alternative source was found. It is possible that different strains of Atlantic salmon may 
vary in their susceptibility to disease. Fish from Howietoun may have possessed a 
naturally higher resistance to IPNV and this may also explain the lack of success with 
the challenge. Variation in intraspecific resistance to disease in various species of 
salmonids has been well documented. Silim et a l  (1982) found that on challenging two 
strains of brook trout with IPNV a strain from Nebraska were more than twice as 
susceptible than a strain from Quebec. This group found similar differences in 
susceptibility to IPN for rainbow trout of different origins. Okamoto, Matsumoto, Kato, 
Tazaki, Tanaka, Hanada, Susuki, Takamatsu, Tayama and Sano (1987) demonstrated 
differences in susceptibility to IPN between two strains of rainbow trout, one strain 
suffered almost 100 % mortality, whilst another suffered only 5 % mortality.
The possibility that the fish may have been previously exposed to the virus and may 
have been latent carriers of IPNV was also considered, to test this sera was tested for 
neutralising antibodies to IPNV. The sera was found to contain no neutralising 
antibodies and since all control fish tested were IPNV negative it must be assumed that 
the fish had not been previously exposed to the virus.
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The experience with the challenge at CEFAS suggests that Atlantic salmon were able to 
mount an effective immune response against cell cultured IPNV that was likely to be 
non-specific.
To establish if the isolate used in the study at CEFAS had been virulent and to compare 
virulence with another field isolate a further small scale challenge was carried out at the 
SERAD laboratory on the north west coast of Scotland. Atlantic salmon from Aultbea 
were injected with kidney homogenate of two isolates of IPNV, both from Shetland. It 
became apparent at the 10 day sampling from analysis of virus titre that although 
neither isolate had caused mortality the isolate used in the previous challenge was not 
particularly virulent despite the use of kidney homogenate. Indeed 4/5 fish sampled had 
cleared isolate Br. unlike those injected with isolate Os. External examination of the 
two groups of fish showed a marked difference in appearance, the group injected with 
isolate Br. used in the previous challenge appeared perfectly healthy, whilst the other 
group were dark and thin.
Silim et al. (1982) demonstrated variation in virulence of 3 IPNV isolates; one isolate 
was found to be less virulent than other isolates in both lake trout (Salvelinus 
namaycush) and brook trout. LaPatra, Fryer and Rohovec (1993) upon challenging 
rainbow trout with different isolates of IHNV found variation in virulence between three 
isolates of type 3 IHNV, this was thought to be linked to geographical origins of the 
isolates. In order to increase the virulence of the isolate Os. chosen for the family 
challenge and to ensure enough kidney homogenate was available to inject all 1200
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family fish the isolate was passaged through fish once further prior to use in the 
challenge.
The pre-challenge samples taken from the family fish indicated that the fish were not 
only IPNV free but also apparently free of any bacterial infection. A lack of 
neutralising antibodies to IPNV also suggested the fish had not been previously exposed 
to IPNV. Analysis of PCV indicated healthy stocks; Sandnes, Lie and Waagboe (1988) 
found that haematocrit levels ranged between 44-49 % in healthy adult farmed Atlantic 
salmon. Therefore the haematocrit levels found in this study, ranging between 47-57 % 
indicated very healthy fish.
Everything possible was considered when setting up the family challenge in an attempt 
to create a realistic environment, from vaccination to stocking densities. However, 
clinical IPN was not induced and although mortality was demonstrated it is unlikely that 
the majority were attributable to IPN despite the isolation of IPNV from all the 
mortalities. Many of the mortalities displayed external lesions indicative of Vibrio spp. 
infection that were likely to be opportunistic non-specific pathogens as a result of 
handling stress and seawater transfer. Mortality throughout the family trial was greatly 
distorted by the loss of many fish from four IPNV injected tanks due to problems with 
water flow. Although this discounted the possibility of comparing mortality between 
infected families it was still possible to compare them with the controls. Despite the 
losses there was a marked difference in mortality between controls and infected groups 
in many families. Considering all fish were placed under the same amount of stress it is 
possible that IPN infection may have immunosuppressed certain families, predisposing 
them to secondary bacterial infections such as Vibriosis.
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There have been several reports that IPNV may cause immunosuppression. Knott and 
Munro (1986) demonstrated a decreased response in Atlantic salmon to 
phytohaemagglutinin (PHA) in IPNV infected leucocytes compared to uninfected 
leucocytes. Similar work by Tate, Kodama and Izawa (1990) also suggested that IPNV 
might have an immunosuppressive effect on rainbow trout T and B cells. This was 
demonstrated by investigating mitogenic activity of leucocytes infected with IPNV to 
PHA and lipopolysaccharides; infected cells were found to have a reduced activity. 
This is consistent with the action of infectious bursal disease virus (IBDV), an avian 
birnavirus (Chui and Thorsen, 1984). Reasonably then it may follow that virus titre at 
week 3 may be higher in families with higher mortality. However it appears that there 
is little relationship between virus titre at week 3 and mortality, certain families with a 
low titre at week 3 exhibited high mortality and visa versa. This lack of relationship is 
most likely due to the losses of fish experienced; nevertheless it is possible that in 
certain families the combination of stress and IPNV infection may have compromised 
the fish.
Since mortality cannot be clearly demonstrated with IPN another method of identifying 
susceptible and resistant families of fish was needed. The measurement of viral titre 
was considered a valid method to estimate susceptibility, although this is an indirect 
measurement. Virus titre measured in every family at week 3 gave clear and highly 
statistically significant differences in mean titre for each family. It appeared that 
although the fish were originally injected with a fairly low dose of EPNV by necessity, 
the virus was able to replicate and in some families to very high titres. Families with 
high titres of IPNV were considered to be the most susceptible. Families 169, 173 and
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188 in particular had very high titres, but many families had titres of between 1 0 5- 1 0 7 
T C ID 5 0  /g kidney and may be of intermediate susceptibility. Families 180, 185, 192, 
177, 189, 195 and 198 were those with the lowest titres plus significant differences and 
may be considered to be the most resistant to IPN. It is recommended that further work 
be carried out using these families since this study can only be considered to give an 
indication into variations in susceptibility.
These results demonstrated that the different families of Atlantic salmon were not 
equally susceptible to IPN, but possible reasons for this are unclear. Since all the fish 
were injected and sampled on the same days and environmental conditions were 
identical for each group it is likely that the differences are inherent. A very small 
sample was taken from each family at week 3, this was necessary because of the sheer 
numbers of fish challenged and to ensure all samples were taken on the same day. The 
additional samples frozen to back up the results gave very similar titres for all families 
with the exception of one, and in the supplementary samples families were still 
significantly different from each other. This suggested that the data sampled at week 3 
was reliable. However had more fish been sampled at week 3 a higher number of 
families would have been significantly different from each other, as demonstrated by 
the differences found between the supplementary samples at week 3. For example 
families 169 and 187 were not statistically different at week 3 but were in the 
supplementary samples despite the almost the same difference in mean titre of 1 0  
TCID50 /g kidney.
The picture becomes more complicated when considering the incidence of IPNV in the 
control fish sampled at week 3. Possible reasons for the isolation of IPNV are firstly
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that the fish were life long carriers and the stress of transfer, handling and injection and 
lowering of the water level resulted in a recurrence of the virus as documented by 
Roberts and McKnight (1976) in rainbow trout. A second possibility was that the virus 
was present in the seawater surrounding Aultbea Marine Laboratory and the fish were 
infected naturally.
Traditionally the term ‘carrier’ was used to describe fish that had survived a clinical 
outbreak of disease and were apparently healthy but still continued to shed the pathogen 
(Wolf, Quimby, Carlson and Bullock, 1968). It is widely believed that Scotland does 
not have the problem of IPNV carrier status such as is evident in Norway where IPN is 
still a problem in fry and salmon surviving the disease become carriers and take the 
infection to sea (Jarp et a l ,  1994). However Norway also has incidences of IPNV in 
fish with no history of IPN that have been maintained in treated water throughout their 
time in seawater (Taksda 1 et a l,  1998). Similarly to the present study Taksdal et a l  
(1998) found the kidney samples taken prior to the challenge were negative for IPNV 
yet still 6 weeks post transfer the control fish were IPNV positive. This suggests that it 
may be possible that fish do not need to experience an IPN outbreak to become carriers, 
the virus may be vertically transmitted and persist at very low levels until a time when 
the fish is stressed and/or a particular set of conditions are met. If IPNV is present in a 
latent state it may be at levels below the detection limit of current diagnostic methods 
(Sadasiv, 1995) and this may explain the IPNV negative results.
A further possibility is that the size of sample tested may not be large enough to detect 
°ne positive sample, all that is needed to classify a population positive. Thorburn 
(1996) examined the apparent prevalence of fish pathogens (including IPNV) and its
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effect on misclassifying population status. Thorburn stated that a sample of 60 fish 
from a population assuming a very low prevalence of 2 % gives a 70 % group level 
confidence assuming 95 % confidence in the diagnostic test sensitivity. The risk of 
incorrectly classifying a population is 1 minus the group confidence level therefore 
there is a 30 % chance that 60 samples would not include any test positive fish. The 
study found that Atlantic salmon were most likely to have a very low apparent 
prevalence of IPNV and to achieve an acceptable level of confidence it is likely that 
more than 60 fish should be sampled. Thorburn stated that 149 fish would need to be 
sampled for any pathogen to achieve a group level confidence of 95 %, unfortunately 
this is rarely practical and very costly. In this study 50 fish were sampled, giving a 
group level confidence of -60  %, it is likely that a higher number of fish should have 
been sampled and future work should acknowledge this.
The fish may have become infected via the water since the inflow of seawater was not 
being treated. The presence of salmon farms in the loch where the lab draws its water 
suggests that horizontal transmission may have occurred, although there were no 
outbreaks of clinical IPN on any of the farms the fish may still have harboured IPN. 
The matter of whether the fish were carriers cannot be resolved and the positive status 
of the stock of fish not from Landcatch suggests that the fish were infected through the 
water.
The significant although not particularly strong correlation between virus titre at week 3 
and IPNV positive status in the controls suggests there may be a slight link between 
higher titre and positive control status. If the fish were infected through the water 
naturally the correlation indeed indicates a genetic link, the first families to become
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infected were mostly those with higher titres. However if the fish were carriers the titre 
measured in the infected fish at week 3 may not only reflect the replication of the isolate 
injected but also replication of virus already present in the fish.
The progress of infection in the two groups, IPNV injected and control fish over the 7 
weeks were different. A proportion of the IPNV injected fish had cleared the virus by 
week 7 or generally had much lower titres of virus. The results showed that although 
IPNV titre decreased in all but one family by week 7 there were still significant 
differences between the families. At week 7 the number of fish in each family that had 
cleared the infection may be more important than titre. The families with the highest 
percentage of negative fish were the families chosen because of their low titre at week 
3, families 180 and 185. Conversely the infection was progressing in the control fish, as 
shown by the increasing numbers of fish and families infected by week 7. This natural 
infection still did not cause mortalities, but the difference in progression of infection 
may indicate that infecting fish by IP injection with a large inoculum of virus is not the 
most effective method to use. IP injection is often considered not to be the best method 
of challenge because it bypasses the action of external mucosal immune functions and 
gut-associated lymphoid tissue (GALT). Since the control fish underwent a natural 
infection with IPNV and suffered few mortalities it is unlikely that the method of 
administration of IPNV (IP injection) is the reason for the lack of success with the 
challenge.
The inability of various research groups and this study to induce clinical IPN has led to 
speculation that the severe disease outbreaks seen in post-smolts in Shetland and 
Norway may not be caused by IPNV alone. However other pathogens are rarely
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isolated during an IPN outbreak. A further possibility is that there may be certain 
environmental pre-requisites for the disease that are for some reason not met in an 
experimental situation. Jarp et a l,  (1994) suggested that for clinical IPN to occur in 
post-smolts there must not only be the presence of the virus but also an imbalance of 
some kind between the environment and feeding causing added stress to the fish.
A Shetland isolate was chosen for all the challenges presented in this chapter for the 
reason that Shetland experiences particularly bad IPN outbreaks and the isolates may be 
more virulent than those from mainland Scotland. There was a suggestion that since 
IPNV was so virulent in Shetland it was possibly a new serotype (Ross and Munro, 
1995). Pryde, Melvin and Munro (1993) had previously sequenced a 613 base pair 
region of the major IPNV structural epitope VP2 (a serotype specific epitope) of a 
Shetland isolate and the A2 (Sp.) reference strain. They found the two to differ by only 
1 % (6 nucleotides) and concluded the Shetland isolate was of the A2 serotype, the 
deduced amino acid sequences revealed a difference of only one amino acid. However, 
upon examination of various strains of IHNV Kim, Winton and Leong (1994) found 
that changes of a single amino acid in key proteins might greatly influence the virulence 
of the pathogen. In the case of IPNV it is possible that the small changes found in the 
Shetland isolates may well indicate increased virulence but this is not the only factor 
contributing to the disease since challenges in Scotland with the isolates does not cause 
mortality.
Park and Jeong (1996) identified VP3 and VP4 as important immunogens of a Korean 
isolate of IPNV in vitro. They concluded that a portion of the VP3 and VP4 epitope 
must be projected through VP2 to the surface of the viral particles. They noted that
124 Chapter 4
these epitopes were very labile with storage at -20°C and suggested that a proteolytic 
protein may have remained on the surface of the virus and degraded them. If VP3 and 
VP4 are indeed important immunogens and are involved in infection and virus 
neutralisation the storage of IPNV isolates used for the challenges may also be 
important.
The type 1 interferon system (IFN a  and P) constitutes one of the first and most 
powerful anti-viral defence mechanisms induced in vertebrates during viral infection 
(Samuel, 1991). Interferon production and detection were unsuccessful in this study. 
Initially CHSE-214 and RTG-2 cells were used to attempt to detect IFN in Atlantic 
salmon serum. The cells did not appear to be sensitive to IFN and since IFNs are 
species specific it was thought possible that the cell lines were incompatible with the 
serum. CHSE-214 cells were previously thought to be incapable of producing 
interferon and were therefore thought to be insensitive to it (Dobos, 1995). However, 
interferon production has recently been demonstrated in CHSE-214 cells in response to 
IFN supernatants produced by Atlantic salmon macrophages but not in response to 
stimulation with poly I:C (Nygaard, Husgard, Sommer, Leong, Robertsen, 2000). RTG- 
2 cells were known to be susceptible to IFN (Dorson, de Kinkelin and Torchy, 1992) 
and consequently IFN production was attempted using poly I:C to act as a positive 
control, however this too was unsuccessful for unknown reasons. AS cells also used in 
this study are apparently both susceptible to IFN and capable of IFN production 
(Nygaard et a l , 2000), in this study the AS cells were found to be refractory to IPNV 
and IFN production was unable to be measured. The reasons for this are unclear, the 
original stock was noted as susceptible to IPNV unfortunately this is no longer the case 
and due to time constraints an alternative source was not found.
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Atlantic salmon are considered to have less lysozyme in comparison to other farmed 
fish species such as rainbow trout (Grinde, Lie, Poppe and Salte, 1988, Lie, Evensen, 
Sorensen and Froysadal, 1989). Grinde et al. (1988) found lysozyme activity to be 
approximately 5877 units/ml and 413 units/ml in rainbow trout and Atlantic salmon 
respectively. These units are for kidney lysozyme, the organ reported to contain the 
most lysozyme (Lie et al., 1989) and using the turbidimetric assay. Lie et al. (1989) 
reported lysozyme units/g kidney to be 33,500 and 2050 in Atlantic salmon 
respectively, these results are not comparable to those in this study where serum and 
units/ml were used. However lysozyme levels in this study were found to be 
particularly high varying from 300 units to 50,000 units/ml. Of the two methods most 
commonly used to measure lysozyme activity (turbidimetric and lysoplate assays) the 
lysoplate assay used in this study has been noted to be the most sensitive of the two (Lie 
et a l, 1989) and this may partially explain the very high levels. Another explanation 
may be the difference in molecular weight (MW) between hen egg white lysozyme 
(HEWL) and Atlantic salmon lysozyme. The MW of HEWL is 14.3 kD, the exact size 
of Atlantic salmon lysozyme is not known but Lie et al. (1989) estimated it to be 
between 12 and 13 kD based on fractionation and gel filtration. Since the lysoplate 
assay is based on diffusion it is tentatively suggested that this difference in MW may 
result in a differential rate of diffusion of the two lysozymes through the gel. It is also 
possible that the presence of Vibrio spp. in the system may have enhanced lysozyme 
activity additionally to the handling stress (Fletcher and White, 1976).
The unusually high lysozyme levels found in this study may indicate the fish were very 
stressed during the challenge, as suggested by Fevolden, Roed and Gjerde (1994). They
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estimated genetic variation in post stress lysozyme activity in Atlantic salmon infected 
with various bacterial fish pathogens. A negative correlation was found between 
lysozyme in stressed fish and disease susceptibility, this suggested that enhanced 
lysozyme activity following exposure to a stressor is not indicative of a more resistant 
fish but a more disease susceptible organism (Fevolden et a l, 1994). It is likely the fish 
were very stressed during the trial, indeed this was intended since it was considered that 
stress may induce the fish to succumb to IPNV infection as demonstrated by Roberts 
and McKnight (1976).
Lysozyme was found to be subject to large individual and family variation as previously 
noted by Roed et al. (1993). For example, family 180 exhibited consistently lower 
lysozyme at both sampling points compared to the other 5 families. Although there was 
no difference between lysozyme levels in the controls and IPNV infected fish at either 
week 3 or 7, there was an effect over time. Pre-challenge lysozyme levels were not 
significantly different from those in the control fish at week 3, however they were 
different from those at week 7. The situation in the IPNV infected fish was different, 
pre-challenge lysozyme levels were significantly different from both week 3 and week 
7, yet levels at weeks 3 and 7 were not significantly different. This shows that although 
there was an increase in lysozyme levels in both groups of fish by week 7 it took much 
longer to increase in the controls. This may suggest that lysozyme is stimulated upon 
infection with IPNV or it may indicate that the IPNV infected fish were more 
susceptible to the stress placed on them. Since lysozyme was found to be suppressed in 
rainbow trout naturally infected with IPNV (Siwicki, Morand, Klein and Kiczka, 1998) 
the latter seems the most likely. To clarify this point further work is needed to measure
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lysozyme immediately post IPNV injection and regularly throughout the following 
weeks to establish a pattern.
Siwicki et a l  (1998) examined the effect of dimerized lysozyme (KLP-602) on non­
specific immunity in IPNV infected rainbow trout. Total leucocyte numbers, relative 
leucocyte count, the phagocytic ability of blood leucocytes, lymphocyte proliferation, 
myeloperoxidase activity in neutrophils, lysozyme activity and total serum Ig levels 
were studied. Dimerized lysozyme was found to significantly increase all immune 
parameters and to decrease IPNV mortality compared to untreated fish, conversely 
IPNV infection was found to suppress all parameters. This appears to confirm the anti­
viral properties of lysozyme. In the present study a positive correlation was found 
between lysozyme and virus titre at week 7  and although significant the r value was 
only 11 % suggesting very little relationship between IPNV titre and lysozyme levels. 
Lysozyme was considered to be unsuitable as a marker for resistance to IPN.
Serum samples taken at week 3 were found to contain neutralising antibodies to IPNV 
confirming that the fish were exposed to the virus in some way from seawater transfer. 
It is worth noting that fish confirmed to be IPNV negative at week 3 possessed 
neutralising antibodies to the virus. Similarly to lysozyme neutralising antibody was 
found to have large individual and family variation. A significant difference was 
observed between neutralising antibody at weeks 3 and 7 in the IPNV infected fish but 
not the controls, suggesting that despite the progressing IPNV infection in the control 
fish neutralising antibody production was stimulated little. It is possible that with a 
natural IPNV infection neutralising antibody response is very slow and may not play a 
significant role in defence against IPNV.
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The role of neutralising antibody response to IPNV infection has previously been 
debated, while certain authors report a correlation between neutralising antibody and 
virus clearance others report a lack of correlation. Wolf, Quimby and Bradford (1963) 
found that brook trout with little neutralising antibody shed the most IPNV while those 
with high neutralising antibody titres shed little virus. Yamamoto (1975) and 
Mangunwiryo and Agius (1988) also reported a correlation in rainbow trout between a 
decrease in IPNV isolation and increasing antibody titres. Conversely Reno (1976) 
reported no correlation in brook trout similarly to Smail and Munro in Atlantic salmon 
(1985). Biering (1997) examined humoral immune response to IPNV in Atlantic 
halibut and found that although there appeared to be a correlation between neutralising 
antibody and virus elimination at the population level, no correlation was found at the 
individual level.
A significant negative correlation was found in the present study between neutralising 
antibody and IPNV titre at week 3. However, antibody measured at this time is unlikely 
to be in response to the injected IPNV but previous exposure to the virus. The complete 
lack of correlation at week 7  suggests that neutralising antibody cannot be used as a 
marker for disease resistance to IPNV. Whitton and Oldstone (1996) state that virus 
specific circulating antibodies are generally not the main protective immune response 
against viral infections in mammals, cytotoxic T-cells are believed to be the most 
important in reducing viral replication. However evidence has not yet been presented in 
teleost fish that cytotoxic T lymphocytes participate in resistance to viral infections 
(Evans and Jaso-Friedman, 1992, Manning and Nakanishi, 1996). Perhaps future
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research should investigate this further. It is possible that complement may play a part 
in viral defence as suggested by Sakai (1992) and this could be measured also.
In conclusion, a reproducible IPNV challenge model was not developed in this study. 
The challenge with cell-cultured IPNV indicated that Atlantic salmon were able to 
rapidly clear the virus possibly through an effective non-specific immune response. 
Kidney homogenate containing virus was found to induce a carrier state rather than 
clinical infection, however a difference in susceptibility between families of Atlantic 
salmon to IPNV was found using virus titre as an indirect measurement of 
susceptibility. The IPNV positive status of the control fish enabled a comparison 
between IP injection and a natural infection. The natural infection appeared to mimic 
the situation in the field progressing slowly over many weeks post seawater transfer 
rather than the rapid infection usually associated with viruses. The enhancement of 
lysozyme activity in IPNV injected fish suggests that fish carrying IPNV may be more 
susceptible to stress than uninfected fish and may indicate activation of phagocytic cell 
populations. The presence of significantly less neutralising antibody in control fish than 
infected fish suggests that neutralising antibody may not play a significant role in IPNV 
infection in the field. The detected genetic variation suggests potential for improvement 
in disease resistance to IPNV in Atlantic salmon.
5. Diagnostic Techniques for IPNV
5.1. Introduction
The lack of adequate control measures for IPNV and the ability of the virus to persist in 
a carrier state without causing disease indicates the need for highly sensitive and rapid 
diagnostic methods (Dixon and Hill, 1983, Lopez-Lastra et al., 1994). Although there 
are at least two IPN vaccines commercially available in Norway, one is an inactivated 
IPNV vaccine (Pettersen, 1997), the other a sub-unit vaccine using recombinant VP2 
(Frost and Ness, 1997) Norway still suffers huge financial losses due to annual IPN 
outbreaks (Cripps, 1999). The efficacy of recombinant DNA vaccines against IPNV are 
presently being evaluated in the UK (Ellis, 2000), however none are yet commercially 
available and this is hampered at present by the lack of adequate challenge models. The 
carrier status that occurs after a clinical outbreak of IPN is often detectable from head 
kidney in cell culture (Johansen and Sommer, 1995). Nevertheless it is possible that 
fish may harbour IPNV at very low levels and never experience an IPN outbreak 
suggesting that IPNV may be present at levels below the detection limit of standard 
tests (Taksdal et a l , 1998). This is particularly crucial for laboratory studies involving 
the assessment of vaccines and disease resistance trials.
A recent survey carried out by Bruneau, Thorburn and Stevensen (1999) estimated the 
sensitivity and accuracy of diagnostic techniques in use for both IPNV and IHNV in 
fish health laboratories around the world. The Delphi Panel Method used in the survey 
involves ascertaining the opinions of a panel of experts through an iterative process, 
answers were obtained to specific questions, the responses summarised and the 
summary returned for reassessment. The results indicated that although the experts 
estimated almost 100 % specificity of the tests in use (cell culture, ELISA, gene probes
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and IF AT) the sensitivity was estimated at under 70 % for all tests. This highlights the 
need for highly sensitive diagnostic tests for many fish pathogens not only IPNV. 
Various diagnostic methods for IPNV were evaluated in this chapter, factors included 
the time taken for the assay, the cost, the sensitivity and where possible the specificity. 
All these methods were compared to cell culture for sensitivity.
5.2. Aims
1. To adapt the RT-PCR using published IPNV primers and establish the sensitivity 
and specificity in tissue homogenates.
2. To develop an ELISA for IPNV detection and evaluate the sensitivity and 
specificity of the assay.
3. To establish an immunohistochemical staining procedure for IPNV detection in 
paraffin embedded tissues.
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5.3. Methods
5.3.1. RT-PCR
5.3.1.1. Preparation of RNase free equipment
Glassware was initially soaked in disinfectant (Decon) for a two hours and rinsed 
thoroughly with nanopure water. Bottles, beakers and cylinders were filled to the top 
with nanopure water and eppendorfs fully immersed in nanopure water, 0 .1 % v/v 
diethyl pyrocarbonate (DEPC, Sigma) was added in the fume cupboard. The DEPC 
solution was pipetted up and down vigorously to disperse the DEPC and left overnight 
in the fume cupboard. To remove the DEPC all solutions were autoclaved at 15 lb for 
2 0  minutes in an autoclave vented outside before discarding the water.
5.3.1.2. RNA extraction from cell culture fluids
RNA was extracted using a NucleoSpin Virus RNA extraction kit (Macherey-Nagel). 
RNase free water was placed into a water bath at 70°C to heat prior to extractions. 
Then 150 pi of purified virus, tissue culture supernatant or kidney homogenate was 
placed into a 1.5 ml microcentrifuge tube, 600 j l l I  of buffer RAVI containing carrier 
RNA (provided with the kit) was added to the sample, pipetted up and down and 
vortexed well. The mixture was then incubated at room temperature for 10 minutes. If 
the solution was turbid after this time the tube was centrifuged at maximum speed 
(13,000 g) for 1 minute. After this or if the solution was clear 600 pi of absolute 
ethanol was added to the clear lysis solution and thoroughly mixed by vortexing. From 
this lysis solution 700 pi was placed into a Nucleospin column in a 2 ml 
microcentrifuge tube and centrifuged at 6500 g for 1 minute. The flow-through was 
then discarded and the rest of the sample (about 750 pi) then placed into the spin 
column and centrifuged at 6500 g for 1 minute. Next 500 pi of buffer RAV3 (provided
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with the kit) was placed into the spin column and centrifuged at 6500 g for 30 seconds, 
this washing step was then repeated. The spin column was then placed into a new 
sterile (RNase free) microcentrifuge tube and centrifuged for 2-3 minutes at maximum 
speed (13500 g) to remove the last traces of buffer RAV3. The spin column was placed 
into another new sterile microcentrifuge tube and 50 pi of pre-heated RNase free water 
(Promega) added to the column, incubated at room temperature for 2 minutes and 
centrifuged for 1 minute at 6500 g. The resulting RNA was transferred to a fresh tube 
and stored at -20°C.
5.3.1.3. RNA extraction from tissue
RNA was initially extracted using a NucleoSpin Virus RNA tissue extraction kit 
(Macherey-Nagel). Atlantic salmon kidneys were stored frozen at -70°C and in 
RNAlater (Ambion) at -20°C. Kidneys were spiked with 100 pi of 1012 TCID50 IPNV 
and RNA extracted. This method of extraction was found to be unsuitable for use with 
kidney tissue from either storage method and an alternative method was found using Tri 
Reagent (Sigma).
Kidney was weighed to give 100 mg, spiked and homogenised in lOx volume of Tri 
Reagent ( 1  ml) using disposable pestles (Sigma) in an RNase free 1.5 ml 
microcentrifuge tube. After homogenisation kidney was centrifuged at 12,000 g for 10 
minutes at 4°C to remove high molecular weight DNA and insoluble material. The 
supernatant was transferred to a fresh RNase free 1.5 ml microcentrifuge tube. To 
allow complete dissociation of nucleoprotein complexes the supernatant was left to 
stand at room temperature for 5  minutes, 2 0 0  pi of chloroform was then added per ml of 
Tri Reagent. The sample was vigorously shaken for 15 seconds and allowed to stand
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for 15 minutes at room temperature. The sample was then centrifuged at 12,000 g for 
15 minutes at 4°C. The colourless upper aqueous phase contained the RNA.
This upper aqueous phase was transferred into a fresh RNase free 1.5 ml 
microcentrifuge tube and 500 jllI of isopropanol (BDH) per ml of original Tri Reagent 
used was added and mixed. The samples were left to stand for 10 minutes at room 
temperature and then centrifuged at 12,000 g for 10 minutes at 4°C. The supernatant 
was removed and the resultant RNA pellet washed by addition of 1 ml of 75 % ethanol 
per ml o f original Tri Reagent. The samples were vortexed and centrifuged at 7,500 g 
for 5 minutes at 4°C. The supernatant was removed and the RNA pellet air dried for 10 
minutes, RNA was re-suspended in 100 pi o f RNase free water.
5.3.I.4. RT-PCR
IPNV primers were synthesised with reference to two published primer sets (Wang, Wi 
and Lee, 1997) at MWG. Primers were re-suspended in RNase free water to a 
concentration of 10 pM and stored frozen in aliquots at -20°C.
Table 5.1: Sequence and location of IPNV primers.
Primer
set
VP2 location Sequence Product
Size
PrD 419-693 5 ’ -CGGAAATACGACATCCAGAGC - 3 274
5 ’ -  TGGCTCCGTTCATGGACTGG - 3
PrF 807-1330 5 ’ -  GCCGACATCGTCAACTCCAC - 3 524
5 ’ -  G AC AGG AT CAT CTT GGC AT A - 3 ’
135 ----------------
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RT-PCR was carried out using Pharmacia Biotech Ready to go RT-PCR beads in 0.2 ml 
tubes. Amplification reactions were carried out in a volume of 50pl, with the RT-PCR 
beads containing 2.0 units of Taq, lOmM tris-HCl, 60mM KC1, 1.5 mM MgCl2, 200 |liM 
of each dNTP, Moloney murine leukemia virus (M-MuLV) reverse transcriptase, 
RNAguard ribonuclease inhibitor and stabilisers. RT-PCR was optimised by 
amplification at 12 annealing temperatures between 50-60°C on a Biometra gradient 
thermal cycler along with varying amounts of template. Once an annealing temperature 
had been chosen primer concentrations were titrated from 0.5 |lM to 0.2 pM and 
concentrations of 0.2 pM for primer set PrF and 0.5 pM for PrD were chosen.
Prior to RT-PCR the appropriate volume of dsRNA and primers were placed into a 
sterile RNase free 0.2 ml PCR tube (AB Gene) and the dsRNA denatured for 10 
minutes at 99.9°C in a PE Applied Biosystems GeneAmp® 2400 thermal cycler, then 
immediately placed on ice for 2 minutes. Meanwhile the appropriate volume of RNase 
free water was added to each RT-PCR bead and left for 5 minutes on ice to re-suspend. 
The denatured RNA and primers were then added to the dissolved RT-PCR bead and 
RT-PCR carried out in the PE Applied Biosystems GeneAmp® 2400 thermal cycler.
Thermal cycling conditions were:
45 minutes at 42°C (reverse transcription)
5 minutes at 95°C (denaturing to destroy any remaining M-MuLV)
35 cycles of: 1 minute at 94°C (denaturing)
1 minute at 55°C (annealing)
1 minute at 72°C (extension)
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10 minutes at 72°C (final extension)
4°C hold
The annealing temperature was increased to 60°C for RT-PCR and the cycles increased 
to 40 for RNA extracted from tissue.
5.3.1.5. Electrophoresis
RT-PCR products were visualised on a 1 % agarose gel, 1 g of agarose (Sigma) was 
dissolved in lx  TBE buffer (Appendix 1) by microwave heating. Once the molten agar 
had cooled to 70°C ethidium bromide (Sigma) was added to a final concentration of 0.5 
pg/ml. The running buffer used was lx  TBE with ethidium bromide added to a final 
concentration of 0.5 pg/ml. The gel was loaded with 5 |il PCR product mixed with 2 pi 
of loading dye, 5 pi PCR marker (Promega) was mixed with 2 pi loading dye and 
loaded onto the first and last lanes of the gel. The gels were run at 80 volts for 1 hour 
and visualised under UV.
5.3.1.6. Sensitivity with purified RNA
IPNV was propagated and purified, using methods described in Chapter 2. RNA was 
extracted from purified virus and RNase free TNE buffer as above. RNA concentration 
was measured using a Jenway 6405UV/Vis spectrophotometer, 10 pi of RNA was 
diluted 1:10 with RNase free water and the absorbance read at 260 and 280 nm. RNA 
concentration was calculated using the following formula from Ito and Joklik (1972).
O.D. at 260 nm x 60 x dilution factor (1 O.D. unit = 60 pg/ml double stranded RNA).
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Viral RNA was then serially diluted to 15 ng/pl, 0.15 ng/jxl, 1.5 pg/jLLl and 15 fg/pl in 
RNase free water, RNA extracted from TNE buffer acted as a negative control. RT- 
PCR was carried out. Once an indication of sensitivity was established RNA was 
further diluted from 15 ng/pl to 11.25, 7.5, 3.75, 1.5 and 0.75 ng/jul and the RT-PCR 
repeated. All products were visualised on an agarose gel as above.
5.3.1.7. Sensitivity using organ samples
Atlantic salmon kidneys were stored frozen at -70°C. IPNV was diluted 1:10 in HBSS 
(Gibco) from neat to 10"15, 100 mg of kidney was spiked with 100 p.1 of alternate 
dilutions beginning with 10' 1 to 10'15, one kidney was spiked with 100 |ll of HBSS to act 
as a negative control. To ascertain the exact virus concentration IPNV was titrated 
(Chapter 2) on the same day as the kidneys were spiked and RNA extracted. The 
kidneys used had been previously homogenised and placed onto CHSE-214 cells and 
had been found to be IPNV negative. RNA was then extracted using the Tri Reagent 
method and RT-PCR carried out.
5.3.1.8. Specificity
To ensure the primers were specific to IPNV various viruses were propagated and 
purified. The viruses used were a selection of those that were legally allowed to be 
grown in the virology laboratory at the Institute of Aquaculture. They were Infectious 
Salmon Anaemia Virus (ISAV), two strains of Piscine Nervous Necrosis Virus 
(PNNV(Nodavirus)), a Mediterranean strain from Seabass (Dicentrarchus labrax) and a 
Japanese strain from Striped Jack (.Pseudocaranx dentex) and Blotched Snakehead 
Virus (BSNV).
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ISAV was propagated on Salmon Head Kidney cells (SHK’s) at 15°C. Cells were 
maintained in L I5 Leibovitz without amino acids, with Glutamax (Gibco). Media was 
supplemented with 5% FBS (Gibco), 2mM L-Glutamine (Gibco), 40mM 2- 
Mercaptoethanol (BDH) and with 50 IU/ml penicillin, 50 pg/ml streptomycin and 100 
pg/ml kanamycin (Gibco). SHK cells were infected with ISAV by pre-formed 
inoculation, media was removed from a 75cm2 flask (Iwaki) of fully confluent SHK 
cells and retained, 3 ml ISAV was placed onto the cells and adsorbed at 15°C for 1 
hour. After this time the conditioned media was replaced and the cells incubated at 
15°C until full CPE was visible.
Both strains of Nodavirus and BSNV were propagated on Striped Snakehead 
fry/peduncle cells (SSN -l’s) at 25°C. Cells were maintained in L15 Leibovitz without 
amino acids (Gibco), media was supplemented with 2 mM L-Glutamine (Gibco), lx 
non-essential amino acids (Sigma) and 10% FBS for cell culture. FBS was lowered to 
5% for virus propagation. SSN-1 cells were infected with both strains of Nodavirus by 
pre-formed inoculation, media was removed from a 75cm“ flask (Iwaki) of fully 
confluent SSN-1 cells, 3 ml each Nodavirus was placed onto the cells and adsorbed for 
30 minutes at 15°C. After this time L I5 containing 5% FBS was added to the flask. 
SSN-1 cells were infected with BSNV by simultaneous inoculation of cells and virus. 
A 25cm2 flask (Iwaki) of fully confluent SSN-1 cells was sub-cultured by washing 
twice with PBS Dulbeccos (without calcium, magnesium and sodium bicarbonate, 
Gibco) and cells harvested using trypsin-EDTA (lx , in HBSS without calcium and 
magnesium, Gibco), and split to a ratio of 1:3. Virus was inoculated at 1/10 of the 
volume of SSN - 1  cell suspension ( 6  ml) in the flask and the cells/virus incubated at
25°C until full CPE was visible.
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All viruses were harvested and clarified by centrifugation in a Denley BR401 
refrigerated centrifuge at 1000 g for 10 minutes. Viruses were purified as in Chapter 2, 
Section 2.5. RNA was extracted (Section 5.2.1.3.) from the viruses and TNE buffer as a 
control using the above method. RNA from each virus and the TNE buffer was 
measured as above and the RNA serially diluted until each sample of viral RNA was at 
a concentration of 5 ng/pl. ISAV, both strains of Nodavirus and BSNV are single 
stranded RNA viruses, the concentration of ssRNA was calculated using the following 
formula:
O.D. at 260 nm x 40 x dilution factor (1 O.D. unit = 40 pg/ml ssRNA).
RT-PCR was then carried out and the products visualised on an agarose gel as above.
5.3.1.9. Detection of IPNV serotypes
To test whether the primers amplified every serotype of IPNV, each serotype was 
propagated by simultaneous inoculation of cells and virus, for method see Chapter 2. 
IPNV serotypes A l, A2 and A3 were propagated in CHSE-214 cells (Chapter 2), B1 
was propagated in bluegill fibroblast cells (BF-2) at 15°C. BF-2 cells were cultured in 
EMEM without amino acids (Gibco) supplemented with 2 mM L-Glutamine (Gibco), 
lx non-essential amino acids (Sigma) and 10% FBS (Gibco). All other serotypes, A4, 
A5, A6 , A7, A8  and A9 were kindly donated by Keith Way at CEFAS and propagated 
on BF-2 cells. Viral RNA was extracted from cell culture supernatant (Section 5.2 .1.3.) 
and RT-PCR carried out, products were visualised on an agarose gel as above. 
Amounts of template RNA were varied for each serotype from 0.5 pi to 3 pi.
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5.3.2. IPNV polyclonal antiserum production
5.3.2.1. IPNV propagation
IPNV (Shetland isolate Br.) was propagated in CHSE-214 cells, 3 fully confluent 175 
cm3 flasks (Iwaki) were infected with IPNV by pre-formed inoculation for 30 minutes at 
15°C (Chapter 2). Once complete CPE was visible the flasks were harvested and 
pooled, virus purified as in Chapter 2, however virus was re-suspended in PBS 
Dulbeccos (Gibco).
5.3.2.2. Antiserum production
Antiserum was produced in a New Zealand white rabbit, blood was collected prior to 
injection from the marginal ear vein. Blood was left to clot overnight at 4°C and 
centrifuged at 1250 g for 10 minutes in a Denley BR401 refrigerated centrifuge. Serum 
supernatant was removed and heat inactivated in a water bath at 56°C for 30 minutes 
and frozen in aliquots at -20°C. Purified virus was emulsified using equal volumes (500 
pi) with Titermax adjuvant (Stratech Scientific Ltd.) and inoculated subcutaneously, 
100 pi of the mixture was injected at 4 sites. A test bleed was taken from the marginal 
ear vein 14 days after the injection; blood was processed as above. A subcutaneous 
booster injection of purified virus and Titermax emulsion (100 pi at 4 sites) was given 4 
weeks later. A further test bleed was taken from the marginal ear vein 7 days later and 
processed as above. The blood taken prior to injection was checked for IPNV 
antibodies by alpha neutralisation. Blood taken after the booster injection was also 
tested by alpha neutralisation to ensure the rabbit was responding to the injections.
The next booster injection was 4  months later; 400 pi of purified virus was 
intravenously injected into the ear vein, 7  days later the rabbit was anaesthetised and
blood taken by cardiac puncture. Blood was left to clot at room temperature for 1 hour 
and then at 4°C overnight, serum supernatant was then removed, the majority of the 
supernatant was heat inactivated as above for use in neutralisations. The rest was left 
untreated for ELISA; all supernatant was stored frozen at -20°C in aliquots.
5.3.2.3. Antiserum titre in cell culture
The titre of the antiserum was determined by alpha neutralisation. The alpha 
neutralisations were carried out in 96 well plates (Iwaki). For the pre-injection bleed 
and post booster bleed an indication of titre was all that was required, antiserum was 
diluted to a working concentration of 1:10 with HBSS plus 2% FBS, from which further 
dilutions of 1:20, 1:50, 1:10'2, 1:10'3, 1:10' 4 and 1:10"5 were made. All wells except 
those in the first column were filled with 90 jLtl of HBSS plus 2 % FBS. Column one 
row one was filled with 100 pi of HBSS to act as a mock, all other wells in column one 
were filled with lOOpl of IPNV. The virus and mock were then titrated 1:10 across the 
plate. Into the top two rows 90 pi of HBSS plus 2 % FBS was added, into the 
remaining 6  rows 90 pi of diluted antisera was added, one row per dilution. The plate 
was incubated at 15°C for 30 minutes, after this time 100 pi of CHSE-214 cells were 
added to each well. The plate was incubated at 15°C for 7 days after which time viral 
CPE was recorded.
To test the titre of the final bleed, an initial neutralisation as described above was 
carried out to gain an idea of the titre; two further neutralisations were then carried out 
to determine the exact titre. The antiserum was serially diluted with HBSS plus 2% 
FBS to 10'3, 10' 4 and 10'5. The neutralisation was performed as above, except each 
dilution of antiserum was in duplicate, plus mock and virus only rows. Once a closer
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estimation of titre was known the antiserum was further diluted using log 5 dilutions to 
10' 4 '2 and 1CT4'9, and to 10' 4 '7 using log 6  dilutions. The neutralisation was performed as 
above with each dilution of antiserum in duplicate, plus mock and virus only rows.
5.2.3.4. Antiserum specificity
The Shetland Br. isolate the antiserum was raised against was confirmed by 
neutralisation as serotype A2 (Sp.). The specificity of the antiserum was tested against 
homologous virus and IPNV reference strains A2 and A3 (Ab.) in duplicate using 
neutralisation titration. The neutralisation was performed as in Chapter 2 with one 
difference, the antiserum was diluted to a working concentration of 1 0 '4.
5.2.3.5. Polyclonal antibody purification
5.2.3.5.I. Sodium sulphate precipitation
Untreated polyclonal antiserum was brought to room temperature by heating for 5 
minutes in a water bath at 25°C. Into 8  ml antiserum 14 % w/v sodium sulphate 
(Na2S0 4 , Sigma) was added and left in a water bath at 25°C for 5 minutes and then 
centrifuged for 15 minutes at full speed (21,000 g) in a IEC Micromax centrifuge. 
Supernatant was removed and the precipitate washed twice with a previously prepared 
solution of 14 % Na2S 0 4 in distilled water. Precipitate was dissolved in 2 ml PBS 
Dulbeccos (Gibco) at room temperature. Optical density of a 1 : 1 0  dilution of the 
suspension in PBS was read at 280 nm to determine protein concentration. An O.D. of 
1-4=1 mg/ml protein.
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5.2.3.5.2. Acid treatment of precipitated antiserum
PBS Dulbeccos (Gibco) was adjusted to pH 2.1 using hydrochloric acid (BDH). The 
appropriate volume of acidic PBS was added to the precipitated antiserum to give a 
final protein concentration of 3.6 mg/ml. The solution was left on a slow stirrer for 30 
minutes, after this time the pH was brought up to 7.0 by addition of solid tris (Sigma). 
The purified acid treated antibody was stored in aliquots at -20°C.
5.3.3. ELISA
5.3.3.I. Optimisation
The ELISA plate (Immulon) was initially coated with the purified acid treated 
polyclonal antibody at concentrations of both 5 and 10 pg/ml and the AS-1 monoclonal 
(DiagXotics) the detector antibody at concentrations varying from 1 :1 0 0 - 1 :1 0 0 0 . This 
method was unsuccessful even when amplified with StreptAvidin horseradish 
peroxidase (HRP) (Scottish Antibody Production Unit (SAPU)). To ensure both 
antibodies were binding to the virus an indirect ELISA was carried out. ELISA plates 
were coated with 100 pl/well of 1 % poly-L-lysine (Sigma) diluted in coating buffer for 
an hour at room temperature. The plates were then washed 3 times with low salt wash 
buffer and 100 pi of IPNV placed into the wells and incubated overnight at 4°C. 
Purified polyclonal antibody was diluted to 1:500 and monoclonal antibody was diluted 
to 1:500, 100 pi of each was added to the plates.
The AS- 1  monoclonal was then selected as the capture antibody and the polyclonal 
antibody as the detector antibody. The AS-1 monoclonal was diluted to 1:500; various 
dilutions of purified polyclonal antibody were tested including 5, 1, 0.1, and 0.01 pc/ml. 
Various blocking agents were then tested in an attempt to prevent non-specific bindinc ,
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1 % bovine serum albumin (BSA, Sigma), 3 % caesin (skimmed milk, Cadbury’s 
Marvel) and 5 % gelatin (BDH) to block the monoclonal and 2.5 % gelatin as a diluent 
for the antigen, antibody and conjugate.
5.3.3.2. Sandwich ELISA
Prior to the ELISA kidney samples were heated to 40°C for 30 minutes to reduce levels 
of non-specific binding (Keith Way, pers. comm). A 96 well ELISA plate was coated 
with 100 p.1 of a 1:500 dilution of concentrated monoclonal antibody, AS-1 at 1.9mg/ml 
(DiagXotics) in coating buffer (pH 9.6, Appendix 1). The plate was incubated 
overnight at 4°C. After this time the plate was washed in low salt wash buffer (pH 7.3, 
Appendix 1) three times. The plate was then blocked with 250 jllI of 3 % w/v caesin in 
distilled water for 1 hour at 37°C and the plate washed as above. The antigen was 
diluted in 3 % casein in low salt wash buffer and 100 jllI added to each well and 
incubated at room temperature for an hour on a Titertek plate shaker. The plate was 
washed five times in high salt wash buffer (pH 7.6, Appendix 1) and incubated for 5 
minutes on the last wash at room temperature. Purified polyclonal antibody was diluted 
in 3 % casein to a concentration of 0.5 Jig/ml, 100 |il was added to each well and the 
plate incubated for an hour at room temperature. The plate was then washed as above. 
Biotin labelled donkey anti-rabbit IgG (SAPU) was diluted 1:1000 in conjugate buffer 
(Appendix 1 ) and 1 0 0  jllI added to each well. The plate was incubated at room 
temperature for an hour and the above washing step was repeated. StreptAvidin HRP 
was diluted 1 : 1 0 0 0  in conjugate buffer and 1 0 0  pi added to each well and the plate 
incubated at room temperature for 30 minutes. The plate was washed again as above. 
Substrate indicator solution was prepared by adding 3 ’3’5’5’-tetramethylbenidine 
dihydrochloride (TMB, Sigma) to 1:2 acetic acid:distilled water, 150 fil of this
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chromogen solution was then added to 15 ml substrate buffer along with 5 pi of HbO: 
(Sigma), 100 j_il of this was added to every well and incubated at room temperature for 
10 minutes. The reaction was stopped by addition of 50 pi of 2M H2SO4 (Sigma). The 
plate was read at 450 nm in a Titertek Multiskan Plus ELISA reader.
The sensitivity of the ELISA was evaluated using cell culture IPNV and a negative 
kidney homogenate spiked with a known amount of virus; negative controls of cell 
culture supernatant and negative kidney homogenate were used. The samples were 
assayed neat, diluted 1:10, 1:100 and 1:1000 and then transferred to the ELISA plate. 
At the same time the dilutions were titrated onto CHSE-214 cells to ascertain the exact 
titre of the virus (Chapter 2).
5.3.4. Immunohistochemistry
5.3.4.1. Optimisation
Initially the polyclonal rabbit antiserum produced in this study was used to stain 
paraffin embedded sections. Various dilutions of antiserum were tried, from 1:50 -  
1:1000, no IPNV staining was visible. To attempt to unmask the antigens the slides 
were placed in the microwave at each incubation for 1 0  minutes, this too was 
unsuccessful using the polyclonal antiserum. The AS-1 monoclonal used for the ELISA 
was then tested at concentrations between 1:25 and 1:1000 without microwaving. A 
dilution of 1:500 was found to be optimal.
5.3.4.2. Immunohistochemistry
Paraffin embedded sections were used, tissues were fixed, processed and sectioned as in 
Chapter 2. Sections were dewaxed in xylene for 5 minutes and re-hydrated in 1 0 0  %
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ethanol for 2 minutes and 70 % ethanol for 1.5 minutes and rinsed in distilled water. 
Rings were drawn around the sections with a PAP pen (BDH). All incubations were 
carried out in a humid chamber at room temperature.
Slides were incubated with 10 % v/v hydrogen peroxide in methanol for 10 minutes to 
block exogenous peroxidase activity. The slides were then washed 3x with Tris 
Buffered Saline (TBS, Appendix 1). Non-specific binding was blocked using normal 
goat serum (SAPU) diluted 1:10 in TBS for 10 minutes. The goat serum was tapped off 
and the slides washed as above. Monoclonal antibody AS-1 (DiagXotics) was diluted 
1:500 from an original concentration of 1.9 mg/ml, placed onto sections and incubated 
for 60 minutes. Controls of negative tissue incubated with AS-1 and positive tissue 
incubated with PBS (Gibco) were also used. After this time the slides were washed as 
above. Biotin anti-mouse IgG (SAPU) was diluted 1:1000 in TBS, the sections coated 
and incubated for 60 minutes, sections were then washed as above. StreptAvidin HRP 
(SAPU) was diluted 1:1000 in TBS and placed onto the slides for 60 minutes, the 
sections were again washed as above. To visualise a reaction the slides were incubated 
for 15 minutes with 3 ’3 diaminobenzidine tetrachloride (DAB). A solution of 1 % H2O2 
was prepared, 100 jllI of this was added to 0.5 ml DAB (1.5 mg/ml) and 5 ml TBS. 
After 15 minutes the reaction was stopped by immersion of the slides in tap water.
Sections were counterstained with haematoxylin for 4 minutes, washed in tap water and 
immersed in Scotts tap water solution (STWS) for 30 seconds. Sections were then 
dehydrated in 70 % ethanol for 30 seconds, two baths of absolute alcohol for 2  minutes 
^ d  1.5 minutes. Finally slides were rinsed in xylene for 5 minutes and sections
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coverslipped using pertex (Celipath), Sections were examined under a light 
microscope, IPNV positive tissue stained brown.
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5.4. Results
5.4.1. RT-PCR
5.4.1.1. Sensitivity
Using purified IPNV RNA the detection limit o f the RT-PCR using primer set PrD was 
found to be 1.5 ng/pl (Figure 5.1).
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Figure 5 .1: Sensitivity o f RT-PCR using primer set PrD. Lane 1: 15ng/pl; lane 2: 11.25 
ng/pl; lane 3: 7.5 ng/ptl; lane 4: 3.75 ng/pil; lane 5: 1.5 ng/pl; lane 6 : 0.75 ng/pl; lane 7: 
TNE buffer extract.
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Using purified IPNV RNA the detection limit o f the RT-PCR using primer set PrF was 
found to be 0.75 ng/pl (Figure 5.2).
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Figure 5.2: Sensitivity o f  RT-PCR using primer set PrF. Lane 1: 15ng/pl; lane 2: 11.25 
ng/pl; lane 3: 7.5 ng/pl; lane 4: 3.75 ng/jil; lane 5: 1.5 ng/pl; lane 6 : 0.75 ng/pl; lane 7: 
0.1 ng/pl; lane 8 : TNE buffer extract.
Primer set PrF wasTound to be slightly more sensitive than PrD.
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5.4.1.2. Specificity
Both primer sets were found to only amplify IPNV RNA (Figure 5.3), no band was 
visible when using RNA from ISAV, two strains o f Nodavirus and BSNV.
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Figure 5.3: Specificity o f RT-PCR for both primer sets. Lanes 1-6 using PrD, lanes 7- 
12 using PrF. Lanes 1 and 7: IPNV; lanes 2 and 8 : ISAV; lanes 3 and 9: Maltese 
Nodavirus; lanes 4 and 10: Japanese Nodavirus; lanes 5 and 11: BSNV; Lanes 6  and 12: 
TNE buffer extract.
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Primer set PrD was found to amplify 7/10 serotypes o f  IPNV (Figure 5.4), A l, A2, A4,
A6 , A7 and A9. The primer set also amplified A5 however the product at this serotype 
was very faint.
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Figure 5.4: Amplification o f IPNV serotypes with primer set PrD. Lane 1: A l; lane 2: 
A2; lane 3: A3; lane 4: A4; lane 5: A5; lane 6 : A6 ; lane 7: A7; lane 8 : A8 ; lane 9: A9; 
lane 10: B l; lane 11: BF-2 cell culture supernatant.
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Primer set PrF was found to amplify 6/10 serotypes o f IPNV (Figure 5.5), A l, A2, A3, 
A5, A7 and A8. Faint bands were also visible at A4 and A9 however amplification was 
not consistent with these serotypes.
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Figure 5.5: Amplification o f IPNV serotypes with primer set PrF. Lane 1: A l; lane 2: 
A2; lane 3: A3; lane 4: A4; lane 5: A5; lane 6: A6; lane 7: A7; lane 8: A8; lane 9: A9; 
lane 10: B l; lane 11: BF-2 cell culture supernatant.
Neither primer set PrD nor PrF amplified serotype B l. However using both primer sets 
it was possible to amplify 9/10 serotypes o f EPNV.
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5.4.I.3. Adaptation of RT-PCR for use with tissue
Amplification o f IPNV from kidney using the tissue extraction kit was repeatedly 
unsuccessful, even using the most sensitive primer set PrF (Figure 5.6). Note the 
amplification o f spurious non-specific bands rather than IPNV in lane 2.
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Figure 5.6: Amplification o f RNA extracted using the tissue extraction kit from IPNV 
spiked kidney tissue using primer set PrF. Lane 1: A2 positive control; lane 2: 2 pi 
spiked kidney RNA; lane 3: 0.5 pi spiked kidney RNA; Lane 4: HBSS spiked kidney 
RNA.
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Amplification o f  IPNV RNA from kidney was successful using Tri Reagent to extract 
IPNV RNA from kidney spiked with high titre virus (Figure 5.7).
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Figure 5.7: Amplification o f RNA extracted using Tri Reagent from kidney tissue 
spiked with 1 0 12 TCID 50 IPNV using primer set PrF. Lane 1: A2 positive control; lane 
2: 1 pi spiked kidney RNA; lane 3: 2 pi spiked kidney RNA; lane 4: HBSS spiked 
kidney RNA.
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5.4.1.3. Sensitivity using tissue
Amplification o f  IPNV from kidney spiked with various dilutions o f virus was 
unsuccessful with primer set PrD even at dilutions as low as 10'1 (108 TCIDso/ml) 
(Figure 5.8).
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Figure 5.8: Sensitivity o f primer set PrD using IPNV spiked kidney RNA. Lane 1: A2 
positive control; lane 2: 10'1 IPNV; lane 3: 10’3 IPNV; lane 4: HBSS spiked kidney 
RNA.
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However amplification was successful using primer set PrF. A product was visualised 
only at the lowest dilution o f 10'1, this equates to 1 0 8 TCID 50 IPNV/ml but not at 1 0 6 
TCIDso/ml (Figure 5.9). Alternative dilutions o f IPNV were amplified therefore the 
RT-PCR was sensitive to between 107 and 108 TCID50/ml.
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Figure 5.9: Sensitivity o f primer set PrF using IPNV spiked kidney RNA. Lane 1: A2 
positive control; lane 2: 107 IPNV; lane 3: 105 IPNV; lane 4: HBSS spiked kidney 
RNA.
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5.4.2. A ntiserum  specificity and  titre
The polyclonal antiserum  was found not to neutralise IPNV serotype A3 (Ab.) reference 
strain but was found to neutralise IPNV A2 (Sp.) reference strain. The 50 % 
neutralisation titre o f the antiserum  using hom ologous virus was found to be 10,000.
5.4.3. ELISA
The sandwich ELISA  was unsuccessful using the purified polyclonal antibody as the 
capture antibody with different dilutions of IPNV (Figure 5.10). There was very little 
difference in the optical density O.D. between IPNV and the negative control of 
EMEM.
1 1 / 2  
□  1 /4
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Figure 5.10: Sandwich ELISA using 5 pg/m l polyclonal antibody as the capture 
antibody at two dilutions o f IPNV.
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The AS-1 m onoclonal antibody was shown to react well with IPNV in an indirect 
ELISA at a dilution of 1:500 (stock concentration of 1.9 mg/ml). However non-specific 
binding in the negative controls was above an O.D. of 0.1 and appeared to increase with 
higher dilutions o f EM EM .
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Figure 5.11: D etection of IPNV using AS-1 monoclonal antibody.
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Although the polyclonal antibody appeared to react well with IPNV in an indirect 
ELISA the same level o f reaction was seen with the negative controls of EM EM  (Figure 
5.12).
1 -r       u  IPNV
□ EMEM
neat 1/10 1/100 1/1000
Dilution factor
Figure 5.12: Detection o f IPNV using 10 Jlg/ml polyclonal antibody.
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Changing the capture antibody to the m onoclonal antibody at a dilution o f 1:500 
produced a good reaction with IPNV (Figure 5.13). A comparison o f 1 % BSA and 2.5 
% gelatin as blocking agents showed that neither BSA nor gelatin were particularly 
efficient at blocking non-specific binding. Reducing the polyclonal antibody 
concentration to 1 (Ig/ml did little to lower non-specific binding, binding with gelatin 
was as high as 0.3 and 0.2 with BSA.
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Figure 5.13: Sandwich ELISA using the AS-1 monoclonal as the capture antibody 
comparing 1 % BSA and gelatin as blocking agents.
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To attem pt to reduce non-specific binding the polyclonal antibody was titrated out from 
1 ftg/ml to 0.01 flg/ml using 1 % BSA as the blocking agent. Reducing the 
concentrations o f polyclonal antibody appeared to have little effect on non-specific 
binding, the blanks containing no antibody were just as high as those with antibody and 
still above 0.1.
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0.6  -
1 0.1 0.01 blank
Polyclonal antibody concentration (ug/ml)
Figure 5.14: A comparison o f different concentrations of polyclonal antibody.
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The concentration o f polyclonal antibody chosen based on the earlier titration was 0.5 
pg/ml. Using caesin as a blocking agent at this concentration of polyclonal was 
successful at blocking non-specific binding (Figure 5.15), which was below an O.D. of 
0.1 (0.05-0.07).
1
0.9 
0.8 
0.7 
0.6
0.4
0.3
0.2
0.1
0
Figure 5.15: Com parison of 1 % BSA and 3 % caesin as blocking agents.
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The sensitivity of the ELISA was little different using cell cultured IPNV or spiked 
kidney homogenate, both were sensitive to 1012-5 TCID50/ml (the 1:100 dilution in 
Figure 5.16). The sensitivity threshold of the ELISA was 3 times the O.D. of the 
negative controls, in this case 0.285.
□ 1/100 
□ 1/1000
T hreshold L im it
EMEM IPNV Negative tissue Positive tissue
Cell culture Kidney homogenate
Figure 5.16: Sensitivity of the sandwich ELISA in cell culture and spiked kidney 
homogenate.
163 C hapter 5
5.4.4. Immunohistochemistry
IPNV was successfully identified using AS-1 monoclonal antibody, lesions in the 
pancreas tissue stained positive for IPNV (Figures 5.17 and 5.20).
Figure 5.17: Pancreas from IPN positive fish analysed using immunohistochemistry 
with the AS-1 monoclonal antibody. Magnification: x20. Note areas o f intense IPNV 
staining (arrows).
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Figure 5.18: Pancreas from IPNV positive fish analysed by immunohistochemistry 
using PBS. Magnification: x20. Note the lack o f IPNV specific staining.
Figure 5.19: Pancreas from IPN negative fish analysed by immunohistochemistry with 
the AS-1 monoclonal antibody. Magnification: x20.
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Figure 5.20: Pancreas from IPN positive fish analysed by immunohistochemistry with 
the AS-1 monoclonal antibody. Magnification: x40. Note intense staining o f exocrine 
pancreas cells (arrows).
A certain amount o f background staining was present in the IPNV positive tissue 
stained with PBS upon examination o f the slide under high magnifications (Figure 
5.21). There was also a certain amount o f staining in the IPNV negative tissue stained 
with the AS-1 monoclonal (Figure 5.22). This was mainly staining o f the fat cell 
membranes that was considered unlikely to be confused with specific IPNV staining in 
the pancreas.
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Figure 5.21: Pancreas from IPN positive fish analysed by immunohistochemistry with 
PBS. Magnification: x40. Note slight non-specific staining in exocrine pancreas cells 
(arrows).
— V. V *
Figure 5.22: Pancreas from IPN negative fish analysed by immunohistochemistry with
the AS-1 monoclonal antibody. Magnification: x40. Note non-specific staining o f 
membranes in negative tissue (arrows).
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5.5. Discussion
Cell culture was found to be the most sensitive detection method for IPNV in the 
present study. The process of simultaneous inoculation of IPNV and CHSE-214 cells is 
likely to be more sensitive than the inoculation of IPNV onto pre-formed cell 
monolayers. In a simultaneous inoculation the cells are slightly compromised giving 
the virus a greater opportunity for infection, particularly with a low level of infection.
The sensitivity of RT-PCR is often measured using pure viral RNA and to enable 
comparison the sensitivity using purified IPNV RNA was carried out in this study. In 
the present study primer sets PrD and PrF were found to be sensitive to 1.5 ng and 750 
pg respectively, Wang et al. (1997) found primer set PrD to be sensitive to 15 fg and 
PrF to 15 pg. Lopez-Lastra et al. (1994) examined 5 primer sets and found the most 
sensitive primer set to amplify 1 pg of purified IPNV RNA. The adaptation of the RT- 
PCR to RT-PCR beads appears to have reduced the sensitivity using purified IPNV 
RNA, however whilst Wang et a l (1997) found PrD to be the most sensitive the present 
study found PrF to be the most sensitive. Wang et al. (1997) used the A l (West 
Buxton) serotype to establish sensitivity; the present study used the A2 (Sp.) serotype. 
Slight differences in the nucleotide sequence of the two serotypes may explain the 
difference in amplification efficiency.
The use of purified RNA to assess sensitivity is not representative of the utility of the 
RT-PCR in the field where the assay is likely to be much less sensitive due to 
contaminants such as kidney RNA. Many publications establish sensitivity using 
purified RNA but do not do the same for tissue homogenates (Lopez-Lastra et al., 1994, 
Wang et al., 1997). RT-PCR may potentially be as sensitive as cell culture for detection
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of IPNV, however of the 2 primer sets examined in this study PrD failed to amplify the 
virus at all from spiked kidney homogenate and primer set PrF was only sensitive to 
between 107 and 108 TCIDso/ml. Blake, Schill, McAllister, Lee, Singer and Nicholson 
(1995) assessed the sensitivity of the RT-PCR compared to cell culture for detection of 
IPNV, they concluded that with one primer set the RT-PCR was as accurate as cell 
culture isolation for detecting virus in kidneys from asymptomatic carrier fish. Blake et 
al. (1995) assessed 4 different primer sets and established sensitivity for both cell 
culture and tissue homogenates to be between 103 2 and 104'6 plaque forming units 
(PFU)/ml. Assessment of viral titre using PFU’s is not directly comparable to the 
TCID50 method and unfortunately the two sensitivities cannot be compared.
It is likely that the RNA tissue extraction kit initially used in this study was ineffective 
at removing the high levels of DNA, RNA and protein present in the kidney as 
demonstrated by the very viscous nature of the tissue homogenate. The Tri reagent 
RNA extraction method removed all protein and DNA, only total RNA was pelleted and 
re-suspended. The high amount of RNA present in the kidney is likely to be responsible 
for inhibition of amplification of the RT-PCR from tissue. An alternative organ could 
be sought for IPNV isolation for use in RT-PCR, unfortunately alternatives such as the 
pancreas and gut or spleen are also very rich in nucleic acids and may harbour too little 
virus, particularly for detecting carrier status.
The 10 minute denaturation step of dsRNA and primers prior to RT-PCR was adapted 
from Davis and Boyle (1990) and Lopez-Lastra et a l  (1994). A factor that may affect 
the sensitivity of the RT-PCR is this denaturation step; the amount of dsRNA split into 
ssRNA and annealed to the primers may vary with each PCR due to the high secondary
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structure of dsRNA. Lopez-Lastra et al. (1994) assessed a number of temperatures for 
the denaturation step and found that a proteinase K digestion of the dsRNA followed by 
10 minutes denaturation at 104°C gave the best results. Wang et al. (1997) denatured 
IPNV dsRNA at 110°C for 10 minutes whilst Davis and Boyle (1990) denatured IBDV 
dsRNA at 100°C for 10 minutes. Dobos (1995) states that the IPNV dsRNA genome 
has a Tm (melting point) of 89°C, therefore heating to any temperature above 89°C 
should denature the dsRNA. It is possible that with increasing temperatures above 89°C 
the more dsRNA is denatured and the more sensitive the RT-PCR. In the present study 
denaturation was 100°C for 10 minutes, it is possible that the RT-PCR may be more 
sensitive with denaturation at a higher temperature.
Staining of agarose gels with ethidium bromide is not particularly sensitive and to 
increase the detection limit of EPNV cDNA may be visualised using polyacrylamide gel 
electrophoresis (PAGE) and stained with silver stain (Berry and Samuel, 1982, Herring, 
Inglis, Ojeh, Snodgrass and Menzies, 1982). Berry and Samuel (1982) assessed the 
detection limit of dsRNA using PAGE, staining with silver stain and ethidium bromide. 
They found that silver stain was between 10-30 times more sensitive than ethidium 
bromide. Lopez-Lastra et al. (1994) established the detection limit of the RT-PCR to be 
1 pg using PAGE, this is more sensitive than the RT-PCR described in the present study 
however W ang et al. (1997) found the sensitivity with primer set PrD to be 15 fg 
visualising cDNA on agarose gels. Lopez-Lastra et al. (1994) increased the sensitivity 
of their RT-PCR with the use of a nested PCR, Suzuki, Hosono and Kasuda (1997) 
increased the sensitivity of their IPNV RT-PCR from 1 pg to 1 fg using nested PCR. 
However a nested PCR increases the chances of obtaining false positive results.
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It is possible that decreasing the volume of RNase free water used to re-suspend the 
RNA from 100 )il to 50 pi may increase the sensitivity, yet this will also further 
concentrate total RNA and may only inhibit the assay further. Performing the RT-PCR 
in two steps, an RT step and a PCR step may also increase sensitivity although this too 
has drawbacks, the time taken for the assay is increased along with the potential for 
contamination. Alternatively, dsRNA has been found to be resistant to RNase A 
digestion in the presence of high salt levels unlike ssRNA and it is possible to remove 
the ssRNA component in this way (Nicholson, 1996). This is likely to be the most 
effective method for increasing the sensitivity of the RT-PCR and will not significantly 
increase the time taken for the RNA extraction. This method should be examined for 
future use.
Despite the low sensitivity of the RT-PCR it was found to be specific to IPNV; ISAV, 
BSNV and two strains of Nodavirus did not produce a product. These viruses were 
chosen for two reasons; they could be legally cultured at the Institute and they were 
viruses that may co-exist with IPNV around the world. Wang et al. (1997) also 
concluded that the primers were specific to IPNV since amplification of IHNV and 
IBDV failed to produce a product.
In light of the poor sensitivity of the RT-PCR it is unlikely the test could be used 
routinely as a diagnostic method, nevertheless it does have potential to confirm IPNV 
infection upon the appearance of CPE in cell culture. This does have its limitations 
since both sets of primers were shown not to amplify all serotypes of IPNV; this 
depends on the serotypes of the virus present in the area of isolation. However, the use 
of both primer sets does allow for amplification of all 9 serotypes of IPNV within
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serogroup A. TV-1 is a shellfish isolate and was not amplified by either primer set, it is 
the only representative to date of serogroup B and is present in the UK. RT-PCR does 
not give any information on the serotype of IPNV and it is likely that a titration 
neutralisation will still be required. The PCR does allow for a rapid diagnosis of 
infection and results may be determined in one day rather than 7, the time required for a 
neutralisation titration.
The sandwich ELISA was found to be less sensitive than the RT-PCR, the detection 
limit was 1012'5 TCIDso/ml, although the sensitivity of the assay does not decrease when 
comparing cell cultured IPNV to spiked tissue homogenates. ELISA tests can never be 
sensitive enough to detect the very low virus levels typical of carrier fish, but are able to 
detect virus in infected cell cultures (Davis et a l,  1994). However the ELISA 
developed in this study appears not to detect even high titres of virus in cell culture. 
ELISA protocols have previously been published with sensitivities of 106 PFU/ml, 105 
TCIDso/ml and 103 TCIDso/ml (Dixon and Hill, 1983a, Davis et a l, 1994, Vazquez 
Branas, Coll Morales and Estepa, 1994).
It is possible that one of the two antibodies used in the ELISA may be a low avidity 
antibody. The polyclonal antibody was found to be ineffective at staining IPNV in 
immunohistochemistry and this may indicate that it is the polyclonal with a low avidity 
and is removed with the rigorous washes performed in both the ELISA and 
immunohistochemistry. The epitopes the polyclonal antibody reacts with may be 
investigated using Western blotting. Alternatively since the epitopes the polyclonal 
antibody reacts with were not assessed in this study it is possible that the two antibodies 
are competing for the same sites. The AS-1 monoclonal reacts with VP2, this is
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considered to be the major protein involved in the infectivity of IPNV (Caswell-Reno et 
al., 1986). It is possible that since both antibodies are neutralising antibodies they may 
both be competing for overlapping epitopes on VP2. Additional anti-IPNV monoclonal 
antibodies can be purchased from DiagXotics that are not neutralising; this may result in 
a much more sensitive assay.
Initially high non-specific binding was a problem with the ELISA; this was reduced to a 
certain extent with the use of the low salt wash buffer (containing Tween) rather than 
PBS for dilution of IPNV, polyclonal antibody and conjugate. However it was not until 
caesin was used for blocking and added to the low salt wash buffer diluent that non­
specific binding was reduced to below an O.D. of 0.1.
Unfortunately due to time constraints the specificity of the ELISA could not be 
evaluated. However the specificity of the polyclonal antiserum to IPNV serotypes 
found in the UK is known from neutralisation titrations, it was shown to only neutralise 
A2 (Sp.) serotype. There may still be some cross reactivity in ELISA with A3 (Ab.) 
serotype particularly since the AS-1 monoclonal is specific to VP2 and will react with 
all serotypes of JPNV in serogroup A.
The ELISA has potential for use as a confirmatory test after cell culture has identified a 
viral infection and eliminates the need for a titration neutralisation unless the serotype 
of the virus is necessary. The ELISA has the advantage of being very rapid with results 
obtained in approximately 5 hours, rather than 7 days. Recently RT-PCR and ELISA 
have been combined as a diagnostic technique for IPNV (Munoz, Opazo, Burzio and 
Miguel, 2000). They established that the RT-PCR-ELISA is more sensitive than RT-
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PCR alone but did not quote sensitivities; this method has potential as an alternative 
diagnostic technique.
The immunohistochemical staining of IPNV in pancreatic lesions was successful using 
the AS-1 monoclonal. The sensitivity of the assay could not be assessed, however 
Biering and Bergh (1996) estimated the sensitivity of their immunohistochemistry 
(IHC) to be 105 TCID 5o/ml based on infection trials with larval halibut. It is likely that 
the assay would be most useful for confirmation of IPNV infection where pathology is 
apparent. As a diagnostic method it allows for the simultaneous evaluation of 
morphological lesions and IPNV staining (Evensen and Rimstad, 1990). It is also a 
very rapid, straightforward test with results visible in 4-5 hours. It is possible that use 
of the kidney for immunohistochemistry may be more sensitive since virus is isolated 
from the kidney, often regardless of any attendant pathology in the pancreas. It has 
been noted that in formalin fixed tissue antigens may be masked by cross-linking of 
proteins around the antigenic sites (Elias, Gown, Nakamora, Wilbur, Herman, Jaffe, 
Battifora and Brigati, 1989). Staining may be further increased with the use of antigen 
retrieval-IHC, microwaving in the presence of a suitable buffer to avoid tissue 
degradation (Maniatis, Morris, Adams and Pearson, 2000). An advantage to using the 
AS-1 monoclonal is that as it is specific to VP2 it will stain all serotypes of IPNV.
A certain amount of background staining was visible in the IPNV positive tissue stained 
with PBS and the IPNV negative tissue stained with AS-1 monoclonal, however there 
were still marked differences and IPNV positive staining was clearly visible. There 
may be potential for this to be improved in the future.
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Pathology for IPN not only includes pancreatic lesions but sloughing of the gut mucosa 
to form a catarrhal exudate (Smail et al. 1995). Smail et al. (1995) demonstrated the 
immunohistochemical staining of the necrotised tips of the gut villi in Atlantic salmon 
suffering an acute outbreak of IPN. Interestingly in this study whilst the pancreatic 
lesions stained positive for EPNV, the extensive gut pathology remained unstained.
In-situ hybridisation may be a more sensitive diagnostic method for IPNV and could be 
examined in the future. Biering and Bergh (1996) developed in-situ hybridisation for 
IPNV in halibut larvae and found that it was no more sensitive than the IHC, but 
suggested that in situ hybridisation may be amplified either by using in situ PCR or 
using amplifying complexes between the probe and the antibody.
In conclusion from the methods presented in this chapter, RT-PCR, ELISA and IHC, 
RT-PCR was found to be the most sensitive in tissue homogenates. The ELISA is in 
need of further validation and sensitivity may be improved with the use of an alternative 
monoclonal antibody raised against a different IPNV protein. Despite the insensitivity 
of the RT-PCR and ELISA they are both very rapid and if used in conjunction with cell 
culture provide conclusive results within one day. IHC has the advantage of allowing 
simultaneous evaluation of lesions and the presence of IPNV in clinical cases. Cell 
culture remains the most sensitive method of detection for IPNV.
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6. Final Discussion
Microsatellites are ideally suited to disease resistance studies, particularly those 
involving IPNV since laboratory based challenges are rarely successful in producing 
clinical disease (Sadasiv, 1995, Taksdal et al., 1998). The use of microsatellites allows 
field trials to be carried out; the results of which are likely to be a much more accurate 
representation of differences in resistance to infection between families than that of a 
laboratory based challenge.
Many problems were however encountered in the microsatellite study, mainly due to the 
lack of precautions taken by the fish farm to prevent the mixing of family fish with 
production fish whose parents had not been genotyped. The project was possibly a little 
ambitious bearing in mind the early stage of the family programme at the fish farm. 
However the microsatellite system was carefully examined as a result of this to ensure 
that the mistakes were not within the genotyping system with the result that it should 
reliably assign approximately 80% of fish susceptible to disease to a single family in the 
future. Due to the problems experienced with the microsatellite study and the amount 
of time taken to process the data, samples were not taken from further years’ mortalities 
in the field. As a result the original aim of comparing data from the field to that 
obtained from experimental challenges could not be fulfilled.
A succession of laboratory based IPN challenges were undertaken in this study. These 
however did not produce clinical IPN and indeed initially many of the fish did not even 
become carriers but appeared to have completely cleared the virus. This may have been 
as a result o f an alteration of the virus during cell culture (Rimstad et al., 1991), the 
isolate may not have been particularly virulent or alternatively the virulence may have
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been lost during storage. The use of a different isolate of IPNV stored for an equal 
length of time appeared to persist in the fish and actively replicate but still did not cause 
clinical disease. It is remarkable that a virus that appears to be so pathogenic in the field 
can replicate to titres as high as 1011 TCED50 /g kidney in fish in experimental facilities 
and not cause death or even IPN pathology. W olf (1988) states that where IPNV is the 
cause of death one finds titres of between 106 to 109 infection units per gram of tissue. 
It is likely that in the field titres of this level would cause death however it is clear that 
the statement does not apply to Atlantic salmon post-smolts infected with IPNV under 
experimental conditions.
The reasons for the discrepancy between the field and laboratory situation are unclear 
but it would seem that there are aspects to the disease in the field that are not replicated 
in the laboratory. Not in the least of which is the very slow progression of the disease 
over three months, something not usually associated with viral diseases or mirrored 
under experimental conditions. By chance this was the case with the control fish that 
were later proven to be IPNV positive yet still mortality was not demonstrated. The 
dynamics of the disease in the field are poorly understood and further work is necessary 
to elucidate this.
Landcatch maintain up to 200 separate family groups of Atlantic salmon until the fish 
are approximately 8 months old, at this time the fish are mixed and placed in large tanks 
to make room for the next years batch of eggs. Since the microsatellite study had given 
no indication as to which families were susceptible or resistant, the families used in the 
experimental challenge were chosen at random. Data gained from this challenge may 
have been more informative had an indication of resistance been known.
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Still marked differences were found between different families of Atlantic salmon in 
their ability to respond to and clear IPNV. Certain families exhibited very high titres of 
the virus (1011 TCID 50 /g kidney) whilst others had very low titres (102 TCED50 /g 
kidney) due to the fact that certain individuals had cleared the virus altogether at 3 
weeks post injection. These differences are likely to be genetic since all the fish were 
injected and sampled on the same day and suggest that there is potential for 
improvement in resistance to IPN in Atlantic salmon that should be explored in the 
future.
Atlantic salmon smolts about to be put to sea are more often than not vaccinated with a 
triple vaccine against Aeromonas salmonicida, Vibrio anguilcirum and Vibrio 
salmonicida 6 weeks prior to seawater transfer. The family fish used in this study were 
vaccinated against Aeromonas salmonicida only two weeks prior to transfer due to an 
error at the fish farm. The time of experimental IPN challenge was delayed to 4 weeks 
post transfer as a result. This delay may have affected the success of the challenge, 
since in previous challenges the fish were challenged within 48 hours post transfer. 
This may also explain the Vibriosis mortalities experienced during the family challenge 
as only the vaccine against Aeromonas salmonicida was administered not the triple 
vaccine as planned.
Challenges with IPNV in Atlantic salmon fry have previously been successful (Taksdal 
et al., 1997, Ramstad et al., 1997). It is possible that the pattern of mortalities 
experienced with challenging different families of Atlantic salmon fry may be 
reproduced upon challenge with post-smolts. This requires the use of the same family
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groups, with the post-smolt challenge using the siblings of the fry. This is hampered by 
the lack of an experimental challenge model for IPNV in post-smolts. However it could 
be attempted in the future either with the use of an experimental challenge should one 
become available or using a field challenge aided by the use of microsatellites. Should 
there be a good correlation between the two for the purposes of disease resistance trials 
the problematic challenges with post-smolts would not be needed and could be replaced 
with a fry challenge alone.
It was found that neutralising antibody titre did not correlate to virus titre, this is in 
agreement with Reno (1976), Smail and Munro (1985), and Biering (1997). It is 
possible that neutralising antibodies only play a limited role in defence against IPNV in 
a natural infection, based on the statistically insignificant differences in neutralising 
antibody titres throughout the course of the progressing natural IPNV infection in the 
control fish. Lysozyme was also found not to correlate well with IPNV titre. This may 
have arisen due to the concurrent bacterial infection with Vibrio spp. that was not a 
problem for all fish. However the potential role of lysozyme in defence against IPNV 
has been demonstrated (Siwicki et a l, 1998) and this should be investigated further 
along with phagocytic cellular responses.
Many studies have been carried out into lysozyme activity (Mock and Peters, 1990, 
Roed et a l, 1993, Fevolden et al., 1994, Marsden et a l, 1996). The different methods 
used to measure lysozyme and expression of results, e.g. units/ml or units/g tissue 
allows for little comparison between studies. It is suggested that assays to measure not 
only lysozyme but also other parameters be standardised to aid comparison.
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During the course of the family challenge with IPNV the control fish were found to be 
IPNV positive despite the fact that the fish had been found negative prior to the 
challenge. Exactly how the fish became infected was not proven but it highlighted the 
need for highly sensitive diagnostic methods. This has previously been noted with 
many pathogens but particularly IPNV (Dixon and Hill, 1983, Lopez-Lastra et al., 1994, 
Bruneau et al., 1999). Various diagnostic methods were investigated in this study and 
tissue culture was found to be the most sensitive.
RT-PCR is perhaps the test with the greatest potential for high sensitivity and functions 
well as a test to confirm IPNV infection once CPE is present in cell culture. However 
due to the high concentration of nucleic acids in the kidney amplification from tissue 
samples it was problematic. The RNA tissue extraction kit was not able to remove all 
high molecular weight DNA, protein and RNA. The most efficient extraction method 
was Tri reagent, yielding only RNA, however due to the high concentration of RNA in 
the kidney the RT-PCR was found to be far less sensitive than cell culture. 
Nevertheless it may be possible to increase the sensitivity of the test with the treatment 
of extracted kidney and IPNV RNA with RNase A to remove ssRNA from the kidney 
(Nicholson, 1996).
I 7 5An ELISA test was developed with a sensitivity of 10 ““ TCIDso/ml, due to time 
constraints the ELISA could not be fully evaluated. The results did however indicate 
that it may function more efficiently if an alternative monoclonal antibody was chosen. 
Immunohistochemistry was shown to be a useful rapid diagnostic test, it allows the 
simultaneous evaluation of pathology and IPNV infection (Evensen and Rimstad, 1990) 
however is unlikely to be very sensitive.
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This study has evaluated the use of microsatellite analysis to genotype fish susceptible 
to EPNV and discussed the problems associated with it. Various diagnostic methods 
have been developed with a view to increasing the detection limit of IPNV, however 
cell culture remains the most sensitive method. This work has also provided a valuable 
insight into the responses of different families of Atlantic salmon to infection with 
IPNV under experimental conditions.
Disease resistant fish are the ideal solution to many disease problems. However this is a 
very long term goal and requires years of preparation and commitment particularly if 
disease resistance at the family level rather than strain is the goal. It also requires trial 
periods to iron out any unforeseen problems and a large amount of investment. Few 
fish farms are in a position to carry out this type of work or have the necessary 
experience. However it is a goal worth pursuing, particularly with IPN in light of the 
huge financial losses and the lack of either control methods or a suitable vaccine.
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Appendix 1 
Buffers and Media 
DNA Extraction Buffer
200mM Tris-HCl, pH 8.0 
250mM NaCl 
25mM EDTA 
0.5% SDS
Dissolve tris, NaCl and EDTA into nanopure water and autoclave. SDS was added after 
autoclaving from a 25% stock solution that had previously been filter sterilised.
/
TE Buffer I
O.lmM EDTA 
lOmM Tris
Dissolve both in 100ml nanopure water and alter pH to 8.0 with dilute HC1, autoclave.
TBE Buffer (lOx)
55g Boric acid 
108g Tris 
8.3g EDTA
Dissolve into nanopure water and filter using 0.45pm filter. Dilute 1:10 with nanopure 
water for use.
TNE Buffer
lOOmM NaCl 
20mM Trizma 
Im M ED TA
Dissolve all 3 into nanopure water, adjust to pH 7.5, and autoclave.
10% APS
0. lg  ammonium persulphate 
lm l nanopure water.
Dissolve.
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ABI loading dye - 25mM EDTA/50mg/ml blue dextran
0.93g EDTA
Add 90ml nanopure water, adjust to pH8 
Bring to 100ml with nanopure water.
Add 50mg blue dextran to 1ml of EDTA solution.
Tryptone soya agar+sodium chloride
20g TSA
7.5g sodium chloride
Mix and autoclave, pour when hand hot into 20 petri dishes.
10% Neutral Buffered Formalin
4g sodium dihydrogen phosphate (monohydrate)
6.5g disodium hydrogen phosphate (anhydrous)
100ml formaldehyde 
900ml distilled water
1 % Crystal Violet (500 ml)
Dissolve 5g crystal violet into 100 ml 95% ethanol. Make up to 500 ml with PBS. 
Dissolve and filter.
Safranine Solution
0.25g safranine 
10ml 95% ethanol 
90ml dH20
Iodine Solution
lg  iodine
2g potassium iodide 
300ml dH20
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Scotts tap water substitute
3.5g sodium bicarbonate 
20g magnesium sulphate 
11 tap water
Dissolve by heating if necessary, add several crystals of thymol to preserve.
Mayers Haemalum
2g haematoxylin
0.4g sodium iodate 
lOOg potassium alum 
2g citric acid 
lOOg chloral hydrate 
21 distilled water
Allow the haematoxylin, alum and sodium iodate to dissolve overnight in 21 of distilled 
water. Add chloral hydrate and citric acid, bring to the boil for 5 minutes.
1% Eosin
20g eosin yellowish
Dissolve in 500ml distilled water, top up to 21 with distilled water.
Putts Eosin
4g eosin yellowish 
2g potassium dichromate 
40ml saturated Aq picric acid 
40ml absolute ethanol 
320ml distilled water
Dissolve eosin and dichromate in the ethanol. Add distilled water then picric acid.
For final eosin solution
Mix 1 part Putts eosin with 8 parts 1% eosin.
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Sodium  Phosphate B uffer pH  6.2 (0.07M)
1. 5.5g sodium di-hydrogen orthophosphate in 200 ml dH20
2. 2.83g di-sodium hydrogen orthophosphate in 100 ml d ^ O
Take 122.1 ml of solution 1 and mix with 27.0 ml of solution 2. Add 276 ml dHiO and 
autoclave.
T ris B uffered Saline (TBS) pH  7.6 
50 mM Tris-HCl 
123 mM NaCl
ELISA  Buffers 
C hap ter 4 ELISA  
C arbonate  B uffer (pH  9.5)
1.5g/l sodium carbonate 
2.93g/l sodium bicarbonate 
0.2g/l sodium azide
PBS Thiom ersol (pH 7.2)
8.0g/l sodium chloride
0.2g/l potassium di-hydrogen orthophosphate 
1.4g/l disodium hydrogen orthophosphate 
0.2g/l potassium chloride 
0.2g/l thiomersol
PBST (pH 7.2)
PBS thiomersol with 0.5 ml Tween 20/litre 
PBSN (pH  7.2)
PBS thiomersol with 1 % sodium azide.
Chapter 5 ELISA 
Coating Buffer
Dissolve one carbonate-bicarbonate capsule (Sigma) into 100ml dH20 .
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Low Salt Wash Buffer (lOx)
24.2g trizma base 
222.2g sodium chloride 
lg  thiomersol 
5 ml Tween 20
Dissolve in 1 litre of dH20 and adjust pH to 7.3 with concentrated HC1.
High Salt Wash Buffer (lOx)
24.2g trizma base 
292.2g sodium chloride 
lg  thiomersol 
10 ml Tween 20
Dissolve in 1 litre of dH20 and adjust pH to 7.7 with concentrated HC1.
Phosphate Buffered Saline (PBS)
(0.02M phosphate, 0 .15M NaCl)
0.876g sodium di-hydrogen orthophosphate 
2.56g di-sodium hydrogen orthophosphate 
8.77g sodium chloride
Dissolve in 1 litre dH20  and adjust to pH 7.2.
Substrate Buffer
21g citric acid 
8.2g sodium acetate 
Adjust pH to 5.4.
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Appendix 2
Histology Methodology 
Processing Schedule
1. 50 % methylated spirit 1 hour
2. 80% methylated spirit 2 hours
3. 100% methylated spirit 2 hours
4. 100% methylated spirit 2 hours
5. 100% methylated spirit 2 hours
6. 100% ethanol 2 hours
7. 100% ethanol 2 hours
8. chloroform 1 hour
9. chloroform 1 hour
10. molten wax 2 hours
11. molten wax 2 hours
12. molten wax 2 hours
Haematoxylin and Eosin staining
1. Xylene (dewaxing) 5 min
2. Absolute alcohol 1 2 min
3. Methylated spirit 1.5 min
4. Wash in tap water
5. Haematoxylin 5min
6. Wash in tap water
7. Acid alcohol 3 quick
8. Wash in tap water
9. Schotts tap water 1 min
10. Wash in tap water
11. Eosin 5 min
12. Wash in tap water
13. Methylated spirit 30 sec
14. Absolute Alcohol II 2 min
15. Absolute alcohol I 1.5 min
16. Xylene (clearing) 5 min
17. Xylene (coverslip)
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A ppendix 3
G enotyping results and  allele coding
Table A -l: Results of Out Skerries mortalities parentage assignment
Fam ily N um ber of susceptible 
individuals assigned to 
family
2 2
4 2
14 2
19 4
29 3
67 2
69 4
71 3
72 2
74 5
75 2
76 2
81 2
94 4
102 3
113 4
150 3
152 2
Other families with only one offspring assigned to them:
1, 16, 23, 28, 42, 48, 50, 51, 56, 66, 70, 73, 77, 89, 90, 93, 95, 96, 100, 108, 116, 117, 
122, 147, 153, 162, 163.
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Allele A ssignm ent
Table A-2: Allele coding for each locus.
Assigned
le tter
Ssa202 Ssal71 Ssal97 Ssa85
A 240 200 164 123
B 244 212 168 125
C 248 216 172 131
D 252 220 176 133
E 256 224 180 135
F 260 228 184 136
G 264 232 188 138
H 268 236 192 140
I 272 238 196 145
J 276 245 200 147
K 250 204 149
L 205 208 151
M 218 212 155
N 240 220 157
O 222 244 159
P 252 142
Q 256
R 260
S 264
Double underline indicates alleles in 1996 year class only 
Single underline indicates alleles in 1997 year class only
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Appendix 4
Trends in temperature for each challenge at Aultbea
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Figure A -l: Seawater temperature trends during Passage 1 at Aultbea.
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Figure A-2: Seawater temperature trends during Passage 2 at Aultbea.
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Figure A-3: Seawater temperatures during the family challenge.
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